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ABSTRACT 
 
Role of Type IV Secretion Systems in Trafficking of Virulence Determinants of 
Burkholderia cenocepacia.  (August 2006) 
Amanda Suzanne Engledow, B.S., Texas A&M University 
Chair of Advisory Committee:  Dr. Carlos F. Gonzalez 
 
Type IV secretion systems have been identified in several human pathogens including 
Bordetella pertussis, Helicobacter pylori, and Legionella pneumophila. These systems 
are responsible for the translocation of virulence proteins and/or DNA, thereby playing 
an important role in the pathogenesis of infection and plasticity of genomes. 
Burkholderia cenocepacia is an important opportunistic human pathogen, particularly in 
persons with cystic fibrosis (CF).  Respiratory tract infection by B. cenocepacia in CF 
patients is often associated with a decline in respiratory function, and can result in acute 
systemic infection.  Burkholderia cenocepacia strain K56-2 is part of the epidemic and 
clinically problematic ET12 lineage. Two type IV secretion systems have been identified 
in this strain; one system is plasmid encoded (designated the Ptw type IV secretion 
system) whereas the other is chromosomally encoded (designated the VirB/D type IV 
secretion system) and shows homology to the Agrobacterium tumefaciens VirB/D4 type 
IV secretion system.  It was determined that the plasmid encoded Ptw system is a 
chimeric type IV secretion system composed of VirB/D4-like elements and F-specific 
subunits.  More recently, it was found that this system translocates a protein effector 
(PtwE1) that is cytotoxic to plant cells.   It was also determined that the positively 
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charged C-terminal region of PtwE1 is important for translocation via the Ptw type IV 
secretion system.  Strains of the epidemic B. cenocepacia PHDC lineage contain only a 
chromosomal VirB/D4-like type IV secretion system (designated BcVirB/D); and a 
putative effector protein associated with this system has been identified that has C-
terminal transport signal and sequences different from the effectors of the Ptw type IV 
secretion system. It has also been shown that a competing plasmid substrate and a 
plasmid fertility inhibition factor act to render B. cenocepacia of the PHDC lineage 
incapable of expressing a plant phenotype.  Thus, three type IV secretion systems have 
been identified in epidemic B. cenocepacia lineages.  From two of these, an effector has 
been identified that has cytotoxic effects on eukaryotic cells, and at least one of these 
type IV secretion systems is able to translocate DNA substrates.   
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CHAPTER I 
GENERAL INTRODUCTION 
 
Burkholderia cepacia was initially identified as the causative agent of soft rot of onion 
(Burkholder, 1950). Currently, this bacterium is a well-documented opportunistic 
pathogen of individuals with cystic fibrosis (CF) (Govan and Deretic, 1996, LiPuma, 
1998), a notable bioremediation agent (Tomasek et al., 1989), and an effective 
constituent in biological control practices of plant disease (Kang et al., 1998). Recently, 
comprehensive polyphasic taxonomic reassessment has shown that several distinct 
genomic species exist among bacterial isolates previously identified as “B. cepacia” 
based solely on phenotypic analysis (Gillis et al., 1995; Coenye et al., 2001a,b,c; 
Vandamme et al., 1997; Vandamme et al., 2000; Vandamme et al., 2002; Vandamme et 
al., 2003; Vermis et al., 2004). Each of the nine species in this group, which is now 
referred to collectively as the “B. cepacia complex” (Bcc), has received a formal 
binomial designation. Using 16S rDNA and recA directed species-specific PCR assays 
(LiPuma et al., 1999; Mahenthiralingam et al., 2000a), all nine Bcc species have been 
identified from sputum culture isolates recovered from approximately 1700 CF patients 
in the US (LiPuma et al., 2001; LiPuma, unpublished). The distribution of species 
however, is quite disproportionate. Approximately one-half of infected patients harbor B. 
cenocepacia, whereas 38% are infected with B. multivorans (LiPuma et al., 2001).  
 
_____________ 
This dissertation follows the style of Molecular Microbiology. 
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 In the mid-1980s, many CF treatment centers noted dramatically increasing rates of 
“B. cepacia” infection among their patients, with up to 45% of patients becoming 
infected in some centers. Studies by multiple laboratories employed genotyping analyses 
to identify the existence, in several treatment centers, of so-called “epidemic” strains that 
were common to multiple patients (LiPuma et al., 1988). In 1994, Johnson et al. (1994) 
used multilocus enzyme electrophoresis to identify a B. cepacia strain (designated ET12) 
that was especially common among CF patients in Ontario, Canada. Through presumed 
interpatient transmission at an international CF summer camp, this strain spread to the 
United Kingdom, where it now accounts for nearly one-half of Bcc-infected CF patients 
(Pitt et al., 1996). In another study, Kumar et al. (1997) used macro-restriction digestion 
with pulsed field gel electrophoresis (PFGE) analysis to demonstrate that 29 of 32 B. 
cepacia isolates from five CF centers in Michigan were the same strain type (since 
referred to as the Midwest clone). That same year, Mahenthiralingam et al. (1997) 
identified several other B. cepacia strains that also infected more than one CF patient. 
All of these studies preceded the appreciation that “B. cepacia” is actually comprised of 
multiple distinct species (as detailed above). Retrospective analyses of these ‘epidemic’ 
strains now indicate that all are B. cenocepacia. In contrast, relatively few ‘epidemic’ 
strains have been found in the other eight Bcc species. 
 Recently, another B. cenocepacia strain has been described, and designated PHDC, 
which is recovered from essentially all Bcc-infected CF patients in the mid-Atlantic 
region of the US (Chen et al., 2001). In a retrospective analysis of stored isolates using 
various genotyping methods, including random amplified polymorphic DNA (RAPD) 
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typing, repetitive element PCR typing (rep-PCR) and PFGE, the 20-year persistence of 
strain PHDC has been demonstrated in a large CF treatment center, and has uncovered 
the spread of this strain to a second center, apparently via a patient who transferred care 
between centers (Chen et al., 2001). Subsequently, this strain has been identified in 
agricultural soil from upstate New York onion fields (LiPuma et al., 2002), as well as in 
CF patients receiving care in 24 US states (Liu et al., 2003) and Europe (Coenye et al., 
2004).  
  Relatively little is known regarding specific virulence factors or pathogenic 
mechanisms of the Bcc (Hutchison and Govan, 2000). Postulated virulence determinants 
for B. cenocepacia include hemolysins (Hutchison et al., 1998; Vasil et al., 1990), 
siderophores (Sokol et al., 1999), and cable pili (Sajjan et al., 2000b). A hemolysin 
induces apoptosis and degranulation of phagocytes (Hutchison et al., 1998), and 
siderophore production, regulated by quorum sensing (Lewenza et al., 1999), may play a 
role in colonization of animal lung and spleen tissues (Sokol et al., 1999). 
 Studies in our laboratory have established that in the plant pathogenic B. cepacia type 
strain ATCC 25416, a plasmid encoded pectate hydrolase (Peh), is a virulence factor 
necessary for maceration of onion tissue (Gonzalez et al., 1997). Derivatives of ATCC 
25416 that have been cured of the Peh-encoding plasmid do not macerate onion tissue. 
However, the Peh negative derivatives remain capable of causing a plant tissue 
watersoaking (ptw) phenotype that results from loss of cell membrane integrity and the 
accumulation of fluids in the intracellular spaces of plant tissue (Gonzalez et al., 1997). 
Knockout mutants for the ptw phenotype cured of the Peh-encoding plasmid caused no 
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symptoms on plant tissue. Introduction of the cloned pehA into the ptw-negative, Peh-
negative mutants failed to restore the plant tissue maceration phenotype, although Peh 
was expressed and secreted in vitro. These results indicate that Peh is a virulence factor, 
whereas the ptw phenotype is a pathogenicity factor since bacteria do not cause 
symptoms on plant tissue without this function. In a survey of Bcc species, we found that 
only B. cepacia and B. cenocepacia strains (and one B. vietnamiensis) produced the ptw 
phenotype, suggesting that members of these genomic species may produce a cytotoxic 
factor(s) that affects eukaryotic cell integrity (Engledow et al., 2004). 
 In recent years, a body of research has substantiated the concept that bacterial 
pathogens share common secretion mechanisms for the delivery of virulence 
determinants (Christie and Vogel, 2000; Plano et al., 2001). There are numerous 
examples of the importance of type III (Plano et al., 2001) and type IV secretion systems 
(Christie, 2001) in the infection process for both plant and animal pathogens, with 
evidence that elements of the secretion systems show an ancestral relationship to 
bacterial transport machinery. It has been hypothesized that type III secretion systems 
are derived from flagellar assembly constituents modified to function as a transport 
mechanism for virulence factors (Macnab, 1999). The type IV secretion system from 
Agrobacterium tumefaciens was the first to be identified and is used to deliver oncogenic 
transfer DNA and effector proteins to plant cells during infection (Christie, 2001; Kumar 
and Das, 2002). Presently, type IV secretion systems can be categorized as (i) 
conjugation systems that mediate DNA transfer to recipient cells, (ii) effector 
translocator systems that transfer molecules termed effectors to eukaryotic cells during 
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infection, or (iii) DNA uptake or release systems mediating exchange of DNA with the 
milieu (Ding et al., 2003). The Legionella pneumophila Dot/Icm transporter is an 
example of a type IV secretion system that is capable of both conjugation and effector 
translocation (e.g., RalF) (Nagai and Roy, 2003). Helicobacter pylori possesses two type 
IV secretion systems with differing roles. The Cag secretory apparatus functions in the 
translocation of CagA into host cells, and the Com system is used to uptake DNA to 
facilitate genetic variation and enhance cell survival (Ding et al., 2003; Dhar et al., 
2003). 
 Recently, a plasposon mutagenesis system was used to generate 5000 random 
mutants, of ET12 strain K56-2, which were screened for ptw activity using the plant 
tissue assay. Genomic analysis of the ptw-negative mutants identified a cluster of genes 
that encoded proteins with similarities to components of type IV secretion systems, and 
appeared to play a role in the expression of the ptw phenotype. Because of the known 
importance which translocation systems play in the delivery of virulence determinants it 
is important to determine if B. cenocepacia possesses a similar system, what substrate(s) 
that system is transporting, and whether or not it is necessary for pathogenicity in the 
plant and/or human systems. 
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CHAPTER II 
INVOLVEMENT OF A PLASMID ENCODED TYPE IV SECRETION SYSTEM 
IN THE PLANT TISSUE WATERSOAKING PHENOTYPE OF  
Burkholderia cenocepacia AND THE STIMULATION OF IL-8 RELEASE FROM 
BRONCHIAL EPITHELIAL CELLS* 
 
INTRODUCTION 
 
 The Burkholderia cepacia complex (Bcc) consists of nine genomovars recently 
elevated to species status (Coenye et al., 2001a, b, c; Vandamme et al., 2002; 
Vandamme et al., 2003; Vermis et al., 2004).  Members of the Bcc include plant and 
animal pathogens as well as catabolically active soil saprophytes (Tomasek et al., 1989).  
Some Bcc members can cause life-threatening respiratory infections particularly in 
persons with cystic fibrosis (CF) (LiPuma, 2003).  Studies indicate that 85 to 90% of 
strains isolated from infected CF patients are B. cenocepacia or B. mulitvorans, with 
other Bcc species infrequently isolated (LiPuma, 1998).  Several epidemic clonal 
lineages of B. cenocepacia have been identified (Coenye and LiPuma, 2002), including:  
the ET12 lineage, which is responsible for infecting many CF patients in Canada and the 
_____________ 
* Part of the data reported in this chapter is reprinted with permission from 
“Involvement of a plasmid-encoded type IV secretion system in the plant tissue 
watersoaking phenotype of Burkholderia cenocepacia” by Engledow, A.S, Medrano 
E.G, Mahenthiralingam, E, LiPuma, J.J., and Gonzalez, C.F. (2004) J Bacteriol 186: 
6015-6024. Copyright 2004 by American Society of Microbiology. 
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UK (Johnson et al., 1994; Ledson et al., 2002); the PHDC lineage, responsible for nearly 
all Bcc infections in the mid-Atlantic region of the USA (Chen et al., 2001); and the 
Midwest lineage that is responsible for infecting numerous patients in CF centers in the 
mid-western region of the USA (LiPuma et al., 2001). Factors that account for the 
apparent enhanced capacity of epidemic clones for human infection are unknown.   
 Postulated clinically associated virulence determinants for B. cenocepacia include 
hemolysins (Hutchison et al., 1998; Vasil et al., 1990), siderophores (Sokol et al., 1999), 
and cable pili (Sajjan et al., 2000a).  The hemolysin induces apoptosis and degranulation 
of phagocytes (Hutchison et al., 1998), and siderophore production, regulated by quorum 
sensing (Lewenza et al., 1999), plays a role in the primary colonization process of 
animal lung and spleen tissues (Sokol et al., 1999).  Cable pili are important in 
adherence to the respiratory mucosal blanket and epithelial cells (Sajjan et al., 2000a).   
 In B. cepacia type strain ATCC 25416, a plant pathogenic representative of the Bcc, a 
plasmid encoded pectate hydrolase (Peh) is a virulence factor necessary for maceration 
of onion tissue (Gonzalez et al., 1997).  Derivatives of ATCC 25416 that have been 
cured of the Peh-encoding plasmid do not macerate onion tissue.  However, the Peh-
negative derivatives remain capable of causing a plant tissue watersoaking (ptw) 
phenotype that results from loss of cell membrane integrity and the accumulation of 
fluids in the intracellular spaces of plant tissue (Frederick et al., 2001).  In a survey of 
isolates from the Bcc experimental strain panel (Mahenthiralingam et al., 2000b), we 
found that all of the B. cepacia and B. cenocepacia strains tested and one B. 
vietnamiensis produced the ptw phenotype, suggesting that members of these genomic 
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species may produce a cytotoxic factor(s) that affects plant cell integrity (Medrano, 
2002). 
 In recent years, a body of research has substantiated the concept that bacterial 
pathogens share common secretion mechanisms for the delivery of virulence 
determinants (Christie and Vogel, 2000; Plano et al., 2001).  There are numerous 
examples of the importance of type III (Plano et al., 2001) and type IV secretion systems 
(Christie, 2001) in the infection process for both plant and animal pathogens, with 
evidence that elements of the secretion systems show an ancestral relationship to 
bacterial transport machinery.  It has been hypothesized that type III secretion systems 
are derived from flagellar assembly constituents modified to function as a transport 
mechanism for virulence factors (Macnab, 1999).  The type IV secretion system from 
Agrobacterium tumefaciens was the first to be identified and is used to deliver oncogenic 
transfer DNA and effector proteins to plant cells during infection (Christie, 2001; Kumar 
and Das, 2002).  Currently, type IV secretion systems can be categorized as (i) 
conjugation systems that mediate DNA transfer to recipient cells; (ii) “effector 
translocator” systems that transfer molecules termed effectors to eukaryotic cells during 
infection; or (iii) “DNA uptake or release” systems mediating exchange of DNA with the 
milieu (Ding et al., 2003).  The Legionella pneumophila Dot/Icm transporter is an 
example of a type IV secretion system that is capable of both conjugation and effector 
translocation (e.g. RalF) (Nagai and Roy, 2003).  Helicobacter pylori possesses two type 
IV secretion systems with differing roles.  The Cag secretory apparatus functions in the 
translocation of CagA into host cells, and the Com system is used to uptake DNA to 
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facilitate genetic variation and enhance cell survival. (Ding et al., 2003; Dhar et al., 
2003). 
 Recently, bacterial type IV secretion systems also have been implicated in playing a 
major role in inducing inflammatory responses from infected host tissues (Bauer et al., 
2005).  For example, effector proteins translocated from bacterial to host cells via type 
IV secretion systems stimulated an intense inflammatory response from epithelium 
infected by H. pylori or Bartonella henselae (Bauer et al., 2005; Schmid et al., 2004).  
Of particular interest to our studies is the growing appreciation of the roles that type IV 
secretion systems play in the virulence of certain human respiratory pathogens, including 
B. pertussis and L. pneumophilia (Christie, 2001).  Infection mediated lung inflammation 
is a major cause of morbidity and mortality in persons with CF (Chmiel and Davis, 
2003; Hilliard et al., 2002).  Airway epithelium plays an important role in lung 
inflammation by expressing C-X-C chemokines, including interleukin 8 (IL-8), in 
response to invading pathogens (Strieter, 2002).  Pathogens that are capable of 
stimulating high levels of chemokines from infected airway epithelium thereby likely 
add to the severity of the inflammation-induced lung disease that is a hallmark of CF.   
  This study reports on the presence of both a plasmid and a chromosomally 
encoded type IV secretion system in B. cenocepacia strain K56-2, describes the 
involvement of the plasmid encoded system in the export of a putative protein(s) 
responsible for the ptw phenotype, and shows that the Ptw type IV secretion system is 
involved in the induction of an IL-8 response of brochial epithelial cells as well as 
production of the ptw phenotype. 
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EXPERIMENTAL PROCEDURES 
 
Media and growth conditions 
 
Descriptions of plasmids and bacterial strains used in this study are listed in Tables 2.1 
and 2.2, respectively.  Luria Bertanni (LB) medium was used for routine maintenance of 
cultures.  Minimal medium Vogel Bonner (Vogel and Bonner, 1965) amended with 
1.0% glucose (VBG) was used in mating experiments.  Minimal medium M9 (Sambrook 
et al., 1989) containing 1.0% glucose was used for culturing bacteria for supernatant 
analysis.  Burkholderia cenocepacia and Escherichia coli strains were grown at 37ºC.  
Media were supplemented with appropriate concentrations of antibiotics as needed for 
selection.  Antibiotics were added to media at the following concentrations; 500µg/ml of 
chloramphenicol (Cm) and 500µg/ml of trimethoprim (Tp) for selection and 
maintenance of B. cenocepacia; and 10 µg/ml tetracycline (Tc), 10 µg/ml gentamicin 
(Gm), 40 µg/ml ampicillin and 100 µg/ml Tp for E. coli. 
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Table 2.1. Plasmids used in Chapter II. 
Plasmid Relevant Characteristicsa Reference 
pK56-2 92 kb resident plasmid of B. cenocepacia strain K56-2 
containing the ptw cluster. 
This study 
pDrive Cloning Vector:  Kmr, Apr, pUC origin, T7, SP6, lacZα+ Qiagen 
pRK2013 Kmr, Tra+, Mob+, ColE1 replicon Figurski and Helinski, 
1979 
pBR325 Tcr, Apr, Cmr, ColE1 replicon Blank and Wilson, 1982 
pR388 IncW, Sur, Tpr Datta and Hedges, 1972 
pTnMod-RTp’ Tn5, R6K oriR, Tpr Dennis and Zlystra, 1998 
pScosBC1 cosmid with K56-2 genomic library Sokol et al., 1999 
pSBC-9F5 pScosBC1 with K56-2 genomic DNA containing ptwD4 and 
ptwC 
This study 
pSBC-3H3 pScosBC1 with K56-2 genomic DNA containing ptwB4 and 
ptwB10 
This study 
pJQ200SK Gmr, sacB, Mob+, P15A replicon Quandt and Hines, 1993 
pURF047 IncW, Ampr, Gmr, Mob+, lacZα+, Par+, derivative of pURF043 Swarup et al., 1991 
pASE101 pURF047 with 2.0 kb Tpr cassette inserted at ScaI site of Apr 
cassette 
This study 
pASE102 pJQ200SK containing 10 kb BamHI fragment (pSBC-9F5) 
containing ptwD4 and ptwC inserted in the MCS 
This study 
pASE103 pJQ200SK containing 11 kb BamHI fragment (pSBC-3H3) 
containing ptwB4 and ptwB10 inserted in the MCS 
This study 
pASE104 pASE101 containing 10 kb BamHI fragment (pSBC-9F5) 
containing ptwD4 and ptwC inserted in the MCS 
This study 
pASE105 pASE101 containing 11 kb BamHI fragment (pSBC1-3H3) 
containing ptwB4 and ptwB10 inserted in the MCS 
This study 
pASE106 PASE102 with 1.9 kb Tcr cassette from pBR325 inserted in the 
EcoRV site of ptwD4 
This study 
pASE107 pASE102 with 1.9 kb Tcr cassette from pBR325 inserted in the 
ScaI site of ptwC 
This study 
pASE108 pASE103 with 1.9 kb Tcr cassette from pBR325 inserted in the 
ApaI site of ptwB4 
This study 
pASE109 pASE103 with 1.9 kb Tcr cassette from pBR325 inserted in the 
SacI site of ptwB10 
This study 
pDrive-virB6 pDrive containing 1.5 kb PCR product containing virB6 This study 
pDrive-virB11 pDrive containing 1.9 kb PCR product containing virB11 This study 
pJQ200SK -virB6 pJQ200SK containing virB6 from pASE110 This study 
pJQ200SK –
virB11 
pJQ200SK containing virB11 from pASE111 This study 
pJQ200SK -
virB6::Tc 
pASE112 with 1.9 kb Tcr cassette from pBR325 inserted into 
the SalI site of virB6 
This study 
pJQ200SK -
virB11::Tc 
pASE113 with 1.9 kb Tcr cassette from pBR325 inserted into 
the HindIII site of virB11 
This study 
a Apr, Cmr, Kmr, Sur, Tcr, and Tpr = resistance to ampicillin, chloramphenicol, kanamyacin, sulphonamide, 
tetracycline, and trimethoprim, respectively. Ptw=plant tissue watersoaking phenotype. + and – =  positive and 
negative for phenotype, respectively.
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Table 2.2. Bacterial strains used in Chapter II. 
Strain Relevant Characteristicsa, b Reference 
Burkholderia cenocepacia   
K56-2 CF respritory isolate, ptw+ Sokol et al., 1999 
GM237 K56-2 ptwD4::RTp', ptw- This study 
GM238 K56-2::RTp', ptw+ This study 
GM241 K56-2::RTp', ptw- This study 
GM242 K56-2 ptwD4::RTp', ptw- This study 
GM243 K56-2::RTp', ptw- This study 
AE307 K56-2 ptwD4::Tc, ptw- This study 
AE320 K56-2 ptwC::Tc, ptw+ This study 
AE321 K56-2 ptwB4::Tc, ptw- This study 
AE322 K56-2 ptwB10::Tc, ptw- This study 
AE310 AE307 (pASE104), ptw+ This study 
AE323 AE321 (pASE105), ptw+ This study 
AE324 AE322 (pASE105), ptw+ This study 
AE360 K56-2 virB6::Tc, ptw+ This study 
AE361 K56-2 virB11::Tc, ptw+ This study 
   
Escherichia coli   
DH10B F−, mcrA, ∆(mrr-hsdRMS-
mcrBC), φ80dlacZ∆M15, 
∆lacX74, deoR, recA1, endA1, 
araD139, ∆(ara, leu)7697, 
galU,galK1, rpsL, nupG 
Life Technologies, Inc. 
(Gaithersburg, MD) 
HB101 F-, recA13 Boyer and Roulland-
Dussoix, 1969 
CC118λpir ∆lacX74, galE, galK, thi-1, 
rpsE, rpoB, recA1, lysogenized 
with λ pir phage 
Herrero et al., 1990 
a Tcr, and Tpr = resistance to tetracycline, and trimethoprim, respectively. Ptw=plant tissue watersoaking   
phenotype. + and – = positive and negative for phenotype, respectively.
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Plant tissue assay and growth study 
 
Plant tissue watersoaking (ptw) activity was determined as previously described 
(Gonzalez et al., 1997).  Onion cultivar 1015Y was used for plant tissue assays.  Onion 
bulb scales were pierced and then inoculated, in triplicate, with 10 µl of an aqueous 
suspension of the isolate being tested as previously described (Gonzalez et al., 1997).  
Aqueous bacterial suspensions were adjusted spectrophotometrically (A425 = 0.5) to yield 
a final concentration of ~106 CFU/scale.  Sterile double distilled-deionized water was 
used as a negative control and strain K56-2 served as the positive control in all 
experiments.  Scales were placed on a sheet of aluminum foil that had been surface 
sterilized with 70% ethanol in containers layered with paper towels that were moistened 
with double distilled-deionized water, sealed, and incubated at 37ºC.  Plant tissue 
watersoaking activity was assessed at 24, 48, and 72 h post-inoculation by measuring the 
vertical and horizontal diameters of the zones for triplicate samples in three independent 
experiments.  Data were reported as the average area of tissue watersoaking ± SD for the 
three independent experiments in triplicate. 
 To obtain a quantitative measure of growth in plant tissue, for strains K56-2, AE307, 
and AE310, bulb scales were inoculated with an aqueous suspension of the strains as 
described above.  At 0, 24, 48 and 72 h post inoculation watersoaked zones were 
measured and tissue was processed to determine the bacterial population.  Scales were 
commuted and crushed in 0.0125M phosphate buffer pH 7.1 containing Triton X-100 
(0.01%) using a sterile mortar and pestle.  A dilution series of each tissue slurry was 
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plated to LB agar amended with 10µg/ml of Gm and 10µg/ml of Tc and incubated at 
37ºC for 48 h.  Population data for each time interval was expressed as the average 
CFU/g of tissue ± SD for three independent experiments in triplicate.  Tissue 
watersoaking data were reported as the average area of watersoaking ± SD for three 
independent experiments in triplicate. 
 
Activity testing of culture supernatants 
 
Cultures of strain K56-2, AE307 (K56-2 ptwD4-Tc), and AE310 (K56-2 ptwD4-Tc 
complement) were grown at 37ºC in M9 medium and harvested at late exponential phase 
(A425 = 0.9) by centrifugation (16,000 x g, 15 min at 5ºC).  Supernatants (1 L) were filter 
sterilized using 0.22 µM filters (Pall) and concentrated to 3 ml using an Amicon 
ultrafiltration stirred cell (MWCO 10,000).  Protein concentration of supernatant 
concentrates was determined by the method of Koch and Putnam (1971).  Concentrated 
uninoculated medium (1L) served as the negative control. 
 Plant protoplasts were used as the plant tissue system to obtain a quantitative 
measurement of activities of concentrated culture supernatants.  Initial testing 
demonstrated that onion and carrot protoplasts were similar in sensitivity, and carrots 
were chosen because the presence of chromoplasts facilitated a more accurate evaluation 
of plasmolytic activity.  Protoplasts were obtained using the following procedure (Jones 
et al., 1990).  Young carrots were placed in a 10% sodium hypochlorite solution for 5 
min and then rinsed four times with sterile double distilled-deionized water.  The 
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epidermis was resected with a sterile scalpel and discarded.  Cortical and phloem tissues 
were obtained, diced into fragments ~2 mm in width and placed in a sterile petri dish 
containing 20 ml of a filter sterilized enzyme solution.  The enzyme solution contained 
10% mannitol (Fisher), 1.5% cellulase (CalBiochem), 0.25% macerase (CalBiochem), 
and 0.75% bovine serum albumin (BSA) fraction V (Sigma) (Jones et al., 1990).  Tissue 
was digested in the dark for 5 h at 28ºC with gentle shaking (50 rpm).  The carrot tissue 
was strained through nylon mesh and centrifuged (825 x g for 5 min at 25ºC).  The 
supernatant was removed using a pipette, avoiding disturbance of the protoplasts.  The 
protoplasts were washed with 20 ml of 10% mannitol by resuspending with gentle 
swirling and centrifuged.  The supernatant was removed and the pellet was gently 
resuspended in 10 ml of 10% mannitol and a 5 ml 20% sucrose cushion was carefully 
layered in the bottom of the tube.  The sample was centrifuged, and the protoplasts were 
collected from the interface and counted using a hemacytometer (Hausser Scientific).  
On average, 1.8 x 106 protoplasts/ml were obtained. 
 The plasmolytic activity of supernatants was determined by using concentrates 
standardized to a protein concentration of 0.2 µg/ml in 10% mannitol.  The standardized 
concentrates as well as dilutions (1:1, 1:5, and 1:10) were added to protoplasts.  Assay 
mixtures and controls were incubated in 96-well microtiter plates (Corning) with an 
average concentration of 50 protoplasts per well.  Assays, done in triplicate, were 
observed for changes in protoplast integrity at 2 h intervals for 8 h using a Zeiss inverted 
microscope.  In addition, the effect of temperature on plasmolytic activity was tested by 
heating concentrates to 100ºC for 10 min or, 80º, 65º, or 37ºC for 1 h.  Concentrates 
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were also individually treated with 1 mg/ml final concentrations of: proteinase K 
(Boehringer Mannhein) dissolved in 0.05 M Tris-HCl, pH 8; DNase I (Sigma, 3200 
units/mg) in 50 mM Tris-HCl, pH 7.5, 10mM MgCl2, and 50 µg/ml BSA; or RNase A 
(Sigma, 100 units/mg) in 0.25 M Tris-HCl, pH 6.8.  All reactions were incubated at 
temperatures optimal for each enzyme’s activity and were then adjusted to 10% mannitol 
before mixing with protoplasts.  Each incubation duration was performed in duplicate in 
three independent experiments with an average of 50 protoplasts examined at 0, 2, 4, 6, 
and 8 h.  Data were expressed as percent plasmolysis ± SD for three independent 
experiments.  Plasmolysis was analyzed as a function of time, dilution, treatment, and 
their interactions.  Level of statistical significance of the different variables was 
determined with an analysis of variance (ANOVA).  Statistical analysis was performed 
using SAS software and the general linear model procedure (SAS Institute Inc.).    
 
Mating experiments 
 
For triparental matings, donor, mobilizer and recipient suspensions were made in LB 
broth from cultures grown on solid media under selective conditions, as appropriate, for 
18 h. Bacterial suspensions were adjusted spectrophotometrically (A600 = 0.5), mixed at 
an equal ratio (1:1:1), and transferred to a positively charged sterile membrane layered 
on a 100 x 15 mm LB agar petri dish.  Following a 6 h incubation period, the cells from 
the mating and respective controls were washed twice in phosphate buffer (0.125 M, pH 
7.1) by centrifugation (12,096 x g for 10 min at 5ºC).  The bacterial pellets were 
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suspended in phosphate buffer and dilution plated to VBG amended with 500 µg/ml of 
Tc and/or 500 µg/ml of Tp.  Single colony isolates of individual transconjugants were 
obtained by streaking on selective media.  Cultures were subjected to survey lysis 
followed by agarose gel electrophoresis (Gonzalez and Vidaver, 1979) to confirm 
plasmid transfer.  
 
Plasposon mutagenesis 
 
The plasposon pTnMod-RTp’ was employed to obtain initial ptw-negative K56-2 
mutants of strain K56-2 (Dennis and Zylstra, 1998).  Transconjugants were selected on 
VBG supplemented with 500 µg/ml of Tp.  After 48 h of incubation at 37ºC, isolated 
colonies were transferred to homologous media to confirm selection.  Trimethoprim 
resistant transconjugants were evaluated for ptw activity using the onion tissue assay.  
Transconjugants that no longer demonstrated the ptw phenotype were single colony 
purified, retested, and retained for further analysis. 
 
DNA isolation and sequence analysis 
 
Genomic DNA was extracted from plasposon generated ptw-negative K56-2 mutants 
using a DNeasy Kit (Qiagen).  Three micrograms of DNA were digested with PstI and 
self-ligated using T4 DNA ligase (New England Biolabs).  The resulting plasmids were 
transformed into E. coli CC118 λ pir by CaCl2 transformation (Sambrook et al., 1989) 
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and selected on LB agar amended with 100 µg/ml of Tp.  Survey lysis and agarose gel 
electrophoresis were conducted to confirm the presence of plasmid DNA in the 
transformants.  Plasmid DNA for sequencing was extracted using a HiSpeed Plasmid 
Midi Kit (Qiagen).  Primers designed from the 5’ and 3’ termini of the plasposon insert 
were designated RTp1 and RTp2 (Table 2.3), respectively, and were used to sequence 
the cloned genomic DNA from B. cenocepacia strain K56-2.  Sequencing was conducted 
by the Institute of Developmental and Molecular Biology, Gene Technologies 
Laboratory at Texas A&M University.  MacVector 7.0 (Oxford Molecular Ltd.) was 
used for DNA sequence analysis.  DNA sequence for B. cenocepacia strain J2315 was 
produced by the Pathogen Sequencing Group at the Sanger Institute, Hinxton, 
Cambridge and can be obtained from http://www.sanger.ac.uk/Projects/B cenocepacia/. 
 
Site-directed mutagenesis 
 
Using PCR analysis, ptwD4, ptwC, ptwB4, and ptwB10 were found to be located on two 
cosmids from a previously constructed K56-2 library (Sokol et al., 1999).  Primer sets 
PD4 (PD4-1 and PD4-2), PC (PC-1 and PC-2), PB4 (PB4-1 and PB4-2), and PB10 
(PB10-1 and PB10-2) (Table 2.3) were designed based on sequence data from the B. 
cenocepacia Genome Project.  Each PCR reaction (50 µl) was performed using a Taq 
PCR Core Kit (Qiagen) and a GeneAmp 2700 (Applied Biosystems).  Reactions were 
run for 25 cycles and parameters were as follows:  denaturation at 95ºC for 30 sec; 
annealing at 55, 52, 56.5, and 54ºC for 1 min for primer sets PD4, PC, PB4, and PB10 
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(Table 2.3) respectively; and extension at 72ºC for 1 min 15 sec.  Resulting products 
were analyzed by agarose gel electrophoresis.  It was determined that cosmid pSBC-9F5 
contained ptwD4 and ptwC, and that pSBC-3H3 harbored ptwB4 and ptwB10, 
respectively.  Genes ptwD4, ptwC, ptwB4, and ptwB10, were disrupted using site-
directed mutagenesis.  A 10 kb BamHI fragment from pSBC-9F5 and an 11 kb BamHI 
fragment from pSBC-3H3 were individually inserted into the MCS of pJQ200SK to 
construct pASE102 and pASE103, respectively.  Plasmids pASE102 and pASE103 were 
transformed into E. coli DH10B by electroporation (25 µF; 2.5 kV; 200 Ω) followed by 
selection on LB agar amended with 10µg/ml of Gm.  Orientation of inserted DNA was 
determined by restriction enzyme digest analysis using SmaI.  Only plasmids containing 
insertions that were in-frame were used in the subsequent experiments.  Using pASE102, 
plasmids pASE106 and pASE107 were constructed by inserting a Tc-resistance cassette, 
obtained as a 1.9 kb fragment from pBR325 (Blank and Wilson, 1982), into the EcoRV 
and ScaI sites of ptwD4 and ptwC, respectively.  Plasmids pASE108 and pASE109 were 
constructed by inserting the Tc-cassette into the ApaI and SacI sites of ptwB4 and 
ptwB10, of pASE103, respectively.  Constructs pASE106, pASE107, pASE108, and 
pASE109 were electroporated into E. coli DH10B and transformants were selected on 
LB agar amended with 10 µg/ml of Tc and 10 µg/ml of Gm.   
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Table 2.3. Primers used in Chapter II. 
Primera Gene Relevant Characteristics Reference 
RTp1 Tpr cassette 5'-GGTACCGTCGACATGCATGG-3' This study 
RTp2 Tpr cassette 5'-CAGTGCAAATTTATCCTGTG-3' This study 
PD4-1 ptwD4 5'-TGACTCAGCGAAGGAA-3' This study 
PD4-2 ptwD4 5'-ATCCGGTGGAAGCAA-3' This study 
PC-1 ptwC 5'-CACTCCGACATCGAAT-3' This study 
PC-2 ptwC 5'-AACTGTGTAGGACACT-3' This study 
PB10-1 ptwB10 5'-ATGCTTGTCGATGTTGCA-3' This study 
PB10-2 ptwB10 5'-TTCCGACGACTTCCAT-3' This study 
PB4-1 ptwB4 5'-AACTCAAGATGAATCAT-3' This study 
PB4-2 ptwB4 5'-AGAACGCATGGTGTTGA-3' This study 
VB1-1 virB1 5’-GACAGATCATGCGTGT-3’ This study 
VB1-2 virB1 5’-AGGAGGAGACACAGGAGT-3’ This study 
VB4-1 virB4 5’-ATCGCACTGTTGATCGTTG-3’ This study 
VB4-2 virB4 5’-TCACGTTACGTGTGCATAC-3’ This study 
VB6-1 virB6 5’-AAGGTGGTGTTCTATGAA-3’ This study 
VB6-2 virB6 5’-ACAGTACGATATGCGTGAA-3’ This study 
VB11-1 virB11 5’-TTCAAGTAACGATTGCTGA-3’ This study 
VB11-2 virB11 5’-TGCAAATCGAGTTCTGGTA-3’ This study 
VD4-1 virD4 5’-TGTTATGAGACAGATTGCA-3’ This study 
VD4-2 virD4 5’-AGATAAGGATGGTCAGGT-3’ This study 
a 1=forward primer; 2=reverse primer.  
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 Insertion of the Tc-resistance cassette was confirmed by restriction enzyme digest 
analysis using BamHI and PCR using primer sets PD4, PC, PB4, and PB10 (Table 2.3) 
to confirm a 1.9 kb increase in plasmid size and PCR product, respectively. Plasmids 
pASE106, pASE107, pASE108, and pASE109 were individually mobilized into K56-2 
by utilizing pRK2013 in triparental matings (plated to VBG amended with 500 µg/ml of 
Tc), to yield genetic exchange mutants.  Tetracycline resistant transconjugants were 
single colony purified and retested for Tcr.  PCR using primer sets PD4, PC, PB4, and 
PB10 and plasmid survey lysis were used to confirm allelic exchange, reflected by the 
increase in PCR product and loss of the suicide vector.  Single colony isolates were 
tested for the ptw phenotype. 
 Genes virB6 and virB11, from the chromosomally located type IV secretion system, 
were disrupted by site-directed mutagenesis.  Primer sets VB6 (VB6-1 and VB6-2) and 
VB11 (VB11-1 and VB11-2) (Table 2.3) were designed based on sequence data from the 
Sanger Centre.  Each PCR reaction was performed as described above except that the 
cycle parameters were as follows:  denaturation at 95˚C for 30 sec; annealing at 57.5 and 
56˚C for 1 min for primer sets VB6 and VB11, respectively; and extension at 72˚C for 1 
min 15 sec.  PCR products were individually ligated into vector pDrive (Qiagen) and 
transformed into E. coli DH10B by electroporation followed by selection on LB agar 
amended with 40 µg/ml of Ap to yield pDrive-virB6 and pDrive-virB11, respectively.  
Genes virB6 and virB11 were excised from pDrive-virB6 and pDrive-virB11, 
respectively by double digestion using restriction enzymes PstI and XhoI and 
individually inserted into the MCS of pJQ200SK to construct pJQ200SK-virB6 and 
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pJQ200SK-virB11, respectively.  Plasmids pJQ200SK-virB6 and pJQ200SK-virB11 
were transformed into E. coli DH10B by electroporation followed by selection on LB 
agar amended with 10 µg/ml of Gm.  Using pJQ200SK-virB6 and pJQ200SK-virB11, 
plasmids pJQ200SK-virB6::Tc and pJQ200SK-virB11::Tc were constructed by inserting 
a Tc-resistance cassette, from pBR325, into the SalI and HindIII sites of virB6 or virB11, 
respectively.  Constructs pJQ200SK-virB6::Tc and pJQ200SK-virB11::Tc were 
individually electroporated into E. coli DH10B and transformants were selected on LB 
agar amended with 10 µg/ml of Tc and 10 µg/ml of Gm.  Insertion of the Tc-resistance 
cassette was confirmed by restriction enzyme digest analysis using BamHI and PCR 
primer sets VB6 and VB11 to confirm a 1.9 kb increase in plasmid size and PCR 
product, respectively.  Plasmids pJQ200SK-virB6::Tc and pJQ200SK-virB11::Tc were 
individually mobilized into K56-2 by triparental matings, to yield genetic exchange 
mutants.  Tetracycline resistant transconjugants were single colony purified and retested 
for Tcr.  PCR using primer sets VB6 and VB11 and plasmid survey lysis were used to 
confirm allelic exchange, reflected by the increase in PCR product and loss of the 
suicide vector.  Single colony isolates were tested for the ptw phenotype.   
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Complementation of disrupted genes 
 
Complementation of the disrupted ptwD4, ptwB4, or ptwB10 were accomplished in 
trans.  Plasmid pURF047 (Swarup et al., 1991) was amended by inserting a Tp-
resistance cassette, obtained from R388 as a BamHI fragment, into the ScaI site in the 
bla gene to obtain pASE101.  A 10 kb BamHI fragment from pSBC-9F5 that contained 
ptwD4, and an 11 kb BamHI fragment from pSBC-3H3 that contained ptwB4 and 
ptwB11 were individually inserted into the MCS of pASE101 resulting in pASE104 and 
pASE105, respectively.  Plasmids pASE104 and pASE105 were electrotransformed into 
E. coli DH10B, followed by selection on LB agar amended with 100 µg/ml of Tp and 10 
µg/ml of Gm.  Orientation of inserted DNA was determined by restriction enzyme digest 
analysis using ScaI.  Only plasmids containing in-frame insertions were used in the 
subsequent experiments.  Plasmid pASE104 was mobilized into AE307 and pASE105 
was mobilized into AE321 and AE322 to complement insertionally disrupted ptw genes. 
Tetracycline resistant and Tpr transconjugants were single colony purified and retested 
for antibiotic resistance.  Plasmid survey lysis and PCR were used to confirm plasmid 
transfer, which was reflected by the presence of both the resident and complement 
plasmid as well as inserted and uninserted PCR products. 
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Epithelial cell cultures   
 
The IB3 cell line is an adenovirus 12-SV40 hybrid-transformed human bronchial 
epithelial cell line derived from a CF patient (DF508/W1282X). The C38 cell line is 
derived from IB3, and stably expresses a transfected functional CF transmembrane 
conductance regulator protein (Zeitlin et al., 1991).  Both cell lines were grown in LHC-
8 medium supplemented with 5% fetal bovine serum (FBS) (Invitrogen), 50 U/ml 
penicillin, and 50 µg/ml streptomycin.  
 The 16HBE14o- (16HBE) cell line is an SV-40 large T antigen transformed human 
bronchial epithelial cell line and was kindly provided by Dr. Dieter Gruenert (Cozens et 
al., 1994). Cells were maintained in minimal essential medium containing 10% heat-
inactivated FBS, 100 U/ml penicillin, and 100 µg/ml streptomycin (Invitrogen). To 
obtain polarized 16HBE monolayers, cells were grown in Transwells (Costar) with 3 µ 
pore size membranes; transepithelial electrical resistance (TER) was measured as 
described previously (Kim et al., 2005). 16HBE cell monolayers with TER values >350 
Ω/cm2 were used in epithelial transmigration assays.  
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Stimulation of IL-8 secretion   
 
IB3 and C38 cells (1 x 105 cells/well) seeded in 24 well culture plates were grown to 80-
90% confluence in supplemented LHC-8 medium. Cells were shifted to serum- and 
antibiotic-free LHC-8 medium, incubated for 16 h and then infected with strain K56-2, 
AE307, or AE310 at a multiplicity of infection (MOI) of 0.1. For infection of bronchial 
epithelial cells, bacteria were grown in LB broth or LHC-8 media (Biosource 
International) for 16h at 37oC in an orbital shaker, harvested by centrifugation, and 
suspended in PBS (Sambrook et al., 1989) to the desired concentration. Cells incubated 
with cell culture media alone served as negative controls.  After 24 h of incubation, an 
aliquot of media was collected, serially diluted, and plated to determine bacterial density.  
The remaining media was centrifuged and the amount of IL-8 in the supernatant was 
determined by ELISA (R&D systems).   
 
Epithelial transmigration assays 
 
Polarized 16HBE cell layers with a TER >350 Ω/cm2 were maintained in antibiotic free 
supplemented medium for 24 h prior to infection with selected bacterial strains.  Cell 
cultures were infected with bacteria at an MOI of 1 and bacteria in the basolateral 
chambers were quantified at 4, 8, 12, and 24 h post infection. The TER was measured at 
the same time points. 
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RESULTS 
 
Isolation and characterization of ptw-negative mutants 
 
A total of 5000 transconjugants, of strain K56-2, were obtained using the plasposon 
mutagenesis system.  Genomic DNA from 20 randomly selected transconjugants were 
digested with PstI, which does not cleave the TnMod-RTp’ insert.  The DNA fragments 
were separated by agarose gel electrophoresis, and Southern blots were probed with the 
Tp-cassette to determine the randomness of insertion.  It was determined that the 
plasposon system was suitable for the generation of random mutations in the genome of 
B. cenocepacia strain K56-2.   
 From the pool of 5000 transconjugants, 56 mutants were verified as ptw-negative 
using the plant tissue assay (Fig. 2.1), and demonstrated no other apparent phenotypic 
differences when compared to the parental strain.  The DNA flanking the plasposon 
insertion site of 10 ptw-negative mutants was cloned, sequenced, and a BLAST search 
was performed.  The translated gene products disrupted in clone GM237 and GM242
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Fig. 2.1.  Analysis of Ptw type IV secretion system using the plant tissue watersoaking 
assay. (A) Pierced onion bulb scale inoculated with B. cenocepacia strain K56-2 
showing partial tissue collapse and translucence characteristic of the plant tissue 
watersoaking (ptw) phenotype.  (B) Pierced onion bulb scale inoculated with sterile 
water (ptw-negative).  (C) Pierced onion bulb scale inoculated with ptw-negative mutant 
AE307.  All ptw-negative mutants expressed no ptw activity on onion tissue and 
inoculated scales showed the same symptoms as that in Fig. 2.1C. 
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(Table 2.2) showed homology toVirD4-like proteins, whereas GM241 and GM243 
(Table 2.2) showed homology to a putative regulator and promoter, respectively.  Thus, 
our initial inquiry was focused on determining if strain K56-2 possessed and/or utilized a 
similar transfer system. 
Using sequence data from the B. cenocepacia Genome Project, a 60 kb region 
proximal to the identified virD4-like gene was analyzed.  Strain J2315, the subject of the 
genome sequence project is a member of the ET12 clonal lineage as is strain K56-2 
(Mahenthiranlingam et al., 2000b), and hence the arrangement of genes and their 
sequence was expected to be similar.  A cluster of 11 genes potentially involved in the 
delivery of the ptw effector(s) was identified and designated the ptw cluster (Fig. 2.2).  
Southern analysis of K56-2 lysates determined that the ptw cluster was located on a 92 
kb resident plasmid.  Other isolates of the ET12 lineage (J2315, BC7 and C5424) were 
also shown to harbor the ptw cluster on their resident plasmids.  The resident plasmid, 
designated pK56-2 has a G-C ratio of 62.7% and the ptw cluster has a G-C ratio of 61%, 
whereas the value for the whole genome is 66.9%.  
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Fig. 2.2.  A 45 kb segment from plasmid pK56-2 containing the ptw cluster.  
Designation of genes was based on homology to gene products of transfer and 
translocation related proteins and are depicted by solid arrows. ORFs having no 
homologs are illustrated by patterned arrows. 
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DNA sequence and protein similarities of the ptw cluster 
 
The encoded products of the ptw cluster showed homology to various translocation 
and/or conjugation related proteins from other bacteria including A. tumefaciens, 
Salmonella typhi, Vibrio cholerae, Novosphingobium aromaticivorans, and E. coli.  
Based on amino acid sequence similarity to TraD and other VirD4-like proteins the 
predicted function of ptwD4 could involve nucleoside triphosphatase activity (NTPase) 
and may therefore serve as an active motor for secretion (Schröeder et al., 2002; 
Schröeder and Lanka, 2003).  PtwB4 and its homolog VirB4 of the VirB/D system may 
also exhibit NTPase activity (Baron et al., 2002).  Based on homology to R388 TrwC, 
PtwC may function as a component of a relaxosome (Llosa et al., 1994).  PtwB7, 
PtwB8, PtwB9, and PtwB10 were predicted to form complexes in the periplasm and/or 
membrane to create the pore (Yeo and Waksman, 2004).  PtwB11 was also predicted to 
have NTPase activity and is part of the TraG subfamily, which belongs to the large 
superfamily of “type II/IV secretion NTPases” (Planet et al., 2001).  PtwN as well as 
PtwU had no VirB/D homologs; however, they possessed homology to TraN and TraU 
of the F plasmid, respectively.  In the F plasmid system TraN is an adhesin and TraU is 
involved in mating pair stabilization (Lawley et al., 2003).  Based on analysis of gene 
products with sequence similarity and the probable involvement in the expression of the 
ptw phenotype, ptwD4, ptwC, ptwB4, and ptwB10 were chosen for further analysis.  
Translation of the ptwD4 sequence resulted in a protein that was 640 amino acids in 
length, with a predicted MW of 72 kDa and a pI of 6.6.  Further analysis of the PtwD4 
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amino acid sequence, using reverse position specific BLAST (rpsBLAST) and the 
conserved domain database (CDD), revealed a predicted Walker A (P-loop) and B site 
for nucleotide binding (Walker et al., 1982) that is characteristic of type IV secretion 
ATP-binding proteins (Yeo and Waksman, 2004).  The predicted P-loop nucleotide 
binding motif extends from 117 to 124 in the amino acid sequence and the Walker B 
motif extends from 338 to 344.  The translated sequence of ptwB4 was 1013 amino acids 
in length, with a predicted MW of 108 kDa and a pI of 6.0.  Further analysis of the 
PtwB4 amino acid sequence for hydrophobicity revealed four putative transmembrane 
domains which is characteristic of type IV secretion NTPases (Yeo and Waksman, 
2004).  Translation of the ptwB10 sequence resulted in a protein that was 278 amino 
acids in length, with a predicted MW of 30 kDa and a pI of 5.2.  Using rpsBLAST and 
the CDD, PtwB10 was shown to contain a well conserved C-terminal hydrophobic 
region (Yeo and Waksman, 2004).  Translation of the ptwC sequence resulted in a 
protein that was 940 amino acids in length, with a predicted MW of 104 kDa and a pI of 
6.0.  A Pustell protein matrix analysis comparing PtwC and TrwC from R388 illustrated 
regions of similarity between the sequences.  At the N-terminus (amino acids 1-200), 
PtwC and TrwC showed a 42% identity and signature motifs 2 and 3 that are conserved 
in proteins with DNA nicking activities (Llosa et al., 1994).  An analysis of the PtwC C-
terminal sequence indicated that PtwC contained 7 motifs (I, Ib, II, III, IV, V, and IV) 
characteristic of helicases (Hodgman, 1988). 
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Site-directed disruption of the ptw or virB/D clusters and its effect on the ptw 
phenotype 
 
Translated products of the ptw cluster showed homology to proteins from known type IV 
secretion systems.  Based on their predicted function, the role of ptwD4, ptwC, ptwB4, 
and ptwB10 in the expression of the ptw phenotype was determined.  Watersoaking 
mutants of K56-2 with a disrupted ptwD4 were obtained in the initial screening of the 
plasposon generated mutants and by site-directed mutagenesis (Fig. 2.1 and Table 2.2).  
Site-directed mutagenesis of ptwD4, ptwC, and ptwB10 was accomplished by individual 
mobilization of pASE106, pASE107, pASE108, and pASE109, respectively, into K56-2.  
Tetracycline resistant transconjugants showed a 1.9 kb increase in PCR product, which 
reflected the insertion of the Tc-cassette. Insertions in ptwD4, ptwB4, and ptwB10 
resulted in loss of the ptw phenotype, whereas disruption of ptwC did not.  
Representative insertionally inactivated ptw-negative mutants of ptwD4, ptwB4, and 
ptwB10 were designated AE307, AE321, and AE322 respectively, whereas the inserted 
ptwC derivative was designated AE320 (Table 2.2). 
 Complementation of ptw-negative mutants was accomplished by mobilization of 
pASE104 into AE307, and pASE105 into AE321 or AE322 and selecting for Tcr and 
Tpr-transconjugants.  All transconjugants tested were ptw-positive (Fig. 2.3).  Plasmid 
pURF047 derivatives were used in complementation studies (Defeyer et al., 1990).  A 
survey of transconjugant lysates confirmed plasmid transfer.  Representatives of ptw-
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positive complemented ptwD4, ptwB4, and ptwB10 mutants were designated AE310, 
AE323, and AE324, respectively (Fig. 2.3). 
 Genomic analysis of the J2315 sequence from the Sanger Centre identified a second 
cluster on chromosome II (designated VirB/D), which showed homology to the VirB/D4 
type IV secretion system of A. tumefaciens (Fig. 2.4).  Using PCR analysis, the presence 
of virB1, virB4, virB6, virB11, and virD4 (Table 2.3), that span the entire VirB/D cluster, 
were confirmed in K56-2.  In A. tumefaciens virB6 is thought to mediate assembly of the 
pilus and a functional secretion machine through its effects on virB7 and virB9 
multimerization (Jakubowski et al., 2003), and virB11 is predicted to function as an 
NTPase, which provides the necessary energy for secretion (Yeo and Waksman, 2004).  
Based on their predicted function, the role of virB6 and virB11 in the expression of the 
ptw phenotype was assessed.  Site-directed mutagenesis of virB6 and virB11 was 
accomplished by individual mobilization of pASE114 and pASE115 into K56-2, 
yielding AE360 and AE361, respectively.  Tetracycline resistant transconjugants showed 
a 1.9 kb increase in PCR product, which reflected the insertion of the Tc-cassette.  
Disruption of virB6 or virB11 did not result in loss of the ptw phenotype.   
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Fig. 2.3.  Complementation of ptw-negative mutants. (A) Pierced onion bulb scale 
inoculated with strain K56-2 showing characteristic ptw activity.  (B) Pierced onion bulb 
scale inoculated with B. cenocepacia ptw-negative mutant AE307 showing no ptw 
activity. (C) Pierced onion bulb scale inoculated with complemented AE307 (AE310) 
showing restored ptw activity.   
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Fig. 2.4.  A 12 kb segment containing a virB/D like type IV secretion system cluster 
located on chromosome two of B. cenocepacia strain J2315.  Designation of genes was 
based on homology to gene products of transfer and translocation related proteins and 
are depicted as solid arrows.  Genes virB1, virB4, virB6, virB11, and virD4 have been 
identified in strain K56-2.   
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Partial characterization of watersoaking effector(s) and population dynamics 
 
Plant tissue assays indicated that the parental strain K56-2 and the complemented mutant 
(AE310) caused watersoaking, whereas the ptwD4 mutant (AE307) did not (Fig. 2.3).  
Growth and watersoaking were monitored over a 72 h period using the plant tissue assay 
to determine the contribution of ptw activity in survival and growth.  Over the 72 h 
period both K56-2 and AE310 showed an approximate 100-fold increase in CFU/g of 
tissue and an increase in the watersoaking area, whereas AE307 showed no watersoaking 
activity and an approximate 1000-fold decrease in CFU/g of tissue over the same period 
(Table 2.4). 
 
 
 
 
 
 
 
Table 2.4. Growth and watersoaking activity of B. cenocepacia strain K56-2 and its 
derivatives in onion tissue. 
 
 Straina,b
Time K56-2 AE307 AE310 
0 h 6.5 x 105 ± 2.5a (0 ± 0)b 4.2 x 105 ± 1.7 (0 ± 0) 7.3 x 105 ± 2.0 (0 ± 0) 
24 h 6.1 x 104 ± 3.3 (90 ± 20) 5.6 x 104 ± 1.0 (0 ± 0) 4.4 x 104 ± 2.9 (120 ± 11) 
48 h 4.5 x 106 ± 1.7 (178 ± 42) 6.7 x 103 ± 1.6 (0 ± 0) 5.1 x 106 ± 3.5 (193 ± 14) 
72 h 4.4 x 107 ± 3.1 (304 ± 18) 5.8 x 102 ± 3.1 (0 ± 0) 8.6 x 107 ± 5.5 (347 ± 33) 
a Average CFU/g tissue ± SD for three independent experiments in triplicate. 
b Numbers in parentheses are the average area of tissue watersoaking (mm2) ± SD for  
   three independent experiments in triplicate.  All strains were plated on LB amended    
   with 10 µg/ml Tc and 10 µg/ml of Gm.  
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 Based on analysis of the ptw cluster and the putative role of a type IV secretion 
system in the export of an effector molecule(s), it was of interest to determine if culture 
supernatant concentrates showed effector activity. Over an 8 h duration, carrot 
protoplasts exposed to M9 medium concentrate did not experience significant 
plasmolysis when compared to the protoplast controls (P>0.05) (Table 2.5 and Fig. 2.5).  
However, significant (P≤0.05) plasmolysis was observed for protoplasts exposed to the 
K56-2 or complemented mutant (AE310) concentrates as early as 2 h, and plasmolysis 
increased at a significant rate for dilutions tested (up to 1:5) over the 8 h time period as 
compared to medium controls.  Concentrated supernatant from the ptwD4 mutant 
(AE307) caused 6.7% plasmolysis after 8 h, which was not statistically different 
(P>0.05) from plasmolysis resulting from treatment with medium controls.  Dilution of 
the K56-2 and AE310 concentrates diluted 1:10 to a protein concentration of 0.02 µg/ml 
reduced activity to levels which approximated that of the control and AE307.  
Temperatures of 37º, 65º, and 80ºC for 1 h or 100ºC for 10 min did not affect the 
plasmolysis activity of the K56-2 concentrate.  Complete inactivation of plasmolysis 
activity was observed when the K56-2 concentrate was treated with proteinase K; 
however, incubation with DNase I or RNase A showed no effect on activity.   
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Table 2.5.  Effect of supernatant concentrates from K56-2, ptwD4 mutant (AE307) and 
complemented ptwD4 mutant (AE310) on carrot protoplasts. 
 
% Plasmolysisb, c
 
Supernatant 
Concentrate 
Concentrate 
Dilutiona
0 h 2 h 4 h 6 h 8 h 
       
M9 0 0x 1.2 ± 1.1x 2.7 ± 1.6x 6.6 ± 1.7x 8.2 ± 3.4x 
medium 1:1 0x 1.5 ± 1.7x 3.4 ± 1.2x 6.4 ± 2.0x 7.5± 2.8x 
 1:5 0x 2.6 ± 1.0x 3.1 ± 1.6x 4.3 ± 1.4x 6.9 ± 2.7x 
 1:10 0x 1.9 ± 1.5x 2.9 ± 1.0x 5.6 ± 2.3x 7.3 ± 2.6x 
       
K56-2 0d 0x 18 ± 4.0y 37 ± 4.1y 57 ± 5.1y 75 ± 5.8y 
 1:1 0x 18 ± 2.1y 38 ± 5.0y 56 ± 6.1y 76 ± 7.6y 
 1:5 0x 18 ± 4.3y 36 ± 5.0y 55 ± 5.6y 73 ± 6.4y 
 1:10 0x 1.6 ± 1.4x 3.6 ± 1.0x 5.9 ± 0.6x 7.3 ± 1.4x 
       
AE307 0d 0x 1.8 ± 1.2x 3.3 ± 0.7x 4.9 ± 1.7x 6.7 ± 1.7x 
 1:1 0x 2.2 ± 1.3x 3.8 ± 2.1x 5.4 ± 1.0x 7.4 ± 1.9x 
 1:5 0x 2.3 ± 1.4x 3.5 ± 0.7x 5.8 ± 1.5x 8.4 ± 1.4x 
 1:10 0x 2.3 ± 1.5x 4.5 ± 1.1x 6.1 ± 0.8x 7.7 ± 0.6x 
       
AE310 0d 0x 19 ± 1.0y 37 ± 3.0y 52 ± 4.0y 78 ± 7.7y 
 1:1 0x 19 ± 1.4y 36 ± 4.9y 52 ± 3.7y 70 ± 6.6y 
 1:5 0x 18 ± 2.0y 39 ± 4.5y 56 ± 4.2y 77 ± 7.0y 
 1:10 0x 1.5 ± 1.0x 1.8 ± 1.0x 6.0 ± 1.6x 7.2 ± 1.0x 
       
None 0 0x 2.0 ± 1.6x 3.1 ± 7.7x 6.7 ± 1.6x 11 ± 2.2x 
       
a All dilutions were adjusted to 10% mannitol 
b Data are mean values ± SD of two replicates for three independent experiments.   
c Values within the columns scored by the same letter were not statistically different at P=0.05. 
d Undiluted concentrate adjusted to 0.2 µg/ml protein in 10% mannitol.   
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Fig. 2.5. Effect of supernatant concentrates from K56-2, ptwD4 mutant (AE307) and 
complemented ptwD4 mutant (AE310) on carrot protoplasts. Data are mean values of 
two replicates for three independent experiments.   
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Role of the Ptw type IV secretion system in stimulation of IL-8 from bronchial 
epithelial cells 
 
IB3 cells were used to investigate the possible role of the Ptw type IV secretion system 
in contributing to IL-8 secretion by CF bronchial epithelial cells.   In preliminary 
experiments, we found that B. cenocepacia strain K56-2 stimulated significantly greater 
IL-8 from IB3 (CF phenotype) cells than from C38 (corrected CF phenotype) cells in 
vitro (Fig. 2.6).  This is similar to what is found with infection of well-differentiated CF 
and non-CF primary airway epithelial cells in vitro (Sajjan et al., 2004).  IB3 cells were 
grown in monolayers, and infected with B. cenocepacia K56-2, the ptw mutant (AE307) 
or the complement (AE310).  After 24 h the amount of IL-8 secretion was measured.  
Compared to wild-type K56-2, IL-8 stimulation by all three ptw mutants was 
significantly attenuated (Fig. 2.7).  Complementation of the ptw mutants in trans 
restored the IL-8 stimulatory activity. 
 To determine whether secreted bacterial products were involved in the stimulation of 
IL-8 from epithelial cells, we examined the effect of bacterial culture supernatants from 
wild-type or ptw mutants on IL-8 secretion.  Supernatants from wild-type K56-2 
stimulated maximum secretion of IL-8 at 6 h post-treatment.  At this time point, 
supernatants from AE307 stimulated significantly (p<0.05) less IL-8 from IB3 cells 
compared to supernatant from wild-type K56-2.  The pro-inflammatory activity of the 
mutant was restored by complementation of respective genes in trans (Fig. 2.8).   
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Fig. 2.6.  Secretion of IL-8 from IB3 and C38 cells in response to infection with wild-
type K56-2.  Assays were performed in triplicate and results for mutants and 
complemented mutants are expressed as pg/ml of IL-8 (+/- SD). 
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Fig. 2.7.  Secretion of IL-8 from IB3 cells in response to infection with wild-type K56-2, 
AE307 (K56-2 ptwD4-Tc), and AE310 (K56-2 ptwD4-Tc complement).  Assays were 
performed in triplicate and results for the mutant and complemented mutant are 
expressed as percent (+/- SD) of the K56-2 positive control. 
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Fig. 2.8.  Stimulation of IL-8 from IB3 cells in response to treatment with bacterial 
culture supernatants from wild-type K56-2, AE307 (K56-2 ptwD4-Tc), and AE310 
(K56-2 ptwD4-Tc complement).  Assays were performed in triplicate and results for the 
mutant and complemented mutant are expressed as percent (+/- SD) of the K56-2 
positive control. 
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DISCUSSION 
 
Previously, Gonzalez et al. (1997) investigated the role of a polygalacturonase (PehA) as 
a virulence factor in B. cepacia strain ATCC 25416.  Derivatives cured of a resident 
plasmid that encodes for the PehA no longer macerated onion tissue; however, the 
derivatives still produced a phenotype described as plant tissue watersoaking.  Of 
interest in the present study was the observation that all B. cepacia and B. cenocepacia 
isolates and a B. vietnamiensis from the Bcc experimental strain panel 
(Mahenthiralingam et al., 2000b) produced the ptw phenotype in onion tissue (Medrano, 
2002).  In this study K56-2, a B. cenocepacia strain that produced the plant disease 
associated phenotype, was genetically analyzed and found to contain a plasmid-borne 
gene cluster designated ptw that encodes a type IV secretion system responsible for the 
translocation of the ptw effector protein(s). 
 The identified gene products in the ptw cluster had homology to proteins from known 
type IV secretion systems.  Bacteria have evolved type IV secretion systems to transfer 
DNA or protein macromolecules to a wide array of target-cell types (Baron et al., 2002; 
Christie, 2001; Nagai and Roy, 2003).  Originally, the nomenclature referred to the 
VirB/D-encoded translocation system of A. tumefaciens and two closely related systems 
encoded by the transfer region of the IncN plasmid pKM101 and the ptl operon of 
Bordetella pertussis (Christie, 2001).  In the past decade, the type IV family has 
expanded considerably in number with the relaxation of defining criteria.  Currently, 
type IV secretion systems are defined as translocation systems ancestrally related to any 
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conjugation system of Gram-negative or -positive bacteria (Christie, 2001; Grohmann et 
al., 2003).  However, it is important to distinguish functional translocation machines 
from mobile elements characteristically found in bacterial genomes.  Ding et al., (2003) 
have suggested that mutagenesis of a putative type IV system should yield a phenotype 
at least consistent with a translocation defect.   
 Christie (2001) has suggested sub-classification of type IV secretion systems based 
on ancestral lineage.  Thus, the VirB/D-type has been designated IVA, and the ColIb-P9 
Tra and L. pneumophila Dot-Icm types have been designated IVB.  This sub-
classification left open the possibility for further division of Gram-negative and -positive 
secretion systems that differ from IVA and IVB.  Therefore, an alternative grouping 
scheme has been suggested by Ding et al. (2003) that separates systems based on 
function and does not replace the one previously described, but rather expands its 
usefulness.  This classification method groups type IV secretion systems as (i) 
conjugation systems, (ii) “effector translocator” systems, or (iii) “DNA uptake or 
release” systems (Dillard and Seifert, 2001).  By definition, the conjugation systems 
deliver DNA substrates by establishing direct physical contact with target cells.  
Examples include the well-studied A. tumefaciens T-DNA transfer system and the F, 
RP4, and R388 plasmid transfer systems.  Although the conjugation systems are known 
mainly for their role in distributing DNA among bacterial populations, they can also 
translocate protein substrates independently of DNA (Wilkins and Thomas, 2000).  
There is also a subset of these systems that can transfer DNA and protein substrates to a 
range of eukaryotic cell types, to include plant, fungal, and human (Bates et al., 1998; 
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Ward and Zambryski, 2001; Waters, 2001).  Most of the members of the type IV effector 
translocator group inject their substrates directly into the eukaryotic cytosol.  This type 
of translocation is now recognized as the dominant virulence mechanism of the 
phytopathogen A. tumefaciens and of several medically important pathogens, including 
H. pylori, L. pneumophilla, Brucella spp., and Bartonella spp. (Burns, 2003).  Also 
included in this subfamily is the Ptl system of B. pertussis, even though this system 
exports its protein substrate independently of host-cell contact.  Presently, at least 10 
type IVA and several type IVB systems can be grouped as effector translocators and are 
thought to be essential for infection (Ding et al., 2003).  The “DNA uptake and release” 
group, which presently contains three members, translocates DNA substrates across the 
cell envelope to or from the extracellular milieu (Ding et al., 2003).  Neisseria 
gonorrhoeae uses a system encoded by the gonococcal genetic island to export DNA 
(Dillard and Seifert, 2001; Hamilton et al., 2001).  Recent studies have established that 
this system is very closely related to the F plasmid conjugation system of E. coli, even 
though it is not performing the same function (Dhar et al., 2003).  The two other 
members of this subfamily, Campylobacter jejuni and H. pylori, translocate DNA in the 
opposite direction promoting genetic variation and cell survival (Bacon et al., 2000; 
Hofreuter et al., 2001).   
 A notable feature of the type IV secretion systems is their extreme versatility.  These 
systems can recognize a wide array of DNA and protein substrates, translocate substrates 
by both cell-contact-dependent and -independent mechanisms and deliver substrates to 
an exceptionally wide range of prokaryotic and eukaryotic taxa (Ding et al., 2003).  The 
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ptw cluster contains homologs to components of multiple type IV secretion systems (Fig. 
2.2).  With respect to function, the plasmid encoded type IV secretion system we have 
identified in B. cenocepacia strain K56-2 was involved in export of an effector(s) that 
was responsible for the ptw phenotype.  The fact that the Ptw system was involved in the 
translocation of a protein(s), that it did not contain all of the necessary genetic 
components to support conjugation, and that no oriT homolog was identified indicate 
that functionally it is a member of the effector translocator subfamily.  The difference in 
the G-C ratio between pK56-2 harboring the ptw cluster (62.7%) and the G-C ratio for 
the entire B. cenocepacia genome (66.9%) suggests acquisition by horizontal transfer 
(Karlin, 2001).   
 The presence of a second type IV secretion system in B. cenocepacia is not 
unprecedented since many bacteria, such as H. pylori and A. tumefaciens, have been 
found to harbor multiple secretion systems (Ding et al., 2003; Kersulyte et al., 2003).  
The type IV secretion system located on chromosome II showed most similarity to that 
of the A. tumefaciens VirB/D translocation system with respect to arrangement and gene 
product similarity (Fig. 2.6).  The difference in the G-C ratio of the chromosomally 
located type IV secretion system (63%) and the G-C ratio of the entire genome (66.9%) 
suggests horizontal acquisition (Karlin, 2001), as with the Ptw translocation system.  
Evidence suggests that the Ptw system is responsible for export of the protein(s) 
involved in expression of the ptw phenotype; however, the substrate(s) translocated by 
the VirB/D4 system is unknown.   
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 Identification of a cluster of genes that encoded proteins with similarities to 
components of a type IV secretion system allowed for strategic generation of K56-2 
mutants to support the hypothesis that such a system was involved in expression of the 
ptw phenotype.  The genes selected for functional characterization were ptwD4, ptwC, 
ptwB4, and ptwB10.  VirD4-like proteins (PtwD4 homologs) are cytoplasmic membrane 
NTP-binding proteins that are essential for coupling the relaxosome to the 
macromolecular transport system (Moncalián et al., 1999; Schröeder and Lanka, 2003).  
It is thought to interact with the oriT bound relaxosome, which is made up of TrwC and 
TrwA, to facilitate DNA transfer (Fekete and Frost, 2000; Llosa et al., 2003).  In the Ptw 
system however, there is no TrwA homolog. The ptwD4 product appears to have similar 
functions to Hp0524 of H. pylori.  The hp0524 product is critical for the transfer of 
CagA from the bacterium to epithelial cells (Fischer et al., 2001).  Further analysis 
revealed that the PtwD4 amino acid sequence contained P-loop and Walker B sites, 
which are characteristic of type IV secretion ATP-binding proteins.  The ptwC product 
had homology to TrwC, which is both a relaxase, that cleaves at the nic site within the 
oriT in a strand- and sequence-specific manner, and a helicase, which is essential for 
transfer (Matson et al., 1993; Matson et al., 2001).  Analysis of PtwC revealed that the 
N-terminus possessed signature motifs (2 and 3) conserved in proteins with DNA 
nicking activities (Llosa et al., 1994) and the C-terminus possessed signature motifs (I, 
Ib, II, III, IV, V, and VI) conserved in DNA helicases (Hodgman, 1988); however, there 
is no identified oriT to facilitate the cleavage and thus linearization required for DNA 
transfer.  VirB10, the PtwB10 homolog, is a protein located in the periplasmic space that 
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is believed to form the core of the transfer machinery and is possibly part of the pore that 
spans the inner and outer membranes (Yeo and Waksman, 2004).  PtwB10 was shown to 
contain the C-terminal hydrophobic region that is characteristic of VirB10-like proteins.  
PtwB4 showed similarity to VirB4 of A. tumefaciens, which is a putative nucleoside 
triphosphatase that may also serve as an active motor for secretion (Yeo and Waksman, 
2004).  VirB4 is a large inner membrane protein with NTPase activity (Yeo and 
Waksman, 2004).  The PtwB4 amino acid sequence was shown to possess four 
transmembrane regions that are characteristic of VirB4-like NTPases (Yeo and 
Waksman, 2004).  The ptw phenotype was not expressed by K56-2 derivatives with a 
disruption in ptwD4, ptwB4, or ptwB10, but was expressed by a derivative with a 
disruption in ptwC.  These results correlated with the predicted function of the gene 
products since successful secretion of the ptw effector protein(s) would likely involve:  a 
protein that potentially couples the moiety to the secretion system and supplies the 
necessary energy for export (PtwD4); a protein that acts in the assembly of the pore 
necessary for the passage of the substrate and provides energy necessary for the system 
to function (PtwB4); and a protein involved in structural formation of a pore (PtwB10); 
but not one involved in the generation of a relaxosome (PtwC).  
 By combining mutational analysis with cytotoxic assays employing both plant tissue 
and protoplasts, a type IV secretion system has been identified that appears to export an 
effector molecule(s) that is proteinacious in nature and responsible for the activity.  This 
activity plays an important role in the ability of B. cenocepacia strain K56-2 to cause 
watersoaking and grow in plant tissue (Fig. 2.2 and Table 2.4).  It appears that in the 
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plant tissue assay the role of the effector(s) is to provide bacterial cells with needed 
nutrients by causing leakage of the plant cell cytosol.  Currently, the role of the putative 
virulence effector protein(s) in contributing to growth and infection in a pulmonary 
environment is unknown; however, the ptw phenotype appears to be common among 
isolates belonging to B. cenocepacia that infect CF patients.  
 Protein DspE of Erwinia amylovora and WtsE of Pantoea stewartii subsp. stewartii, 
are involved in elicitation of the watersoaking phenotype in their respective hosts.  The 
dspE product is a 198 kDa protein that is required for the production of fireblight disease 
symptoms that include watersoaking of apple and pear tissue (Bogdanove et al., 1998).  
A disruption in wtsE renders P. stewartii subsp. stewartii incapable of eliciting an 
observable watersoaking phenotype and causing a systemic corn leaf infection 
(Frederick et al., 2001).  In contrast to the ptw effector molecule(s), a type III secretion 
system is presumed to export DspE and WtsE from the phytopathogen to the plant hosts.  
 There are two types of substrates typically transported by both type III and type IV 
secretion systems (Nagai and Roy, 2003;  Salmond, 1994).  The first group alter host 
processes by mimicking the function of a eukaryotic protein.  Substrate proteins in this 
category however, do not have significant sequence similarities with the eukaryotic 
factor they mimic, which makes identification difficult.  The second class are genes that 
were ‘stolen’ from eukaryotic host cells and then reshaped.  The RalF protein of the L. 
pneumophila Dot/Icm system falls into the latter group (Nagai and Roy, 2003).  
Substrates in this category are relatively easy to identify with genomic analysis.  
Secreted substrates from either group can vary in size from ~22 kDa for A. tumefaciens 
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VirF to ~145 kDa for H. pylori CagA.  They also vary in composition, from monomers 
to multi-subunit structures that may include protein and/or DNA (Ding et al., 2003).  
Thus, there are no universally conserved primary sequence motifs or physical 
characteristics that are readily discernible for secreted effectors.   
 Recently, there has been a growing appreciation of the roles that type IV secretion 
systems play in the virulence of certain human respiratory pathogens, including B. 
pertussis and L. pneumophilia (Christie, 2001). Type IV secretion systems have also 
been found to contribute to the induction of inflammatory responses from infected host 
tissues (Bauer, 2005).  For example, effector proteins translocated from bacteria to host 
cells via type IV secretion systems stimulate an intense inflammatory response from 
gastric epithelium infected by H. pylori and B. henselae (Bauer et al., 2005; Schmid et 
al., 2004).  Indeed, H. pylori mutant strains with a nonfunctional Cag type IV secretion 
system were recently shown to be significantly attenuated in their ability to stimulate IL-
8 production from a variety of cultured mammalian cells (Bauer et al., 2005).   
 It has been previously shown that B. cenocepacia strain K56-2 stimulates release of 
IL-8 from human respiratory epithelial cells (Sajjan et al., 2004).  Although a variety of 
bacterial components, such as LPS, flagella, and pili are likely involved in this process, 
the relative contributions of each of these components to immunostimulation of airway 
epithelial cells during respiratory infection in CF are not well understood.  The results 
from this study indicate that the plasmid encoded Ptw type IV secretion system may also 
contribute to the stimulation of IL-8 from B. cenocepacia infected CF epithelial cells.  
Experiments using sterile broth culture supernatants showed similar results to that 
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observed with bacterial cells, suggesting that secreted effectors are involved in IL-8 
stimulation.   
 In conclusion, this study (Chapter II) has identified a plasmid encoded type IV 
secretion system in B. cenocepacia strain K56-2 that was functionally an effector 
translocator.  The Ptw type IV secretion system was found to be responsible for 
production of the ptw phenotype and at least partially responsible for the stimulation of 
release of IL-8 from human bronchial epithelial cells, caused by B. cenocepacia strain 
K56-2.  Culture supernatant studies on plant protoplast and human bronchial epithelial 
cells indicate that an effector protein translocated into the extracellular milieu by the Ptw 
system is responsible for the toxicity on plant cells as well as the stimulation of IL-8 
release in epithelial cells.  The chromosomally located type IV secretion system showed 
modular similarity to the A. tumefaciens VirB/D4 translocation system; however, it was 
not responsible for the ptw phenotype in B. cenocepacia strain K56-2. 
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CHAPTER III 
IDENTIFICATION OF AN EFFECTOR TRANSLOCATED BY THE 
Burkholderia cenocepacia PTW TYPE IV SECRETION SYSTEM  
 
INTRODUCTION 
 
The Burkholderia cepacia complex (Bcc) is a group of closely related bacterial species 
that are opportunistic pathogens capable of causing life-threatening respiratory 
infections, particularly in persons with cystic fibrosis (CF) (Coenye et al., 2004).  The 
Bcc consists of nine species  (Coenye et al., 2001a, b, c; Vandamme et al., 2002; 
Vandamme et al., 2003; Vermis et al., 2004). Recent analyses indicate that although all 
nine species are capable of causing infection in CF patients, some are much more 
commonly involved than others. In the United States, approximately half of Bcc-infected 
CF patients harbor Burkholderia cenocepacia (LiPuma et al., 1999; Reik et al., 2005); in 
Canada and parts of Europe, the proportion can be as high as 83% (Speert et al., 2002). 
There is extensive evidence for patient to patient spread and nosocomial transmission of 
certain B. cenocepacia strains (Coenye and LiPuma, 2003).  However, the factors that 
account for the apparent enhanced capacity of some B. cenocepacia strains for 
pulmonary infection and/or interpatient spread in CF remain to be elucidated.  
 In recent years, extensive research has shown that bacterial pathogens share common 
secretion mechanisms for the delivery of virulence determinants (Plano et al., 2001, 
Christie and Vogel, 2000).  There are numerous examples of the importance of type III 
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(Plano et al., 2001) and type IV secretion systems (Christie and Vogel, 2000) in the 
infection process for both plant and animal pathogens. It is hypothesized that type III 
secretion systems are derived from flagellar assembly constituents (Macnab, 1999), and 
that the type IV secretion systems share a common ancestry with bacterial conjugation 
systems. Type IV secretion systems are commonly used by bacteria to deliver 
macromolecular substrates to target cells, often for purposes associated with 
pathogenesis (Cascales and Christie, 2003; Llosa and O’Callaghan, 2004). The 
prototypical type IV secretion system is the Agrobacterium tumefaciens nucleoprotein T-
DNA transfer system.  Type IV secretion systems that are required for virulence have 
also been described in medically important pathogens, including the Bordetella pertussis 
Ptl (pertussis toxin) system (Farizo et al., 2000), the Dot/Icm system of Legionella 
pneumophila (Zink et al., 2002), and the cag pathogenicity island (PAI) of Helicobacter 
pylori. 
 The effector molecules secreted by type IV secretion systems have a variety of 
functions.  The most well characterized effector is the pertussis toxin, which is a member 
of the AB5 toxin family (Farizo et al., 2000, Tamura et al., 1982) and is directly 
transferred into the extracellular milieu (Tamura et al., 1982), where it ultimately 
interferes with signaling pathways in the host cells (Malaisse et al., 1984). The L. 
pneumophila Dot/Icm transporter is an example of a type IV secretion system that is 
capable of both conjugation and effector translocation (Nagai and Roy, 2003). Secreted 
effectors include RalF, which is a guanine nucleotide exchange factor for multiple ADP-
ribosylation factor proteins (Nagai et al., 2002), and LidA, for which the biochemical 
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activity is unknown (Conover et al., 2003). H. pylori possesses two type IV secretion 
systems with differing functions: the Cag secretory apparatus (encoded for by the cag 
PAI) translocates CagA into host cells where it induces cellular changes (Censini et al., 
2001), and the Com system is used to uptake DNA to facilitate genetic variation and 
enhance cell survival (Dhar et al., 2003, Ding et al., 2003).   
 In this study (Chapter III) an effector protein, designated PtwE1 was identified, which 
was translocated via the previously identified (Chapter II) Ptw type IV secretion system 
of B. cenocepacia strain K56-2.   
 
EXPERIMENTAL PROCEDURES 
 
Bacterial strains, media, and culture conditions 
 
Descriptions of plasmids and bacterial strains used in this study are listed in Tables 3.1 
and 3.2, respectively. Luria Bertani (LB) medium was used for routine maintenance of 
 56
cultures. Minimal medium Vogel Bonner (Vogel and Bonner, 1965) amended with 1.0% 
glucose (VBG) was used in mating experiments. Minimal medium M9 (Sambrook et al., 
1989) containing 1.0% glucose was used for culturing bacteria for supernatant analysis 
and detection of glutathione S-transferase (GST) fusion proteins; and M9 containing 
1.0% glycerol was used for β-galactosidase assays. Stability testing of pBCRLAR 
derivatives was accomplished using tryptone nutrient broth (TNB) (Hansen and Olsen, 
1978) for liquid culture and VBG amended with 500 µg/ml of trimethoprim (Tp) and 
500 µg/ml tetracycline (Tc) or VBG for selective and non-selective plating.  
Burkholderia cenocepacia and Escherichia coli strains were grown at 37ºC.  Media were 
supplemented with appropriate concentrations of antibiotics as needed for selection.  
Antibiotics were added to media at the following concentrations: 500 µg/ml of 
chloramphenicol (Cm) and 500 µg/ml of trimethoprim (Tp) for selection and 
maintenance of B. cenocepacia isolates and derivatives; and 10 µg/ml tetracycline (Tc), 
10 µg/ml gentamicin (Gm), 40 µg/ml ampicillin (Ap), and 100 µg/ml Tp for selection 
and maintenance of E. coli. 
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Table 3.1. Plasmids and primers used in Chapter III. 
Plasmid Relevant Characteristicsa, b Reference 
pBR325 Tcr, Apr, Cmr, ColE1 replicon Blank and Wilson, 
1982 
pDrive Cloning Vector:  Kmr, Apr, pUC origin, T7, SP6, lacZα+ Qiagen 
pCR2.1 TA cloning vector Invitrogen 
pFUSE oriR6K plasmid containing promoterless lacZYA Baümler et al., 1996 
pGEX4T-1 GST-fusion vector Amersham Biosiences 
pJQ200SK Gmr, sacB, Mob+, P15A replicon Quandt and Hynes, 
1993 
pRK2013 Kmr, Tra+, Mob+, ColE1 replicon Figurski and Helinski, 
1979 
pURFO47-Tp pURF047 with 2.0-kb Tpr cassette inserted at ScaI site of 
Apr cassette 
Chapter II 
pBCRLAR Cmr, Mob+, lacZα+, pBBR1 replicon LiPuma, Univ. of 
Michigan 
pBCRLAR-Tp pBCRLAR containing a blunted Tpr cassette inserted at 
ScaI site of Cmr cassette 
This study 
pDrive-ptwD4 pDrive containing a ptwD4 PCR product This study 
pDrive-ptwE1 pDrive containing a ptwE1 PCR product This study 
pDrive-ptwE2 pDrive containing a ptwE2 PCR product This study 
pDrive-
ptwD4::Cm 
pDrive-ptwD4 containing a blunted BsaAI/BclI Cmr 
fragment from pBR325 in the EcoRV site of ptwD4   
This study 
pDrive-
ptwE1::Cm 
pDrive-ptwE1 containing a blunted BsaAI/BclI Cmr 
fragment from pBR325 in the HaeIII site of ptwE1   
This study 
pDrive-
ptwE2::Cm 
pDrive-ptwE2 containing a blunted BsaAI/BclI Cmr 
fragment from pBR325 in the AluI site of ptwE2   
This study 
pJQ200SK-
ptwD4::Cm 
pJQ200SK containing a BamHI/SacI ptwD4-Cm 
fragment from pDrive-ptwD4::Cm in the MCS 
This study 
pJQ200SK-
ptwE1::Cm 
pJQ200SK containing a BamHI/SacI ptwE1-Cm fragment 
from pDrive-ptwE1::Cm in the MCS 
This study 
pJQ200SK-
ptwE2::Cm 
pJQ200SK containing a BamHI/SacI ptwE2-Cm fragment 
from pDrive-ptwE2::Cm in the MCS 
This study 
pBCRLAR-Tp-
ptwD4 
pBCRLAR-Tp containing a BamHI/SacI ptwD4 fragment 
from pDrive-ptwD4 in the MCS 
This study 
pBCRLAR-Tp-
ptwE1 
pBCRLAR-Tp containing a BamHI/SacI ptwE1 fragment 
from pDrive-ptwE1 in the MCS 
This study 
pCR2.1-ptwB4 pCR2.1 containing a ptwB4 PCR product This study 
pFUSE-ptwB4 pFUSE containing an XbaI/SmaI ptwB4 fragment from 
pCR2.1-ptwB4 in the MCS 
This study 
pDrive-GST pDrive containing a GST PCR product This study 
pDrive-ptwE1-
GST 
pDrive-GST containing a blunted BamHI/SacI ptwE1 
fragment from pDrive-ptwE1 in the blunted KpnI site 
This study 
pDrive-GST-
ptwE1 
pDrive-GST containing a blunted BamHI/SacI ptwE1 
fragment from pDrive-ptwE1 in the blunted HindIII site 
This study 
pDrive-
ptwE1::Cm-GST 
pDrive-GST containing a blunted BamHI/SacI 
ptwE1::Cm fragment from pDrive-ptwE1::Cm in the 
blunted KpnI site 
This study 
pDrive-GST-
ptwE1::Cm 
pDrive-GST containing a blunted BamHI/SacI 
ptwE1::Cm fragment from pDrive-ptwE1::Cm in the 
blunted HindIII site 
This study 
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Table 3.1. Continued 
 
Plasmid Relevant Characteristicsa, b Reference 
pJQ200SK-
ptwE1-GST 
pJQ200SK containing a PstI/SacI ptwE1-GST fragment 
from pDrive-ptwE1-GST in the MCS site 
This study 
pJQ200SK-GST-
ptwE1 
pJQ200SK containing a PstI/SacI GST-ptwE1 fragment 
from pDrive-GST-ptwE1 in the MCS site 
This study 
pJQ200SK-
ptwE1::Cm-GST 
pJQ200SK containing a PstI/SacI ptwE1::Cm-GST 
fragment from pDrive-ptwE1::Cm-GST in the MCS site 
This study 
pJS200SK-GST-
ptwE1::Cm 
pJQ200SK containing a PstI/SacI GST-ptwE1::Cm 
fragment from pDrive-GST-ptwE1::Cm in the MCS site 
This study 
a Apr, Cmr, Gmr, Kmr, Tcr, and Tpr = resistance to ampicillin, chloramphenicol, gentamicin, kanamyacin, 
tetracycline, and trimethoprim, respectively. GST= glutathione S-transferase. + and – = positive and 
negative for phenotype, respectively. 
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Table 3.2. Bacterial strains used in Chapter III. 
 
a Tpr and Cmr= resistance to trimethoprim and chloramphenicol, respectively. Ptw= plant tissue 
watersoaking phenotype. GST= glutathione S-transferase. + and – = positive and negative for 
phenotype, respectively. 
Strain Relevant Characteristicsa, b Reference 
Burkholderia cenocepacia   
K56-2 cystic fibrosis isolate, ptw+ Sokol et al., 1999 
AE349 K56-2 ptwD4::Cm, ptw- This study 
AE350 K56-2 ptwE1::Cm,  ptw- This study 
AE351 K56-2 ptwE2::Cm, ptw+ This study 
AE352  AE349 ( pBCRLAR-Tp-ptwD4 ), ptw+ This Study 
AE353  AE350 ( pBCRLAR-Tp-ptwE1 ), ptw+ This study 
AE354 K56-2 ptwB4-lacZYA, ptw+ This study 
AE355 K56-2 ptwD4::Cm; ptwB4-lacZYA, ptw- This study 
AE356 K56-2 ptwE1::Cm; ptwB4-lacZYA, ptw- This study 
AE357 K56-2 ptwE1-GST (C-terminal fusion),  
ptw-
This study 
AE358 K56-2 GST-ptwE1 (N-terminal fusion),  
ptw+
This study 
AE359 K56-2 ptwD4::Cm; ptwE1::Cm-GST (C-
terminal fusion),  ptw-
This study 
AE360 K56-2 ptwD4::Cm; GST-ptwE1::Cm (N-
terminal fusion),  ptw-
This study 
AE361 K56-2 ptwE1::Cm-GST (C-terminal 
fusion),  ptw-
This study 
AE362 K56-2 GST-ptwE1::Cm (N-terminal 
fusion),  ptw-
This study 
   
Escherichia coli   
DH5αMCR F– mcr A ∆ (mrr-hsdRMS-mcrBC) 
Φ80dlacZ∆M15 ∆(lacZYA-argF)U169 
endA1recA1 deoR thi-1 supE44λ–gyrA96 
relA1 
 
Life Technologies, 
Inc. (Gaithersburg, 
MD) 
ED8654 Met- Borck et al., 1976 
HB101 F-, recA13 Boyer and Roulland-
Dussoix, 1969 
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Effector identification and partial purification 
 
Culture supernatants were obtained as previously described (Chapter II). Briefly, 
cultures of strain K56-2 were grown at 37ºC and harvested at late exponential phase by 
centrifugation.  Supernatants (1 L) were filter sterilized and concentrated by 
ultrafiltration using a membrane with a 10 kDa cut-off.  The protein content of the 
supernatant concentrates was determined by the method of Koch and Putnam (1971). 
Supernatant concentrates (30 ml) were separated by preparative isoelectric focusing 
(IEF), using a Rotofor Cell (Bio-Rad Laboratories), and a pH 3-11 ampholyte (Fluka) 
gradient. The resulting fractions (1-2 ml) were dialyzed against 0.05 M Tris pH 7.0 and 
tested for plasmolytic activity using the carrot protoplast assay as previously described 
(Chapter II).  Active fractions (pH 9-11) were combined and subjected to a second IEF 
separation using a narrow pH 7-11 ampholyte gradient. The active fractions were 
dialyzed against 0.05 M Tris pH 7.0, and tested for plasmolytic activity, and quantified 
for protein concentration.  Samples were concentrated 10X using a speed vac (Savant), 
separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), 
and visualized using a non-fixing sliver stain (Blum et al., 1987). 
 
Activity testing of IEF fractions 
 
Protoplasts were obtained as described in Chapter II (Jones et al., 1990).  Briefly, the 
epidermis of young surface sterilized carrots was resected with a sterile scalpel and 
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discarded.  Cortical and phloem tissues were obtained, diced into fragments and placed 
in a sterile petri dish containing 20 ml of a filter sterilized enzyme solution.  Tissue was 
digested in the dark for 5 h at 28ºC with gentle shaking (50 rpm).  The carrot tissue was 
strained through nylon mesh and centrifuged (825 x g for 5 min at 25ºC).  The 
supernatant was removed using a pipette, and the protoplasts were washed with 20 ml of 
10% mannitol by resuspending with gentle swirling followed by centrifugation.  The 
supernatant was removed and the pellet was gently resuspended in 10 ml of 10% 
mannitol and a 5 ml 20% sucrose cushion was carefully layered in the bottom of the 
tube.  The sample was centrifuged, and the protoplasts were collected from the interface 
and counted using a hemacytometer (Hausser Scientific).  On average, 1.8 x 106 
protoplasts/ml were obtained. 
 The plasmolytic activity of culture supernatants was determined by using 
concentrates that were standardized to a protein concentration of 0.2 µg/ml in 10% 
mannitol.  The standardized concentrates were added to protoplasts.  Assay mixtures and 
controls were incubated in 96-well microtiter plates (Corning) with an average 
concentration of 50 protoplasts per well.  Assays, done in triplicate, were observed for 
changes in protoplast integrity at 2 h intervals for 4 h using a Zeiss inverted microscope.  
Each incubation duration was performed in duplicate in three independent experiments 
with an average of 50 protoplasts examined at 0, 2, and 4 h.  
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Plant tissue assay 
 
Plant tissue watersoaking activity was determined as previously described in Chapter II.  
Briefly, pierced onion bulb scales were inoculated, in triplicate, with 10 µl of an aqueous 
suspension to yield a final concentration of ~106 CFU/scale.  Sterile double distilled-
deionized water was used as a negative control and strain AU1054 served as the positive 
control in all experiments.  Scales were placed on a sheet of surface sterilized aluminum 
foil in containers layered with moistened paper towels, sealed, and incubated at 37ºC.  
Plant tissue watersoaking activity was assessed at 24, 48, and 72 h post-inoculation. 
 
Triparental matings 
 
Triparental matings were performed as previously described in Chapter II.  Briefly, 
donor, mobilizer, and recipient suspensions were made in LB broth from cultures grown 
on solid media under selective conditions, as appropriate, for 18 h. Bacterial suspensions 
were adjusted spectrophotometrically (A600 = 0.5), mixed at an equal ratio (1:1:1), and 
transferred to a positively charged sterile membrane layered on a 100 x 15 mm LB agar 
petri dish.  Following a 6 h incubation period, the cells from the mating and respective 
controls (e.g. donor, mobilizer, and recipient) were washed twice in phosphate buffer 
(0.125 M, pH 7.1) by centrifugation (12,096 x g for 10 min at 5ºC).  The bacterial pellets 
were suspended in phosphate buffer and dilution plated to VBG amended with 500 
µg/ml of Cm and/or 500 µg/ml of Tp, depending on selection needed.  Single colony 
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isolates of individual transconjugants were obtained by streaking on homologous 
selective media.  Cultures were subjected to survey lysis followed by agarose gel 
electrophoresis (Gonzalez and Vidaver, 1979) to confirm plasmid transfer. 
 
Site-directed mutagenesis 
 
For construction of strains AE350 (K56-2 ptwD4::Cm) and AE351 (K56-2 ptwE1::Cm) 
(Table 3.2), products corresponding to ptwD4 and ptwE1, were amplified by PCR using 
primer sets PD4 (PD4-1 and PD4-2), PE1 (PE1-1 and PE1-2), and PE2 (PE2-1 and PE2-
2) (Table 3.3), respectively. Primer sets PD4, PE1, and PE2, (Table 3.3) were designed 
based on sequence data from the B. cenocepacia Genome Project 
(http://www.sanger.ac.uk/Projects/B cenocepacia/).   Each PCR reaction (50 µl) was 
performed using a Taq PCR Master Mix (USB) and a GeneAmp 2700 (Applied 
Biosystems).  Reactions were run for 29 cycles and parameters were as follows:  
denaturation at 95ºC for 1 min; annealing at 55 ºC for 1 min for both primer sets PD4 
and PE1 and annealing at 60°C for PE2; and extension at 72ºC for 1 min. 
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Resulting products were analyzed by agarose gel electrophoresis and cloned into pDrive 
(Qiagen), yielding pDrive-ptwD4, pDrive-ptwE1, and pDrive-ptwE2, respectively. 
Constructs pDrive-ptwD4, pDrive-ptwE1, and pDrive-ptwE2, were transformed into E. 
coli DH5αMCR, by chemical transformation (Sambrook et al., 1989), and transformants 
were selected on LB agar amended with 40 µg/ml of Ap, 50 µM of isopropyl-beta-D-
thiogalactopyranoside (IPTG), and 80 µg/ml 5-bromo-4-chloro-3-indolyl-beta-D-
galactopyranoside (X-gal). Directionality of the insertions was determined by restriction 
enzyme digestion and sequencing analyses (Appendix A).  Specifically, ptwD4 
insertions were determined using SmaI, and ptwE1 and ptwE2 insertions were 
determined using ClaI.  Sequencing was conducted by the Norman E. Borlaug Center for 
Southern Crop Improvement, Laboratory for Plant Genome Technology at Texas A&M 
University.   
 The Cm-resistance cassette, obtained from pBR325 digested with BsaAI and BclI, 
was blunted with T4 Polymerase and inserted into the EcoRV, HaeIII, and AluI sites of 
pDrive-ptwD4, pDrive-ptwE1, and pDrive-ptwE2, respectively to yield pDrive-
ptwD4::Cm, pDrive-ptwE1::Cm, and pDrive-ptwE2::Cm, respectively.  Constructs 
pDrive-ptwD4::Cm, pDrive-ptwE1::Cm, and pDrive-ptwE2::Cm were transformed into 
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Table 3.3. Primers used in Chapter III. 
 
Primera Gene Relevant Characteristics Reference 
PD4-1 ptwD4 5'-TGACTCAGCGAAGGAA-3' Chapter II 
PD4-2 ptwD4 5'-ATCCGGTGGAAGCAA-3' Chapter II 
PE1-1 ptwE1 5’-AGCCTTCACCCGGTAAGGT-3’ This study 
PE1-2 ptwE1 5’-CTAGGTAGGTGAAAATCC-3’ This study 
PE2-1 ptwE2 5’-ACGTGCCGAGATTCTTCAT-3’ This study 
PE2-2 ptwE2 5’-AGGTTCAGATCGACACCGAG-3’ This study 
PB4-1 ptwB4 5’-AACTCAAGATGAATCAT-3’ Chapter II 
PB4-2 ptwB4 5’-AGAACGCATGGTGTTGA-3’ Chapter II 
GST-1 GST 5’-ATGTCCCCTATACTAGGTTA-3’ This study 
GST-2 GST 5’-TCAGTCACGATGCGGC-3’ This study 
a 1=forward primer; 2=reverse primer 
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E. coli DH5αMCR, by chemical transformation (Sambrook et al., 1989), and 
transformants were selected on LB agar amended with 40 µg/ml of Ap and 10 µg/ml of 
Cm. Directionality of the insertions was determined by restriction enzyme digestion and 
sequencing analyses (Appendix B).  Specifically, ptwD4::Cm, ptwE1::Cm, and 
ptwE2::Cm insertions were determined using ScaI.  Plasmids pDrive-ptwD4::Cm, 
pDrive-ptwE1::Cm, and pDrive-ptwE2::Cm were digested with BamHI/SalI to yield 
ptwD4::Cm, ptwE1::Cm, and ptwE2::Cm fragments, which were then ligated to 
pJQ200SK digested with the same restriction enzymes to yield pJQ200SK-ptwD4::Cm, 
pJQ200SK-ptwE1::Cm, and pJQ200SK-ptwE2::Cm, respectively.  Plasmids pJQ200SK-
ptwD4::Cm,  pJQ200SK-ptwE1::Cm, and pJQ200SK-ptwE2::Cm were then transformed 
into E. coli DH5αMCR, by chemical transformation (Sambrook et al., 1989), and 
transformants were selected on LB agar amended with 10 µg/ml of Gm and 10 µg/ml of 
Cm.  Directionality of the insertions was determined by restriction enzyme digestion and 
sequencing analyses (Appendix C).  Specifically, directionality of ptwD4::Cm insertions 
were determined using SalI, and ptwE1::Cm and ptwE2::Cm insertions were determined 
using EcoRI.  Plasmids pJQ200SK-ptwD4::Cm, pJQ200SK-ptwE1::Cm, and pJQ200SK-
ptwE2::Cm were individually mobilized into K56-2 by utilizing pRK2013 in triparental 
matings to obtain allelic exchange mutants.  Exchange mutants were selected on VBG 
amended with 500 µg/ml of Cm. Cm-resistant transconjugants were single colony 
purified and retested for Cmr.  Allelic exchange and loss of the suicide vector was 
confirmed by plasmid survey lysis.  Single colony isolates of insertionally inactivated 
ptwD4 and ptwE1, designated AE349, AE350, and AE351 (Table 3.2), respectively, 
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were tested for the ptw phenotype.  Insertional inactivation of ptwD4 and ptwE1 in 
strains AE349 and AE350, respectively were confirmed by restriction enzyme digestion 
of genomic DNA with BamHI, BamHI/EcoRI, BamHI/ScaI, and BamHI/NotI followed 
by agarose gel electrophoresis and Southern blotting analysis using probes for the Cmr-
cassette, ptwD4 and ptwE1 (Appendix D).  
 
Complementation of disrupted genes 
 
Complementation of the disrupted ptwD4 or ptwE1 was accomplished in trans.  Plasmid 
pBCRLAR (Appendix E) (LiPuma, unpublished) was amended by inserting a Tp-
resistance cassette, obtained from R388 as a BamHI fragment, blunted with T4 
polymerase, into the ScaI site in the Cmr cassette to obtain pBCRLAR-Tp.  Plasmids 
pDrive-ptwD4 and pDrive-ptwE1 were digested with BamHI/SacI, to yield ptwD4 or 
ptwE1 fragments, which were then ligated to pBCRLAR-Tp digested with the same to 
yield pBCRLAR-Tp-ptwD4 and pBCRLAR-Tp-ptwE1, respectively.  Plasmids 
pBCRLAR-Tp-ptwD4 and pBCRLAR-Tp-ptwE1 were then transformed into E. coli 
ED8654, by chemical transformation (Sambrook et al., 1989), and transformants were 
selected on VBG agar amended with 50 µg/ml of Tp and 0.5 mM final concentration of 
methionine.  Plasmids pBCRLAR-Tp-ptwD4 and pBCRLAR-Tp-ptwE1 were then 
individually mobilized into AE349 or AE350, respectively to complement insertionally 
disrupted ptw genes. Chloramphenicol resistant and Tpr transconjugants were single 
colony purified and retested for antibiotic resistance and designated AE352 and AE353 
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(Table 3.2), respectively.  Plasmid survey lysis and PCR were used to confirm plasmid 
transfer, which was reflected by the presence of both the resident and complement 
plasmid as well as inserted and uninserted PCR products. 
 To assess the stability of the constructed plasmids (pBCRLAR-Tp-ptwD4 and 
pBCRLAR-Tp-ptwE1) in the absence of antibiotic selection, cultures (AE352 and 
AE353) were grown in TNB (initial O.D.= 0.05 at 600nm) and the generation time was 
followed spectrophotometrically.  Serial transfers of the cultures were made to obtain 
actively growing cells for 30 generations. Samples were plated at 0, 10, 20, and 30 
generations on selective (VBG amended with 500 µg/ml of Cm and 500 µg/ml of Tp) 
and nonselective media (VBG). The stability of each plasmid was determined by 
comparing the numbers of colonies present on selective and nonselective plates. Means 
from two independent experiments were calculated. 
 
Construction of LacZYA and GST fusion proteins 
 
For construction of strains AE354 (K56-2-ptwB4-lacZYA), AE355 (K56-2-ptwD4::Cm; 
ptwB4-lacZYA), and AE356 (K56-2-ptwE1::Cm; ptwB4-lacZYA) (Table 3.2), a fragment 
corresponding to ptwB4 was amplified by PCR using primer set PB4 (PB4-1 and PB4-2) 
(Table 3.3) and cloned into pCR2.1 (Invitrogen), yielding pCR2.1-ptwB4.  The ptwB4 
fragment was excised by digestion using XbaI and SmaI and ligated to pFUSE (Baümler 
et al., 1996) digested with the same enzymes to yield pFUSE-ptwB4.  Plasmid pFUSE-
ptwB4 was then transformed into E. coli DH5αMCR, by chemical transformation 
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(Sambrook et al., 1989), and transformants were selected on LB agar amended with 10 
µg/ml of Cm.  Directionality of the insertions was determined by restriction enzyme 
digestion with SalI and sequencing analyses (Appendix F).  Plasmid pFUSE-ptwB4 was 
individually mobilized into K56-2, AE349, and AE350, and recombinants were 
designated AE354, AE355, and AE356, respectively, and tested for the ptw phenotype.  
Integration of LacZYA fusions were confirmed by PCR and Southern blot analysis.  
 To obtain the GST cassette, a fragment corresponding to bp 258 to 977 of pGEX4T-1 
was amplified using primer set GST (GST-1 and GST-2) (Table 3.3). Each PCR reaction 
(50 µl) was performed using a Taq PCR Master Mix (USB) and a GeneAmp 2700 
(Applied Biosystems).  Reactions were run for 29 cycles and parameters were as 
follows:  denaturation at 95ºC for 1 min; annealing at 57 ºC for 1 min for primer set 
GST; and extension at 72ºC for 1 min.  Resulting products were analyzed by agarose gel 
electrophoresis and cloned into pDrive (Qiagen), yielding pDrive-GST.  Plasmid pDrive-
GST was transformed into E. coli DH5αMCR, by chemical transformation (Sambrook et 
al., 1989), and transformants were selected on LB agar amended with 40 µg/ml of Ap, 
50 µM of isopropyl-beta-D-thiogalactopyranoside (IPTG), and 80 µg/ml 5-bromo-4-
chloro-3-indolyl-beta-D-galactopyranoside (X-gal). Directionality of the insertion was 
determined by restriction enzyme digestion with BamHI and sequencing analyses 
(Appendix G). Sequencing was conducted by the Norman E. Borlaug Center for 
Southern Crop Improvement, Laboratory for Plant Genome Technology at Texas A&M 
University.  
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 Fragments corresponding to ptwE1 and ptwE1::Cm were obtained using BamHI/SacI 
from pDrive-ptwE1 and pDrive-ptwE1::Cm, respectively. A ptwE1 fragment was 
blunted with T4 polymerase and ligated individually to pDrive-GST digested with 
HindIII or KpnI and then blunted with T4 polymerase, yielding pDrive-ptwE1-GST and 
pDrive-GST-ptwE1.  A ptwE1::Cm fragment was blunted with T4 polymerase and 
ligated individually to pDrive-GST digested with HindIII or KpnI and then blunted with 
T4 polymerase, yielding pDrive-ptwE1::Cm-GST and pDrive-GST-ptwE1::Cm. 
Directionality of the insertion was determined by restriction enzyme digestion with 
BsaAI/XbaI and sequenced to confirm in frame fusion of GST with ptwE1 or ptwE1::Cm 
(Appendix H).   
 Plasmids pDrive-ptwE1-GST, pDrive-GST-ptwE1, pDrive-ptwE1::Cm-GST, and 
pDrive-GST-ptwE1::Cm were digested with EcoRI to yield ptwE1-GST, GST-ptwE1, 
ptwE1::Cm-GST, and GST-ptwE1::Cm fragments, blunted with T4 polymerase, ligated 
to pJQ200SK digested with SmaI to yield pJQ200SK-ptwE1-GST, pJQ200SK-GST-
ptwE1, pJQ200SK-ptwE1::Cm-GST, and pJQ200SK-GST-ptwE1::Cm, respectively.  
Plasmids pJQ200SK-ptwE1-GST, pJQ200Sk-GST-ptwE1, pJQ200SK-ptwE1::Cm-GST, 
and pJQ200SK-GST-ptwE1::Cm were then transformed into E. coli DH5αMCR, by 
chemical transformation (Sambrook et al., 1989), and transformants were selected on LB 
agar amended with 10 µg/ml of Gm and/or 10 µg/ml of Cm.  Directionality of the 
insertions was determined by restriction enzyme digestion with ClaI/XbaI and 
sequencing analyses (Appendix I).   
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 Plasmids pJQ200SK-ptwE1-GST and pJQ200SK-GST-ptwE1 were individually 
mobilized into K56-2 and AE50 (K56-2 ptwD4::Cm) by utilizing pRK2013 in triparental 
matings.  Transconjugants were selected on VBG or VBG amended with 500 µg/ml of 
Cm, respectively.  Transconjugants were single colony purified and loss of the suicide 
vector was confirmed by PCR and plasmid survey lysis (Gonzalez and Vidaver, 1979).  
Single colony isolates were designated AE357 (K56-2 ptwE1-GST), AE358 (K56-2 
GST-ptwE1), AE359 (K56-2 ptwD4::Cm; ptwE1-GST), and AE360 (K56-2 ptwD4::Cm; 
GST-ptwE1), respectively, and tested for the ptw phenotype.  Plasmids pJQ200SK-
ptwE1::Cm-GST and pJQ200SK-GST-ptwE1::Cm were individually mobilized into 
K56-2 by utilizing pRK2013 in triparental matings.  Transconjugants were selected on 
VBG amended with 500 µg/ml of Cm.  Cm-resistant transconjugants were single colony 
purified and loss of the suicide vector was confirmed by plasmid survey lysis (Gonzalez 
and Vidaver, 1979).  Single colony isolates were designated AE361 (K56-2 ptwE1::Cm-
GST), and AE362 (K56-2 GST-ptwE1::Cm), respectively, and tested for the ptw 
phenotype.   
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β-galactosidase assay 
 
β-galactosidase assays were carried out with whole cells as described by Sambrook et al. 
(1989) with the modification that the reaction mixtures were centrifuged before the 
determination of A420. β-galactosidase activity was expressed as Miller Units 
(A420/volume).  Minimal background β-galactosidase activity was detected from strain 
K56-2.  Each β-galactosidase experiment was performed in triplicate in three 
independent experiments.  Data were expressed as average Miller Units ± SD.  
 
Detection of GST fusion proteins 
 
Burkholderia cenocepacia cultures inoculated in 50 ml of M9-glucose to a starting 
optical density of 0.05 at 425 nm were incubated at 37ºC with shaking at 200 rpm for 20 
h.  Bacteria were pelleted and resuspended in 1× Laemmli sample buffer at a 
concentration of 1010 CFU/ml.  Culture supernatants were lyophilized and resuspended 
in 1ml of 1× Laemmli sample buffer.  Both bacterial pellet and supernatants were heated 
at 100ºC for 5 min, and the total protein from 108 CFU (0.01 ml) or 10 µl of 50× 
supernatant was separated by SDS-PAGE (Laemmli, 1970).  Proteins were transferred to 
polyvinylidene difluoride membranes by electro-blotting and probed with polyclonal 
goat antibody to GST (Amersham Biosciences).  The bound antibody was detected by 
using anti-goat IgG conjugated to horseradish peroxidase and HyGlo chemiluminescent 
HRP antibody detection reagent (Denville) using HyBlot CL autoradiography film. 
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RESULTS 
 
Identification of putative effector(s) 
 
Analysis of 10-kb regions flanking the Ptw gene cluster of B. cenocepacia K56-2 
identified an ORF, designated ptwE1 (Fig. 3.1). Translation of ptwE1 sequence predicted 
a protein with a molecular mass of 14 kDa, and showed no significant sequence 
similarity to known proteins by BLAST analysis. An isoelectric point (PI) calculated 
using the ProtParam Tool (http://www.expasy.org/cgi-bin/protparam) was 11.6.   
 Previous studies indicate that an effector protein(s) is translocated by the Ptw type IV 
secretion system into the extracellular milieu (Engledow et al., 2004). Proteins in 
concentrated B. cenocepacia K56-2 broth culture supernatants were separated by 
preparative IEF, which in the presence of a broad ampholyte gradient (pH 3-11) yielded 
three fractions with plasmolytic activity (P>0.05) corresponding to a PI ranging from 9-
ll. To obtain further separation, an additional IEF, using a narrow ampholyte gradient 
(pH 7-11), was performed on the combined plasmolytically active fractions. Two 
fractions exhibited significantly more plasmolytic activity compared to controls or other 
fractions (P> 0.05).  Isoelectric points of plasmolytically active fractions approximately 
correspond to the predicted PI of PtwE1.  
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Fig. 3.1. A 50 kb segment from plasmid pK56-2 containing the Ptw type IV secretion 
system (TFSS) cluster and effector ORFs.  
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 Since recent work indicates that effectors translocated by type IV secretion systems 
contain a conserved positively charged C-terminal signal that is necessary for 
translocation (Simone et al., 2001, Vergunst et al., 2000; Vergunst et al., 2003; Vergunst 
et al., 2005) we analyzed the C-terminal region of PtwE1 for amino acid content, net 
charge, and consensus sequences.  The incidence of Arg residues among the C-terminal 
20 amino acids for PtwE1, was 20%, which is higher than expected for the Arg 
composition of B. cenocepacia proteins (~7.2%), and the calculated net charge was +3. 
Alignment of the 30 C-terminal amino acids of PtwE1 showed similarity in position of 
Arg residues to known type IV secreted proteins (Fig. 3.2).  One additional ORF, 
designated ptwE2, which was positioned upstream of the Ptw system, was identified; 
however, the C-terminal signal did not show homologous Arg residue positioning nor a 
significant increase in incidence of Arg residues, and an insertional mutation had no 
effect on the ptw phenotype.  
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Fig 3.2. Alignment of the C-terminal amino acids of A. tumefaciens VirE2, VirE3, and 
VirF; RSF1010 MobA; and B. cenocepacia effector protein PtwE1. 
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Site-directed mutagenesis of Ptw effector and effect on the ptw phenotype 
 
By combining site-directed mutagenesis of ptwD4 and ptwE1 with cytotoxic assays 
employing both plant tissue and protoplasts, we determined that effector protein PtwE1 
was involved in production of the ptw phenotype. Complementation in trans of the 
mutants resulted in restoration of the ptw phenotype (Fig. 3.3). Stability testing of strains 
AE352 and AE353 showed that pBCRLAR-Tp-ptwD4 and pBCRLAR-Tp-ptwE1 were 
stable for at least 30 generations under non-selective conditions, with an average 
retention rate of 89 % (Table 3.4). In order to determine whether an insertional mutation 
in either ptwD4 or ptwE1 exerted a polar effect on downstream ptw genes, strains 
containing a LacZYA fusion downstream of ptwB4 [AE354 (K56-2 ptwB4-lacZYA), 
AE355 (K56-2 ptwD4::Cm; ptwB4-lacZYA), and AE356 (K56-2 ptwE1::Cm; ptwB4-
lacZYA)] were constructed. Insertional mutations in either ptwD4 or ptwE1 did not result 
in any downstream affects as determined by β-galactosidase activity (Fig. 3.4).  Strain 
AE354 (K56-2 ptwB4::lacZYA) remained capable of producing the ptw phenotype on 
onion tissue.  
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Fig. 3.3. Analysis of PtwE1 using the plant tissue watersoaking assay. (A) Pierced onion 
bulb scale inoculated with B. cenocepacia strain K56-2 showing partial tissue collapse 
and translucence characteristic of the plant tissue watersoaking (ptw) phenotype. (B) 
Pierced onion bulb scale inoculated with ptw-negative mutant (AE349 or AE350). (C) 
Pierced onion bulb scale inoculated with a complemented ptw-negative mutant (AE352 
or AE353).  
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Table 3.4.  Stability testing of plasmids pBCRLAR-Tp-ptwD4 and pBCRLAR-Tp-
ptwE1 in complemented strains AE352 and AE353 of ptwD4 and ptwE1 mutant strains 
AE350 and AE351, respectively.  
 
 % Plasmid Containing CFU a, b
 Strain 
Generations AE352 AE353 
0 100 100 
10 98 97 
20 95 94 
30 89 89 
a Percent plasmid containing CFU are the average for two independent experiments. 
b All strains were grown in TNB medium at 37°C while shaking. 
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Fig 3.4. β-galactosidase activity of K56-2, AE354 (K56-2 ptwB4-lacZYA), AE355 (K56-
2 ptwD4::Cm; ptwB4-lacZYA), and AE355 (K56-2 ptwE1::Cm; ptwB4-lacZYA).  β-
galactosidase activity of AE355 and AE256 is reflective of a nonpolar mutation.  Data 
are expressed as the average of three independent experiments performed in triplicate ± 
SD. 
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Translocation of PtwE1 by the Ptw type IV secretion system  
 
To further determine if the Ptw type IV secretion system was responsible for the 
translocation of PtwE1 into the extracellular milieu, and whether the C-terminal portion 
of PtwE1 was important for that translocation GST fusion strains AE357 (ptwE1-GST), 
AE358 (GST-ptwE1), AE359 (ptwD4::Cm; ptwE1-GST), AE360 (ptwD4::Cm; GST-
ptwE1), AE361 (ptwE1::Cm-GST), and AE362 (GST-ptwE1::Cm) were evaluated for 
translocation of PtwE1. Results from GST experiments are presented in Table 3.5 and 
Figure 3.5. The GST fusion proteins were detectable in culture supernatants from strains 
AE358 and AE362, whereas they were not detectable in strains AE357, AE359, AE360, 
or AE362.  The fusion proteins detected in supernatants of AE358 and AE362 were 
approximately 41 and 73 kDa, respectively, which is the predicted size for ptwE1 
(14kDa) fused with GST (27 kDa) and ptwE1::Cm (46 kDa) fused with GST (27 kDa).  
The GST fusion proteins were also detectable in bacterial pellets from strains AE357, 
AE358, AE359, AE360, AE361, and AE362.  Strains AE357, AE358, AE359, and 
AE360 all showed a fusion protein of approximately 41 kDa, which is the predicted size 
for ptwE1 (14 kDa) fused with GST (27 kDa), whereas strains AE361 and AE362 
showed a fusion protein of about 73 kDa, which is the predicted size for ptwE1::Cm (46 
kDa) fused with GST (27 kDa).  Only strain AE358 remained capable of producing the 
ptw phenotype on onion tissue.   
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Table 3.5. GST fusion protein detection in bacterial culture supernatants and pellets. 
Strains AE357 (ptwE1-GST), AE358 (GST-ptwE1), AE359 (ptwD4::Cm; ptwE1-GST), 
AE360 (ptwD4::Cm; GST-ptwE1), AE361 (ptwE1::Cm-GST), and AE362 (GST-
ptwE1::Cm) were used for GST fusion studies. 
 
Strain Strain Description GST Fusion Detected 
in Supernatant 
GST Fusion 
Detected in Pellet 
Ptw Activity 
AE357 ptwE1-GST (C-terminal 
fusion) 
No Yes No 
AE358 GST-ptwE1 (N-terminal 
fusion) 
Yes Yes Yes 
AE359 ptwD4::Cm; ptwE1-GST 
(C-terminal fusion) 
No Yes No 
AE360 ptwD4::Cm; GST-ptwE1 
(N-terminal fusion) 
No  Yes No 
AE361 ptwE1::Cm-GST (C-
terminal fusion) 
No Yes No 
AE362 GST-ptwE1::Cm (N-
terminal fusion) 
Yes Yes No 
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Fig. 3.5. Western blot analysis of supernatants and pellets from GST fusion strains. 
AE357 (ptwE1-GST), AE358 (GST-ptwE1), AE359 (ptwD4::Cm; ptwE1-GST), AE360 
(ptwD4::Cm; GST-ptwE1), AE361 (ptwE1::Cm-GST), and AE362 (GST-ptwE1::Cm) 
were used for Southern blot analysis. Molecular masses of PtwE1 and PtwE1::Cm are 14 
and 46 kDa, respectively; and molecular mass of GST is 27 kDa.  
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DISCUSSION 
 
Previously, two type IV secretion systems were identified in B. cenocepacia of the 
epidemic ET12 lineage; one system is plasmid encoded (designated the Ptw type IV 
secretion system), whereas the other is chromosomally encoded (designated the VirB/D 
type IV secretion system) and shows homology to the A. tumefaciens VirB/D4 type IV 
secretion system (Engledow et al., 2004).  The plasmid encoded Ptw system is a 
chimeric type IV secretion system composed of VirB/D4-like elements and F-specific 
subunits.  This system is responsible for production of the plant disease-associated ptw 
phenotype and the translocation of Ptw effector protein(s).  Studies in our laboratory 
indicate that this phenotype is expressed by all B. cenocepacia strains included in the 
Bcc experimental strain panel described by Mahenthiralingam et al. (2000b). Studies on 
the chromosomally encoded VirB/D system using mutational analysis indicated that this 
system is not involved in production of the ptw phenotype.  
 Most bacterial protein secretion systems recognize their substrates through a signal in 
the N terminus. For example, there is a clear consensus in the cleavable N-terminal 
signal peptide sequences recognized by the Sec-dependent and twin Arg translocation 
systems (Dilks et al., 2003; Cao and Saier, 2003).  However, to date no consensus has 
been found to define the N-terminal signal of effectors secreted by type III or type IV 
secretion systems. Recent studies of A. tumefaciens and Bartonella henselae type IV 
secretion systems have shown that the interaction between the C-termini of effector 
proteins and VirD4 is a critical step in effector translocation.  In these studies, a 
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positively charged C-terminal signal was present in several type IV secreted proteins 
including the VirE2 effector of A. tumefaciens and the MobA relaxase of RSF1010 
(Vergunst et al., 2005).  In this study two ORFs designated ptwE1 and ptwE2 were 
identified that had no known homologs by BLAST analysis.  The C-terminus of PtwE1 
was positively charged and showed a higher incidence of Arg residues than expected for 
B. cenocepacia proteins, and an alignment of the 30 C-terminal amino acids showed 
similarity in the position of these residues.  In contrast, Ptw2 did not show homologous 
Arg residue positioning, or a significant increase in incidence of Arg residues.  Site-
directed mutagenesis indicated that PtwE1 was involved in the expression of the ptw 
phenotype, whereas PtwE2 was not.   
 Studies utilizing GST fusion proteins showed that PtwE1 was translocated by the Ptw 
type IV secretion system and that the positively charged C-terminal region of PtwE1 is 
important for translocation.  Strains with N-terminal fusions of GST to PtwE1 and a 
functioning type IV secretion system were able to translocate the GST-PtwE1 or GST-
PtwE1-Cm to the extracellular milieu, whereas strains with the same fusions but a non-
functional type IV secretion system coupling protein (PtwD4) did not. Strains with a C-
terminal fusion of GST to PtwE1 were not able to translocated PtwE1 regardless of 
whether or not there was a functional type IV secretion system.  However, GST fusions 
were detected in all cellular fractions of GST fusion strains showing that GST fusion 
proteins were being produced but not exported.  A C-terminal GST fusion to PtwE1 (in 
the presence of a functioning type IV secretion system) resulted in loss of the ptw 
phenotype, since PtwE1 was no longer being translocated by the type IV secretion 
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system. Accumulating evidence suggests that it is the coupling protein that recruits both 
the protein substrates and the nucleoprotein complex to the type IV secretion system 
(Llosa and O’Callaghan, 2004; Cascales and Christie, 2004; Atmakuri et al., 2003; Llosa 
et al., 2002; Escudero et al., 2003; Szpirer et al., 2000). Cascales and Christie (2004) 
recently demonstrated that the coupling protein VirD4 is the first component of the type 
IV secretion system to interact with the T-DNA/VirD2 transfer intermediate. The VirE2 
protein interacts at the cell poles of the bacterium with VirD4 (Atmakuri et al., 2003), 
strongly supporting the model that VirD4 is the cytoplasmic component of the type IV 
secretion system that sorts nucleoprotein complexes and effector proteins for 
translocation and that type IV secretion systems are actually committed protein 
translocation systems (Regensburg-Tuïnk and Hooykaas, 1993; Llosa et al., 2002). 
Translocation of the effector proteins VirF, VirE2, and VirE3 is also mediated by a C-
terminal transport signal (Vergunst et al., 2000; Atmakuri et al., 2004; Vergunst et al., 
2003; Simone et al., 2001); and recent studies show a correlation between a positively 
charged C-terminus and transport function (Vergunst et al., 2005).  
 In conclusion, this study (Chapter III) has identified an effector protein which is 
involved in the production of the ptw phenotype in B. cenocepacia strain K56-2.  The 
effector was also shown to be translocated by the previously identified (Chapter II) Ptw 
type IV secretion system.  Mutational analysis of PtwE1 indicates that it may play a role 
in expression of the ptw phenotype.  GST fusion strains indicate that PtwE1 is 
translocated into the extracellular milieu via the Ptw type IV secretion system and that 
the positively charged C-terminal portion of PtwE1 is involved in the translocation 
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process.  Future studies using the bimolecular fluorescence complementation assay 
(Atmakuri et al., 2003) will elucidate the interaction between PtwE1 and PtwD4. 
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CHAPTER IV 
IDENTIFICATION AND CHARACTERIZATION OF A GROUP IVA TYPE IV 
SECRETION SYSTEM AND EFFECTOR IN Burkholderia cenocepacia OF THE 
PHDC LINEAGE 
 
INTRODUCTION 
 
Organisms belonging to the Burkholderia cepacia complex (Bcc) can cause life 
threatening infections in patients with cystic fibrosis (CF) (Govan and Deretic, 1996; 
LiPuma, 1998). Although Bcc organisms only infect a relatively small proportion of 
these patients, they have a significant impact on survival and numerous reports have 
provided evidence for patient to patient spread and nosocomial transmission (Coenye 
and LiPuma, 2003). Isolates belonging to all nine Bcc species have been recovered from 
the sputum of patients with CF, but recent large scale surveys in several countries 
(Coenye and Vandamme, 2003) have shown that, although there are national differences, 
most patients are infected with B. cenocepacia (Vandamme et al., 2003). Several 
epidemic B. cenocepacia lineages have been described, including the ET12 (Johnson et 
al., 1994), PHDC (Chen et al., 2001), and Midwest (Kumar et al., 1997). Isolates 
belonging to the transatlantic ET12 lineage infect many patients in Canada and the UK, 
whereas isolates belonging to the PHDC lineage appear to be dominant among CF 
patients in the mid-Atlantic region of the USA (Chen et al., 2001) and has also been 
reported in Europe (Coenye et al., 2004). Molecular epidemiological studies have shown 
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that B. cenocepacia strains of the PHDC lineage can be isolated from agricultural soil in 
New York State (LiPuma et al., 2002) and is much more commonly found in CF patients 
in the USA than was initially appreciated (Liu et al., 2003).  Isolates of the Midwest 
lineage are found in the Midwest region of the USA (Kumar et al., 1997).  
 Several putative virulence determinants for B. cenocepacia including hemolysins 
(Hutchinson et al., 1998; Vasil et al., 1990), siderophores (Sokol, et al., 1999), cable pili 
(Sajjan et al., 2000a), and membrane active effector protein(s) (Engledow et al., 2004), 
have been reported.  Burkholderia cenocepacia strain K56-2, is part of the clinically 
problematic ET12 lineage. The strain produces plant tissue watersoaking (ptw) on onion 
tissue, which is a plant disease-associated trait (Engledow et al., 2004).  In Chapter II a 
plasmid-encoded type IV secretion system was identified, in strain K56-2, that is 
functionally an effector translocator and responsible for expression of the ptw 
phenotype; a chromosomally-encoded type IV secretion system was also identified for 
which the function is at this time is unknown (Engledow et al., 2004).  It has been 
determined that the ptw phenotype is common among isolates belonging to B. 
cenocepacia of distinct lineages.  In this study (Chapter IV) it was determined that 
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 isolates representative of the PHDC lineage contain a VirB/D-like type IV secretion 
system, designated BcVirB/D, and at least one putative effector that appears to be 
involved in the expression of the ptw phenotype. The BcVirB/D type IV secretion 
system was found to not only function as an effector translocator, but also as a 
conjugation system. Mutational analysis of the BcVirB/D system indicates that the 
BcVirB2 and BcVirD4 play a functional role in expression of the ptw phenotype and 
DNA transfer. Preliminary characterization of the transfer function indicates that the 
oncogenic suppression activity protein (Osa) can disrupt transfer of proteins via the 
BcVirB/D system. 
 
EXPERIMENTAL PROCEDURES 
 
Media and growth conditions 
 
Descriptions of plasmids and bacterial strains used in this study are listed in Tables 4.1 
and 4.2, respectively.  Luria Bertanni (LB) medium was used for routine maintenance of 
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cultures.  Minimal medium Vogel Bonner (Vogel and Bonner, 1965) amended with 
1.0% glucose (VBG) was used in mating experiments.  Minimal medium M9 (Sambrook 
et al., 1989) containing 1.0% glucose was used for culturing bacteria for supernatant  
analysis.  Stability testing of pBCRLAR derivatives was accomplished using tryptone 
nutrient broth (TNB) (Hansen and Olsen, 1978) for liquid culture and VBG amended 
with 500 µg/ml of trimethoprim (Tp) and 500 µg/ml tetracycline (Tc) or VBG for 
selective and non-selective plating.  Burkholderia cenocepacia and Escherichia coli 
strains were grown at 37ºC.  Media were supplemented with appropriate concentrations 
of antibiotics as needed for selection.  Antibiotics were added to media at the following 
concentrations: 500 µg/ml of chloramphenicol (Cm), 500 µg/ml of trimethoprim (Tp), 
and 500 µg/ml of naldixic acid (Nal) for selection and maintenance of B. cenocepacia 
and B. multivorans isolates and derivatives; and 10 µg/ml tetracycline (Tc), 10 µg/ml 
gentamicin (Gm), 40 µg/ml ampicillin (Ap), and 100 µg/ml Tp for selection and 
maintenance of E. coli. 
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Table 4 .1. Plasmids used in Chapter IV. 
Plasmid Relevant Characteristicsa, b Reference  
pDrive Cloning Vector:  Kmr, Apr, pUC origin, T7, SP6, lacZα+ Qiagen 
pRK2013 Kmr, Tra+, Mob+, ColE1 replicon Figurski and 
Helinski, 1979 
pBR325 Tcr, Apr, Cmr, ColE1 replicon Blank and Wilson, 
1982 
pR388 IncW, Sur, Tpr Datta and Hedges, 
1972 
pJQ200SK Gmr, sacB, Mob+, p15A replicon Quandt and Hynes, 
1993 
pBCRLAR Cmr, Mob+, lacZα+, pBBR1 replicon LiPuma, University 
of Michigan 
pML122 Gmr, Kmr, IncQ, Mob+, p15A replicon Labes et al., 1990 
pKA165 Carbr, virB promoter, osa Berger and 
Christie, 1994 
pURF047-Tp pURF047 with 2.0 kb Tpr cassette inserted at ScaI site of 
Apr cassette 
Chapter II 
pBCRLAR-Tp pBCRLAR containing a blunted Tpr cassette inserted at 
ScaI site of Cmr cassette 
This study 
pDrive-bcvirB2 pDrive containing a bcvirB2 PCR product This study 
pDrive-bcvirD4 pDrive containing a bcvirD4 PCR product This study 
pDrive-bcvirP3 pDrive containing a bcvirP3 PCR product This study 
pDrive-bcvirB2::Cm pDrive-bcvirB2 containing a blunted BsaAI/BclI Cmr 
fragment from pBR325 in the EcoRV site of bcvirB2   
This study 
pDrive-bcvirD4::Cm pDrive-bcvirD4 containing a blunted BsaAI/BclI Cmr 
fragment from pBR325 in the ScaI site of bcvirD4   
This study 
pDrive-bcvirP3::Cm pDrive-bcvirP3 containing a blunted BsaAI/BclI Cmr 
fragment from pBR325 in the BsaAI site of bcvirP3   
This study 
pJQ200SK-
bcvirB2::Cm 
pJQ200SK containing a BamHI/SacI bcvirB2-Cm fragment 
from pDrive-bcvirB2::Cm in the MCS 
This study 
pJQ200SK-
bcvirD4::Cm 
pJQ200SK containing a KpnI/HindIII bcvirD4-Cm 
fragment from pDrive-bcvirD4::Cm in the MCS 
This study 
pJQ200SK-
bcvirP3::Cm 
pJQ200SK containing a BamHI/HindIII bcvirP3-Cm 
fragment from pDrive-bcvirP3::Cm in the MCS 
This study 
pBCRLAR-Tp-
bcvirB2 
pBCRLAR-Tp containing a BamHI/SacI bcvirB2 fragment 
from pDrive-bcvirB2 in the MCS 
This study 
pBCRLAR-Tp-
bcvirD4 
pBCRLAR-Tp containing a KpnI/HindIII bcvirD4 fragment 
from pDrive-bcvirD4 in the MCS 
This study 
pBCRLAR-Tp-
bcvirP3 
pBCRLAR-Tp containing a BamHI/HindIII bcvirP3 
fragment from pDrive-bcvirP3 in the MCS 
This study 
pML122-Tp pML122 containing a blunted BamHI Tpr cassette inserted 
at SmaI of the Gmr cassette 
This study 
pURFO47-Tp-osa pURF047-Tp containing blunted NdeI/XhoI osa fragment 
from pKA165 in the MCS (SmaI) 
This study 
a Apr, Carbr, Cmr, Gmr, Kmr, Sur, Tcr, and Tpr = resistance to ampicillin, carbenicillin, chloramphenicol,     
genamicin, kanamyacin, sulphonamide, tetracycline, and trimethoprim, respectively.  + and – = positive 
and negative for phenotype, respectively. 
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Table 4.2. Bacterial strains used in Chapter IV. 
Strain Relevant Characteristicsa Reference 
Burkholderia cenocepacia   
AU1054 CF respiratory isolate, PHDC lineage, ptw+ LiPuma, J. J. 
(University of 
Michigan) 
AE607 AU1054 bcvirB2::Cm, ptw- This study 
AE608 AU1054 bcvirD4::Cm, ptw- This study 
AE609 AU1054 bcvirP3::Cm, ptw- This study 
AE610 AE607 (pBCRLAR-Tp-bcvirB2), ptw+ This study 
AE611 AE608 (pBCRLAR-Tp-bcvirD4), ptw+ This study 
AE612 AE609 (pBCRLAR-Tp-bcvirP3), ptw+ This study 
AE613 AU1054 (pURFO47-Tp) This study 
AE614 AE608 (pURFO47-Tp) This study 
AE615 AU1054 (pML122-Tp) This study 
AE616 AE608 (pML122-Tp) This study 
AE617 AU1054 (pURFO47-Tp-osa), ptw- This study 
   
Burkholderia multivorans   
TL249-2 Soil isolate, plasmid-free, lys-2, Peh–, ino+, 
ita+
Gaffney and 
Lessie, 1987 
BCS11 TL249-2 (Nalr) This Study 
   
Escherichia coli   
DH5αMCR F-, mcrA, ∆ (mrr-hsdRMS-mcrBC) 
φ80dlacZ∆M15 ∆(lacZYA-argF)U169 
endA1recA1 deoR thi-1 supE44λ–gyrA96 
relA1 
Life Technologies, 
Inc. (Gaithersburg, 
MD) 
HB101 F-, recA13 Boyer and 
Roulland-
Dussoix, 1969 
ED8654 Met- Borck et al., 1976 
a Nalr, Tpr, Cmr= resistance to nalidixic acid, trimethoprim, and chloramphenicol, respectively. Ptw= plant  
tissue watersoaking phenotype. Peh = polygalacturonase phenotype. Ino and ita = ability to catabolize  
myo-inositol and itaconic acid. + and – = positive and negative for phenotype, respectively. 
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Plant tissue assay 
 
Plant tissue watersoaking activity was determined as previously described in Chapter II.  
Briefly, pierced onion bulb scales were inoculated, in triplicate, with 10 µl of an aqueous 
suspension to yield a final concentration of ~106 CFU/scale.  Sterile double distilled-
deionized water was used as a negative control and strain AU1054 served as the positive 
control in all experiments.  Scales were placed on a sheet of surface sterilized aluminum 
foil in containers layered with moistened paper towels, sealed, and incubated at 37ºC.  
Plant tissue watersoaking activity was assessed at 24, 48, and 72 h post-inoculation. 
 
Activity testing of culture supernatants 
 
Culture supernatants were obtained as previously described in Chapter II.  Briefly, 
cultures of strain AU1054, AE608 (AU1054 bcvirD4::Cm), and AE611 [AU1054 
bcvirD4::Cm (pBCRLAR-Tp-bcvirD4)] were grown in M9 medium at 37ºC and 
harvested at late exponential phase (A425 = 0.9) by centrifugation (16,000 x g, 15 min at 
5ºC).  Supernatants (1 L) were filter sterilized using 0.22 µM filters (Pall) and 
concentrated to 3 ml using an Amicon ultrafiltration stirred cell (MWCO 10,000).  
Protein concentration of supernatant concentrates was determined by the method of 
Koch and Putnam (1971).  Concentrated uninoculated medium (1L) served as the 
negative control. 
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 Plant protoplasts were used as the plant tissue system to obtain a quantitative 
measurement of activities of concentrated culture supernatants.  Protoplasts were 
obtained as described in Chapter II (Jones et al., 1990).  Briefly, the epidermis of young 
surface sterilized carrots was resected with a sterile scalpel and discarded.  Cortical and 
phloem tissues were obtained, diced into fragments and placed in a sterile petri dish 
containing 20 ml of a filter sterilized enzyme solution.  Tissue was digested in the dark 
for 5 h at 28ºC with gentle shaking (50 rpm).  The carrot tissue was strained through 
nylon mesh and centrifuged (825 x g for 5 min at 25ºC).  The supernatant was removed 
using a pipette, and the protoplasts were washed with 20 ml of 10% mannitol by 
resuspending with gentle swirling followed by centrifugation.  The supernatant was 
removed and the pellet was gently resuspended in 10 ml of 10% mannitol and a 5 ml 
20% sucrose cushion was carefully layered in the bottom of the tube.  The sample was 
centrifuged, and the protoplasts were collected from the interface and counted using a 
hemacytometer (Hausser Scientific).  On average, 1.8 x 106 protoplasts/ml were 
obtained. 
 The plasmolytic activity of supernatants was determined by using concentrates that 
were standardized to a protein concentration of 0.2 µg/ml in 10% mannitol.  The 
standardized concentrates were added to protoplasts.  Assay mixtures and controls were 
incubated in 96-well microtiter plates (Corning) with an average concentration of 50 
protoplasts per well.  Assays, done in triplicate, were observed for changes in protoplast 
integrity at 2 h intervals for 8 h using a Zeiss inverted microscope.  In addition, the effect 
of temperature, proteinase K, RNase, and DNase on plasmolytic activity was tested as 
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previously described in Chapter II.  Each incubation duration was performed in duplicate 
in three independent experiments with an average of 50 protoplasts examined at 0, 2, 4, 
6, and 8 h.  Data were expressed as percent plasmolysis ± SD for three independent 
experiments.  Plasmolysis was analyzed as a function of time, dilution, treatment and 
their interactions.  Level of statistical significance of the different variables was 
determined with an analysis of variance (ANOVA).  Statistical analysis was performed 
using SAS software and the general linear model procedure (SAS Institute Inc.).    
 
Triparental and biparental matings 
 
Triparental matings were performed as previously described in Chapter II.  Briefly, 
donor, mobilizer, and recipient suspensions were made in LB broth from cultures grown 
on solid media under selective conditions, as appropriate, for 18 h. Bacterial suspensions 
were adjusted spectrophotometrically (A600 = 0.5), mixed at an equal ratio (1:1:1), and 
transferred to a positively charged sterile membrane layered on a 100 x 15 mm LB agar 
petri dish.  Following a 6 h incubation period, the cells from the mating and respective 
controls (e.g. donor, mobilizer, and recipient) were washed twice in phosphate buffer 
(0.125 M, pH 7.1) by centrifugation (12,096 x g for 10 min at 5ºC).  The bacterial pellets 
were suspended in phosphate buffer and dilution plated to VBG amended with 500 
µg/ml of Cm and/or 500 µg/ml of Tp, depending on selection needed.  Single colony 
isolates of individual transconjugants were obtained by streaking on homologous 
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selective media.  Cultures were subjected to survey lysis followed by agarose gel 
electrophoresis (Gonzalez and Vidaver, 1979) to confirm plasmid transfer.  
 For biparental matings, donor strains and recipient strain (BCS11) suspensions were 
made in LB broth from cultures grown on solid media under selective conditions, as 
appropriate, for 18 h. Bacterial suspensions were adjusted spectrophotometrically (A600 
= 0.5), mixed at an equal ratio (1:1), and transferred to a positively charged sterile 
membrane layered on a 100 x 15 mm LB agar petri dish.  Following a 6 h incubation 
period, the cells from the mating and respective controls were washed twice in 
phosphate buffer (0.125 M, pH 7.1) by centrifugation (12,096 x g for 10 min at 5ºC).  
The bacterial pellets were suspended in phosphate buffer and dilution plated to VBG 
amended with 0.5 mM final concentration of lysine and 500µg/ml of Tp.  Single colony 
isolates of individual transconjugants were obtained by streaking on VBG amended with 
0.05 mM final concentration of lysine and 500 µg/ml of Tp and/or 500 µg/ml Tc.  DNA 
was isolated using a miniprep kit (Qiagen) followed by agarose gel electrophoresis to 
confirm plasmid transfer.   
 
Site-directed mutagenesis 
 
For construction of strains AE607 (AU1054 bcvirB2::Cm), AE608 (AU1054 
bcvirD4::Cm), AE609 (AU1054 bcvirP3::Cm) (Table 4.2), products corresponding to 
bcvirB2, bcvirD4, and bcvirP3, were amplified by PCR using primer sets BCVB2 
(BCVB2-1 and BCVB2-2), BCVD4 (BCVD4-1 and BCVD4-2), and BCVP3 (BCVP3-1 
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and BCVP3-2) (Table 4.3), respectively. Primer sets BCVB2, BCVD4, and BCVP3 
(Table 4.3) were designed based on sequence data from the Joint Genome Institute B. 
cenocepacia AU1054 Genome Project (http://genome.jgi-
psf.org/draft_microbes/burca/burca.home.html).  Each PCR reaction (50 µl) was 
performed using a Taq PCR Master Mix (USB) and a GeneAmp 2700 (Applied 
Biosystems).  Reactions were run for 29 cycles and parameters were as follows:  
denaturation at 95ºC for 1 min; annealing at 57, 56, or 56 ºC for 1 min for primer sets 
BCVB2, BCVD4, and BCVP3 respectively; and extension at 72ºC for 1 min.  Resulting 
products were analyzed by agarose gel electrophoresis and cloned into pDrive (Qiagen), 
yielding pDrive-bcvirB2, pDrive-bcvirD4, or pDrive-bcvirP3, respectively. Constructs 
pDrive-bcvirB2, pDrive-bcvirD4, and pDrive-bcvirP3, were transformed into E. coli 
DH5αMCR, by chemical transformation (Sambrook et al., 1989), and transformants 
were selected on LB agar amended with 40 µg/ml of Ap, 50 µM of isopropyl-beta-D-
thiogalactopyranoside (IPTG), and 80 µg/ml 5-bromo-4-chloro-3-indolyl-beta-D-
galactopyranoside (X-gal). Directionality of the insertions was determined by restriction 
enzyme digestion and sequencing analyses (Appendix J).  Specifically, bcvirB2 
insertions were determined using BamHI/EcoRV, bcvirD4 insertions were determined 
using BamHI, and bcvirP3 insertions were determined using SacI.  Sequencing was 
conducted by the Norman E. Borlaug Center for Southern Crop Improvement, 
Laboratory for Plant Genome Technology at Texas A&M University.   
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Table 4.3. Primers used in Chapter IV. 
 
 
 
 
 
 
 
 
 
 
Primera Gene Relevant Characteristics Reference  
BCVB2-1 bcvirB2 5’-GATGGAGTGCATTATGAAATCT-3’ This study 
BCVB2-2 bcvirB2 5’- TTAGGCCGTCGGAATCA -3’ This study 
BCVD4-1 bcvirD4 5’-CATGGTACGACGGCC-3’ This study 
BCVD4-2 bcvirD4 5’-TCATTGAACACCACCACTTG-3’ This study 
BCVP3-1 bcvirP3 5’-CATGGGATCGAGAAAC-3’ This study 
BCVP3-2 bcvirP3 5’-TCAACGGCTCCATCG-3’ This study 
a 1=forward primer; 2=reverse primer 
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 The Cm-resistance cassette, obtained from pBR325 digested with BsaAI and BclI, 
was blunted with T4 Polymerase and inserted into the EcoRV, ScaI, and BsaAI sites of 
pDrive-bcvirB2, pDrive-bcvirD4, and pDrive-bcvirP3, respectively to yield pDrive-
bcvirB2::Cm, pDrive-bcvirD4::Cm, and pDrive-bcvirP3::Cm, respectively.  Constructs  
pDrive-bcvirB2::Cm, pDrive-bcvirD4::Cm, and pDrive-bcvirP3::Cm were transformed 
into E. coli DH5αMCR, by chemical transformation (Sambrook et al., 1989), and 
transformants were selected on LB agar amended with 40 µg/ml of Ap and 10 µg/ml of 
Cm. Directionality of the insertions was determined by restriction enzyme digestion and 
sequencing analyses (Appendix K).  Specifically, bcvirB2::Cm insertions were 
determined using BamHI/EcoRV, bcvirD4::Cm insertions were determined using 
BamHI, and bcvirP3::Cm insertions were determined using SacI.  Plasmids pDrive-
bcvirB2::Cm, pDrive-bcvirD4::Cm, and pDrive-bcvirP3::Cm were digested with 
BamHI/SacI, KpnI/HindIII, and BamHI/HindIII respectively to yield bcvirB2::Cm, 
bcvirD4::Cm, and bcvirP3::Cm fragments, which were then ligated to pJQ200SK 
digested with the same restriction enzymes to yield pJQ200SK-bcvirB2::Cm, 
pJQ200SK-bcvirD4::Cm, and pJQ200SK-bcvirP3::Cm, respectively.  Plasmids 
pJQ200SK-bcvirB2::Cm, pJQ200SK-bcvirD4::Cm, and pJQ200SK-bcvirP3::Cm were 
then transformed into E. coli DH5αMCR, by chemical transformation (Sambrook et al., 
1989), and transformants were selected on LB agar amended with 10 µg/ml of Gm and 
10 µg/ml of Cm.  Directionality of the insertions was determined by restriction enzyme 
digestion and sequencing analyses (Appendix L).  Specifically, directionality of 
bcvirB2::Cm insertions were determined using SmaI, bcvirD4::Cm insertions were 
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determined using BamHI, and bcvirP3::Cm insertions were determined using SacI.  
Plasmids pJQ200SK-bcvirB2::Cm, pJQ200SK-bcvirD4::Cm, and pJQ200SK-
bcvirP3::Cm were individually mobilized into AU1054 by utilizing pRK2013 in 
triparental matings to obtain allelic exchange mutants.  Exchange mutants were selected 
on VBG amended with 500 µg/ml of Cm.  Cm-resistant transconjugants were single 
colony purified and retested for Cmr.  Allelic exchange and loss of the suicide vector 
was confirmed by PCR and plasmid survey lysis (Gonzalez et al., 1997).  Single colony 
isolates of insertionally inactivated bcvirB2, bcvirD4, and bcvirP3, designated AE607, 
AE608, and AE609 (Table 4.2), respectively, were tested for the ptw phenotype.  
Insertional inactivation of bcvirB2, bcvirD4, and bcvirP3 in strains AE607, AE608, and 
AE609, respectively were confirmed by restriction enzyme digestion of genomic DNA 
with ApaI and ApaI/ScaI followed by agarose gel electrophoresis and Southern blot 
analysis using probes for the Cmr-cassette, bcvirB2, bcvirD4, or bcvirP3 (Appendix M).  
 
Complementation of disrupted genes 
 
Complementation of the disrupted bcvirB2, bcvirD4, or bcvirP3 was accomplished in 
trans.  Plasmid pBCRLAR (LiPuma, unpublished) was amended by inserting a Tp-
resistance cassette, obtained from R388 as a BamHI fragment, blunted with T4 
polymerase, into the ScaI site in the Cmr cassette to obtain pBCRLAR-Tp.  Plasmids 
pDrive-bcvirB2, pDrive-bcvirD4, and pDrive-bcvirP3 were digested with BamHI/SacI, 
KpnI/HindIII, and BamHI/HindIII, respectively, to yield bcvirB2, bcvirD4, and bcvirP3 
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fragments, which were then ligated to pBCRLAR-Tp digested with the same to yield 
pBCRLAR-Tp-bcvirB2, pBCRLAR-Tp-bcvirD4, and pBCRLAR-Tp-bcvirP3, 
respectively.  Plasmids pBCRLAR-Tp-bcvirB2, pBCRLAR-Tp-bcvirD4, and 
pBCRLAR-Tp-bcvirP3 were then transformed into E. coli ED8654, by chemical 
transformation (Sambrook et al., 1989), and transformants were selected on VBG agar 
amended with 50 µg/ml of Tp and 0.5 mM final concentration of methionine.  Plasmids 
pBCRLAR-Tp-bcvirB2, pBCRLAR-Tp-bcvirD4, and pBCRLAR-Tp-bcvirP3 were then 
mobilized into AE607, AE608, or AE609, respectively to complement insertionally 
disrupted bcvir genes. Chloramphenicol resistant and Tpr transconjugants were single 
colony purified and retested for antibiotic resistance and designated AE610, AE611, and 
AE612 (Table 4.2), respectively.  Plasmid survey lysis and PCR were used to confirm 
plasmid transfer, which was reflected by the presence of both the resident and 
complement plasmid as well as inserted and uninserted PCR products. 
 To assess the stability of the constructed plasmids (pBCRLAR-Tp-bcvirB2, 
pBCRLAR-TpbcvirD4, and pBCRLAR-TpbcvirP3) in the absence of antibiotic 
selection, cultures (AE610, AE611, and AE612) were grown in TNB (initial O.D.= 0.05 
at 600nm) and the generation time was followed spectrophotometrically.  Serial transfers 
of the cultures were made to obtain actively growing cells for 30 generations. Samples 
were plated at 0, 10, 20, and 30 generations on selective (VBG amended with 500 µg/ml 
of Cm and 500 µg/ml of Tp) and nonselective media (VBG). The stability of each 
plasmid was determined by comparing the numbers of colonies present on selective and 
nonselective plates. Means from two independent experiments were calculated. 
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Mobilization assays  
 
A Tp-resistance cassette, obtained as a BamHI fragment from R388 was blunted with T4 
polymerase. The Tp-resistance cassette was then individually inserted into the SmaI of 
the Gm-resistance cassette site of pML122 (Labes et al., 1990). Plasmid pML122-Tp 
was then transformed into E. coli ED8654, using a chemical transformation, and 
transformants were selected for on VBG amended with 0.5 mM final concentration of 
methionine and 50 µg/ml Tp. Transformants were single colony purified and the 
presence of pML122-Tp was confirmed using minipreps (Qiagen) followed by agarose 
gel electrophoresis.  Plasmids pURFO47-Tp and pML122-Tp were individually 
mobilized into strain AU1054 or AE608 by utilizing pRK2013.  Transconjugants were 
selected for on VBG amended with 500µg/ml of Tp, single colony purified, and 
designated AE613 [AU1054 (pURFO47-Tp)], AE614 [AE608 (pURFO47-Tp)], AE615 
[AU1054 (pML122-Tp)], and AE616 [AE608 (pML122-Tp)] (Table 4.2).  Plasmid 
survey lysis confirmed the presence of plasmids pURFO47-Tp and pML122-Tp.  
Isolates harboring pURFO47-Tp or pML122-Tp were tested for the ptw phenotype. 
Mobilization of pURFO47-Tp or pML122-Tp, which are not self-transmissible, by 
strains AE613, AE614, AE615, and AE616 was tested using biparental matings with 
recipient strain BCS11.  The conjugation frequency for each isolate was calculated as the 
number of CFU transconjugants per intial CFU of the recipient.  
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Oncogenic suppressor activity 
 
The osa gene was obtained as a NdeI/XhoI fragment from pKA165 (Berger and Christie, 
1994), blunted with T4 polymerase, and ligated to the SmaI site of pURFO47-Tp (Table 
4.1). Plasmid pURFO47-Tp-osa was then transformed into E. coli ED8654, using a 
chemical transformation, and transformants were selected for on VBG amended with 0.5 
mM final concentration of methionine and 50 µg/ml Tp. Plasmid pURFO47-Tp-osa was 
mobilized into AU1054 by utilizing pRK2013 in a triparental mating.  Transconjugants 
were selected on VBG amended with 500 µg/ml of Tp.  Single colony isolates of 
individual transconjugants were obtained by streaking on VBG amended with 500 µg/ml 
of Tp, single colony purified, and designated AE617 (Table 4.2).  Cultures were 
subjected to survey lysis followed by agarose gel electrophoresis (Gonzalez and 
Vidaver, 1979) to confirm plasmid transfer.   
 105
RESULTS  
 
DNA sequence and protein similarities of the bcvirB/D cluster 
 
Preliminary evidence obtained using targeted PCR and Southern blot analyses indicated 
the presence of a type IV secretion system in strain AU1054. Using sequence data from 
the JGI B. cenocepacia strain AU1054 Genome Project (http://genome.jgi-
psf.org/draft_microbes/burca/burca.home.html) and BLAST analysis, an entire gene 
cluster was confirmed, with homology to various translocation and/or conjugation 
related systems from other bacteria including Agrobacterium tumefaciens, Xanthomonax 
axonopodis pv. citri, Brucella suis, and E. coli.  The gene cluster was designated 
bcvirB/D (Fig. 4.1), and was analyzed for similarities to other type IV secretion systems. 
The ProtParam Tool (http://www.expasy.ch/tools/protparam.html) was utilized to obtain 
predicted molecular weights (MW) and isoelectric points (PI) for the BcVirB/D proteins, 
and the ProtSite database of protein families and domains 
(http://www.expasy.ch/prosite/) was used to identify motifs.  
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Fig. 4.1.  A 25.6 kb segment containing the BcVirB/D like type IV secretion system 
cluster of B. cenocepacia strain AU1054.  Designation of genes was based on homology 
to gene products of transfer and translocation related proteins. 
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 BcVirB1 had a predicted MW of 22.9 kDa, an isoelectric point PI of 10.1, and 
showed similarity to VirB1-like proteins.  VirB1-like proteins are members of a large 
family of subunits commonly associated with macromolecular surface structures, 
including the type IV secretion system.  The signature of this protein family is a 
lysozyme-like structural fold (Koraimann, 2003; Mushegian et al., 1996) which 
BcVirB1 possesses.  BcVirB2 had a predicted MW of 12.6 kDa, a PI of 9.6, and showed 
similarity to VirB2-like proteins.  VirB2 is the major pilin subunit of the A. tumefaciens 
VirB/D4 T pilus and an essential component of the secretion channel.  Analysis of 
BcVirB2 showed that it is a small protein with a grand average hydropathicity index 
(GRAVY) of 1.008, indicating that it is hydrophobic in nature. BcVirB2 was also found 
to contain a long signal sequence and two hydrophobic stretches, both of which are 
common trait of VirB2-like proteins (Christie et al., 2005).  BcVirB3 had a predicted 
MW of 9.7 kDa, a PI of 7.7, and showed similarity to VirB3-like proteins.  BcVirB3-like 
proteins are short polypeptides with two predicted transmembrane segments near the N-
terminus.  A Clustal W alignment of BcVirB3 with other VirB3-like proteins identify 
clusters of strongly conserved residues (e.g. (GAT)L(ST)RP) and P(VI)G motifs, before 
the predicted transmembrane segment.  BcVirB4 had a predicted MW of 92.9 kDa, a PI 
of 6.6, and shows high similarity to other VirB4-like proteins.  BcVirB4 is predicted to 
be a large inner membrane protein with a consensus Walker A motif (amino acids 456-
463).  A Clustal W alignment of BcVirB4 with other VirB4-like proteins revealed 
extensive sequence similarities.  BcVirB5 had a predicted MW of 16.9 kDa, a PI of 8.6, 
and showed homology to VirB5-like proteins, which are exported to the periplasm and 
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localize extracellularly as components of the pilus (Schmidt-Eisenlohr et al., 1999a, b).  
BcVirB6 had a predicted MW of 39.1 kDa, a PI of 5.9, and showed homology to VirB6-
like proteins.  BcVirB6 is a hydrophobic protein (GRAVY of 0.594) with three predicted 
transmembrane domains.  BcVirB8 had a predicted MW of 31.6 kDa, a PI of 7.8, and 
showed similarity to VirB8-like proteins, which are associated with most type IVA type 
IV secretion systems (Christie et al., 2005).  These VirB8-like subunits are configured as 
bitopic inner membrane proteins with an N-proximal transmembrane segment (Das and 
Xie, 1998; Lawley et al., 2003).  A Clustal W alignment of BcVirB8 with other VirB8-
like proteins confirms and extends an earlier identified sequence conservation between 
residues 100 and 143 and between 190 and 235 (Kumar et al., 2000).  BcVirB9 had a 
predicted MW of 31.0 kDa, a PI of 6.6, and showed similarity to VirB9-like proteins 
which are hydrophilic and predicted to localize in the periplasm or outer membrane 
(Christie et al., 2005; Jakubowski et al., 2005).  BcVirB9 had a GRAVY of -0.208, as 
well as a predicted cell attachment site (amino acids 54-57). Similarities exist between 
the C-terminal and N-terminal regions of VirB9-like proteins, including BcVirB9.  
BcVirB10 had a predicted MW of 43.0 kDa, a PI of 5.4, and showed similarity to 
VirB10-like proteins, which are inner membrane proteins situated with the bulk of the 
protein in the periplasm (Das and Xie, 1998).  BcVirB10 contains a transmembrane  
 109
segment, a Pro-rich region following the transmembrane segment, several coiled-coils 
near the transmembrane segment, and clusters of hydrophobic residues near the C-
terminus; all of which are common features of VirB10 homologs (Chrisite et al., 2005).  
BcVirB11 had a predicted MW of 50.5 kDa, a PI of 9.5, and showed similarity to 
VirB11-like proteins, which are members of a large family of ATPases associated with 
systems dedicated to secretion of macromolecules (Cao and Saier, 2001).  The VirB11-
like ATPases fractionate as cytoplasmic or peripheral inner membrane proteins (Krause 
et al., 2000; Rashkova et al., 1997).  Sequence analysis of BcVirB11 showed that it 
contains a Walker-A site (amino acids 264-271) and that it is very similar to other 
VirB11-like proteins including HP0525 of Helicobacter pylori.  BcVirD4 had a 
predicted MW of 70.3 kDa, a PI of 8.6, and showed similarity to VirD4-like proteins, 
which are also termed Coupling Proteins (CP) (Christie et al., 2005).  BcVirD4 is 
composed of an N-proximal periplasmic loop and a large C-terminal cytoplasmic 
domain (Das and Xie, 1998; Lee et al., 1999), both common features of VirD4-like 
proteins.  BcVirD2 had a predicted MW of 40.2 kDa, a PI of 10.4, and showed similarity 
to VirD2-like proteins, which are relaxases.  
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Site-directed disruption of the bcvirB/D type IV secretion system and the effect on 
the ptw phenotype 
 
Translated products of the bcvirB/D cluster showed homology to proteins from known 
type IV secretion systems.  Based on their predicted function, the role of bcvirB2 and 
bcvirD4 in the expression of the ptw phenotype was determined.  Site-directed 
mutagenesis of bcvirB2 and bcvirD4 resulted in loss of the ptw phenotype and 
complementation in trans restored ptw activity (Fig. 4.2).  Stability testing of AE610, 
AE611, and AE612 showed that pBCRLAR-Tp-bcvirB2, pBCRLAR-TpbcvirD4, and 
pBCRLAR-Tp-bcvirP3 are stable for at least 30 generations under non-selective 
conditions, with an average retention rate of 90 % (Table 4.4). 
 Based on analysis of the bcvirB/D cluster and the putative role of a type IV secretion 
system in the export of an effector molecule(s), it was of interest to determine if culture 
supernatant concentrates showed effector activity.  Over an 8 h duration, carrot 
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Fig. 4.2.  Analysis of the BcVirB/D type IV secretion system using the plant tissue 
watersoaking assay. (A) Pierced onion bulb scale inoculated with B. cenocepacia strain 
AU1054 showing partial tissue collapse and translucence characteristic of the plant 
tissue watersoaking (ptw) phenotype.  (B) Pierced onion bulb scale inoculated with 
sterile water (ptw-negative).  (C) Pierced onion bulb scale inoculated with ptw-negative 
mutant (e.g. AE607, AE608, and AE609).  (D) Pierced onion bulb scale inoculated with 
complemented ptw-negative mutant (e.g. AE610, AE611, and AE612) showing restored 
ptw activity. 
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Table 4.4.  Stability testing of plasmids pBCRLAR-Tp-bcvirB2, pBCRLAR-Tp-
bcvirD4, and pBCRLAR-Tp-bcvirP3 in complemented strains AE610, AE611, and 
AE612 of bcvirB2, bcvirD4, and bcvirP3 mutant strains AE607, AE608, and AE609. 
 
 % Plasmid Containing CFUa, b
 Strain 
Generations AE610 AE611 AE612 
0 100 100 100 
10 98 97 97 
20 95 94 95 
30 91 90 90 
a Percent plasmid containing CFU are the average for two independent experiments. 
b All strains were grown in TNB medium at 37°C while shaking. 
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 protoplasts exposed to M9 medium concentrate did not experience significant 
plasmolysis when compared to the protoplast controls (P>0.05) (Table 4.5 and Fig. 4.3). 
However, significant (P≤0.05) plasmolysis was observed for protoplasts exposed to the 
AU1054 or complemented mutant (AE611) concentrates as early as 2 h, and plasmolysis 
increased at a significant rate for dilutions tested (up to 1:5) over the 8 h time period as 
compared to medium controls.  Concentrated supernatant from the bcvirD4 mutant 
(AE608) caused 6.0% plasmolysis after 8 h, which was not statistically different 
(P>0.05) from plasmolysis resulting from treatment with medium controls.  Dilution of 
the AU1054 and AE611 concentrates diluted 1:10 to a protein concentration of 0.02 
µg/ml reduced activity to levels which approximated that of the control and AE608.  
Temperatures of 37º, 65º, and 80ºC for 1 h or 100ºC for 10 min did not affect the 
plasmolysis activity of the AU1054 concentrate.  Complete inactivation of plasmolysis 
activity was observed when the AU1054 concentrate was treated with proteinase K; 
however, incubation with DNase I or RNase A showed no effect on activity.   
 114
 
 
 
 
Table 4.5.  Effect of supernatant concentrates from AU1054, bcvirD4 mutant (AE608) 
and complemented bcvirD4 mutant (AE611) on carrot protoplasts. 
 
% Plasmolysisb, c
 
Supernatant 
Concentrate 
Concentrate 
Dilutiona
0 h 2 h 4 h 6 h 8 h 
       
M9 0 0x 1.4 ± 1.7x 2.9 ± 1.2x 6.4 ± 1.7x 9.0 ± 1.9x 
medium 1:1 0x 1.2 ± 1.1x 2.2 ± 1.5x 6.2 ± 1.1x 8.5± 2.6x 
 1:5 0x 2.1 ± 1.0x 3.2 ± 1.1x 5.3 ± 2.0x 7.0 ± 2.2x 
 1:10 0x 2.2 ± 1.7x 2.5 ± 1.1x 4.5 ± 2.1x 8.2 ± 2.6x 
       
AU1054 0d 0x 19 ± 3.4y 37 ± 3.4y 59 ± 5.6y 77 ± 6.1y 
 1:1 0x 20 ± 2.1y 39 ± 4.6y 57 ± 5.6y 75 ± 7.1y 
 1:5 0x 19 ± 3.4y 37 ± 4.6y 59 ± 6.1y 76 ± 6.6y 
 1:10 0x 1.4 ± 1.1x 3.2 ± 1.5x 4.9 ± 0.6x 6.9 ± 1.4x 
       
AE608 0d 0x 2.0 ± 1.1x 3.2 ± 0.7x 4.5 ± 1.2x 6.4 ± 1.9x 
 1:1 0x 2.3 ± 1.2x 3.9 ± 2.2x 5.5 ± 1.1x 7.2 ± 1.6x 
 1:5 0x 2.2 ± 1.7x 3.2 ± 1.1x 6.0 ± 0.8x 8.2 ± 1.6x 
 1:10 0x 2.2 ± 1.1x 4.2 ± 1.2x 6.2 ± 1.1x 6.7 ± 0.6x 
       
AE611 0d 0x 20 ± 1.2y 39 ± 2.6y 58 ± 4.6y 79 ± 7.1y 
 1:1 0x 18 ± 1.7y 38 ± 3.7y 54 ± 3.4y 77 ± 6.1y 
 1:5 0x 19 ± 2.1y 40 ± 3.7y 57 ± 3.4y 70 ± 6.6y 
 1:10 0x 2.0 ± 1.1x 2.0 ± 1.1x 6.4 ± 2.2x 7.0 ± 1.2x 
       
None 0 0x 2.0 ± 1.4x 3.2 ± 7.1x 6.9 ± 1.6x 9.1 ± 2.6x 
       
a All dilutions were adjusted to 10% mannitol 
b Data are mean values ± SD of two replicates for three independent experiments.   
c Values within the columns scored by the same letter were not statistically different at P=0.05. 
d Undiluted concentrate adjusted to 0.2 µg/ml protein in 10% mannitol.   
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Fig. 4.3. Effect of supernatant concentrates from AU1054 bcvirD4 mutant (AE608) and 
complemented bcvirD4 mutant (AE611) on carrot protoplasts. 
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Identification of a putative effector translocated by the bcvirB/D type IV secretion 
system 
 
Analysis of 10-kb regions flanking the bcvirB/D gene cluster of B. cenocepacia AU1054 
identified a putative ORF, designated bcvirP3 (Figure 4.1). Translation of the bcvirP3 
sequence predicted a protein with a MW of 19.0 kDa, a PI of 9.5, a GRAVY of -0.138, 
and showed no significant sequence similarity to know proteins by BLAST analysis.  In
 Since recent studies have shown the importance of a positively charged C-terminal 
transport signal in effectors translocated by type IV secretion systems (Simone et al., 
2001; Vergunst et al., 2000; Vergunst et al., 2003; Vergunst et al., 2005) the C-terminal 
regions of bcvirP3was analyzed for amino acid content, net charge, and consensus 
sequences.  The incidence of Arg residues among the C-terminal 20 amino acids, for 
bcvirP3 was 15%, which is higher than expected for the Arg composition of B. 
cenocepacia AU1054 proteins (7%), and the calculated net charge was +2.  Alignment 
of the 30 C-terminal amino acids of bcvirP3 with other known type IV secreted 
effectors, such as VirD2, VirE2, VirE3, and VirF of A. tumefaciens as well as MobA 
from RSF1010, showed similarity in position of Arg residues to known type IV secreted 
proteins (Fig. 4.4).   
 By combining site-directed mutagenesis of bcvirP3 with a cytotoxic assay employing 
plant tissue, it was determined that effector protein BcVirP3 was involved in the 
production of the ptw phenotype.  Complementation in trans of the bcvirP3 mutant 
resulted in restoration of the ptw phenotype (Fig. 4.2). 
 117
 
 
 
 
 
 
 
Fig. 4.4. Alignment of the C-terminal amino acids of A. tumefaciens VirD2, VirE2, 
VirE3, and VirF; RSF1010 MobA; and B. cenocepacia proteins BcVirD2 and BcVirP3. 
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 An ORF which showed homology to VirD2-like proteins was identified during the 
analysis of regions flanking the BcVirB/D type IV secretion system.  In A. tumefaciens 
VirD2 is the relaxase protein that is covalently bound to the 5’ end of the ssDNA 
molecule and is thought to possess the type IV secretion system transport signal and thus 
act as a pilot for the complex. Therefore, we analyzed the BcVirD2 sequence.  BcVirD2 
had a predicted MW of 40.2 kDa, a PI of 10.4, a GRAVY of 0.638, and showed 
similarity to VirD2-like proteins, which are relaxases.  ORF bcvirD2 was analyzed for 
amino acid content, net charge, and consensus sequences.  The incidence of Arg residues 
among the C-terminal 20 amino acids, for bcvirD2, was 15.8%, which is higher than 
expected for the Arg composition of B. cenocepacia AU1054 proteins (7%), and the 
calculated net charges was 0.  Alignment of the 30 C-terminal amino acids of bcvirD2 
with other known type IV secreted effectors, to include VirD2, VirE2, VirE3, and VirF 
of A. tumefaciens as well as MobA from RSF1010, showed similarity in position of Arg 
residues to known type IV secreted proteins (Figure 4.4).   
 
Translocation of DNA and protein substrates 
 
Conjugative plasmids often encode factors that inhibit the transfer of co-resident 
plasmids (Olsen and Shipley, 1975; Yusoff and Stanisich, 1984).  Such fertility 
inhibition factors appear to fall into two broad classes, those acting to repress expression 
of transfer (tra) genes (Gasson and Willetts, 1976; Tanimoto and Iino, 1983), and those 
functioning at a step in the translocation pathway subsequent to the synthesis and 
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assembly of the type IV secretion system (Yusoff and Stanisich, 1984; Winans and 
Walker, 1985). Little is known about the latter.  In A. tumefaciens, two factors have been 
shown to render wild-type cells nearly or completely avirulent, a phenomenon termed 
‘oncogenic suppression’ (Close and Kado, 1991; Ward et al., 1991).  One factor is the 
RSF1010 transfer intermediate composed of the MobA relaxase covalently bound to the 
5’ end of the transferred ssDNA (R-strand) (Ward et al., 1991; Stahl et al., 1998).  The 
second is the Osa protein encoded by the IncW plasmid pSa (Close and Kado, 1991).  
Osa does not affect accumulation or membrane association of VirB proteins (Chen and 
Kado, 1994; Chen and Kado, 1996), but does share sequence similarity to FiwA, a 
fertility inhibition factor (Chen and Kado, 1994; Fong and Stanisich, 1989).  It has been 
postulated that Osa represents a class of fertility inhibition factors acting after type IV 
secretion system machine biogenesis to block one or more steps of translocation 
(Cascales et al., 2005).   
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 Due to the high similarity of the AU1054 BcVirB/D type IV secretion system to the 
A. tumefaciens VirB/D4 type IV secretion system, the role of the BcVirB/D type IV 
secretion system in mobilization of DNA was tested using biparental matings.  Strain 
AE613 [AU1054 (pURFO47-Tp)] was able to mobilize pURFO47-Tp, which is not self-
transmissible, into strain BCS11; however, strain AE614 [AU1054 bcvirD4::Cm 
(pURFO47-Tp)] was not able to mobilize pURFO47-Tp to strain BCS11. Strain AE615 
[AU1054 (pML122-Tp)] was able to mobilize pML122-Tp, which is also not self-
transmissible, to BCS11; however, strain AE616 [AU1054 bcvirD4::Cm (pML122-Tp)] 
was not able to mobilize pML122-Tp to strain BCS11.  The conjugation frequency for 
each isolate was calculated as the number of CFU transconjugants per initial CFU of 
input recipient (Table 4.6). In addition, strains harboring either pURFO47-Tp or 
pML122-Tp retained the ability to cause watersoaking on plant tissue. 
 It was also of interest to determine if an oncogenic suppressor such as Osa had any 
effect on other functions of the BcVirB/D type IV secretion system.  Mobilization of 
pURFO47-Tp::osa into AU1054 (strain AE617) by utilizing a triparental mating resulted 
in the loss of the ptw phenotype. Indicating that Osa interferes with the translocation of 
the putative effector involved in the ptw phenotype. 
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Table 4.6.  Mobilization frequencies of pML122-Tp or pURFO47-Tp by the AU1054 
donor strains into BCS11 in biparental matings. 
 
Donor  Recipient Frequencya
AE613 [AU1054 (pURFO47-Tp)] BCS11 1.1 x 10-5
AE614 [AU1054 bcvirD4::Cm 
(pURFO47-Tp)] 
BCS11 0 
AE615 [AU1054 (pML122-Tp)] BCS11 4.9 x 10-5
AE616 [AU1054 bcvirD4::Cm 
(pML122-Tp)] 
BCS11 0 
a Mobilization frequencies are reported as the number of CFU transconjugants per intial CFU of recipient. 
 122
DISCUSSION 
 
The identified gene products of the bcvirB/D cluster had homology to proteins from 
known type IV secretion systems.  A. tumefaciens utilizes a VirB/D4 type IV secretion 
system to translocate DNA, and protein effector molecules to plant cells during infection 
(Zhu et al., 2000; Cascales and Christie, 2003).  The bacterial type IV secretion systems 
mediate the translocation of macromolecules across the cell envelopes of Gram-negative 
and Gram-positive bacteria (Cascales and Christie, 2003; Grohmann et al., 2003). These 
systems are classified on the basis of an ancestral relatedness to bacterial conjugation 
machines (Christie, 2004; Lawley et al., 2003). The conjugation machines are a large 
subfamily of type IV secretion systems that transmit DNA substrates among diverse 
species of bacteria, and some systems also deliver DNA to fungal, plant, and mammalian 
cells (Bates et al., 1998; Bundock et al., 1995; Schrammeijer et al., 2003; Waters, 2001; 
Zhu et al., 2000). Conjugation systems enable bacteria to adapt to changing 
environments through acquisition of fitness traits.  
 Although conjugation is usually depicted as a mechanism for intercellular DNA 
transfer, recent studies indicate that conjugation systems actually transmit the DNA as a 
nucleoprotein particle composed of a protein component, the relaxase, covalently bound 
to the 5’ end of a molecule of ssDNA (Christie, 2004). In addition, DNA transfer is 
directional, from 5’ to 3’, further suggesting that the relaxase serves to pilot the ssDNA 
through the secretion channel. Conjugation machines might therefore correspond to 
ancestral protein translocation systems that evolved to recognize and translocate 
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relaxases as substrates and, only coincidentally, the “hitch-hiker” ssDNA. With this 
view, it is not surprising that conjugation machines also translocate protein substrates 
independently of associated DNA. Moreover, a second large subfamily of type IV 
secretion systems is now known to translocate only protein substrates to target cells 
(Cascales and Christie, 2003; Ding et al., 2003; Nagai and Roy, 2003). Studies 
conducted over the past 10 years have identified numerous examples in which bacteria 
have appropriated type IV secretion systems for delivery of effector proteins into the 
cytosol of eukaryotic cells (Llosa and O’Callaghan, 2004). Through interkingdom 
protein transfer, these effector translocator systems induce a myriad of changes in host 
cell physiology to aid in the establishment of pathogenic or symbiotic relationships with 
the eukaryotic host (Cascales and Christie, 2003; Ding et al., 2003; Fischer et al., 2002). 
Conjugation and most effector translocator systems transmit their substrates 
intercellularly by a cell-contact-dependent mechanism. Other type IV translocation 
systems deliver DNA substrates to or acquire them from the extracellular environment. 
In Neisseria gonorrhoeae, a type IV secretion machine highly related to the F plasmid 
conjugation system exports DNA substrates to the extracellular milieu (Dillard and 
Seifert, 2001). Conversely, in H. pylori, a competence system mediates uptake of DNA 
from the milieu (Hofreuter et al., 2001; Hofreuter et al., 2003). Such systems are called 
uptake and release systems (Cascales and Christie, 2003; Ding et al., 2003). Besides a 
classification scheme based broadly on function, the type IV secretion systems have 
been grouped as type IVA, IVB, or “other” (Christie and Vogel, 2000). The type IVA 
systems are composed of subunits similar in composition and number to those of the 
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archetypal A. tumefaciens VirB/D4 system (Christie, 2004). The type IVB systems are 
assembled from subunits related to the archetypal Legionella pneumophila Dot/Icm 
system (Segal et al., 2005). The “other” systems bear little or no discernible ancestral 
elatedness to the types IVA or IVB systems and will be named once their subunit 
compositions and phylogenies are better understood. 
 The archetypal VirB/D4 type IV secretion system is assembled from 11 VirB 
proteins, termed the mating pair formation (Mpf) proteins (Lessl et al., 1993), and the 
VirD4 coupling protein (CP) (Ding et al., 2003; Gomis-Ruth et al., 2004), also termed 
the substrate receptor (Atmakuri et al., 2003; Cascales and Christie, 2004).  This system 
is a conjugation apparatus, as shown by its capacity to deliver oncogenic transfer DNA 
(T-DNA) as well as the mobilizable plasmid RSF1010 (IncQ) to target cells through a 
cell-contact-dependent mechanism (Buchanan-Wollaston et al., 1987; Fullner, 1998).  
The identified BcVirB/D type IV secretion system in B. cenocepacia of the PHDC 
lineage most closely resembles the VirB/D4 system of A. tumefaciens.  The fact that the 
BcVirB/D system was involved in both the translocation of a protein as well as DNA, 
indicate that it is functionally a member of the IVA group of type IV secretion systems.   
 Identification of a cluster of genes that encoded proteins with similarities to 
components of a type IV secretion system allowed for strategic generation of AU1054 
mutants to support the hypothesis that such a system was involved in expression of the 
ptw phenotype as well as conjugation.  The genes selected for functional characterization 
were bcvirB2 and bcvirD4.  VirD4-like proteins (BcVirD4 homologs) are cytoplasmic 
membrane NTP-binding proteins that are essential for coupling the relaxosome to the 
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macromolecular transport system (Moncalián et al., 1999; Schröeder and Lanka, 2003).  
Analysis of BcVirD4 revealed a P-loop which is characteristic of type IV secretion ATP-
binding proteins.  VirB2-like proteins (BcVirB2 homologs) are the major pilin subunit 
and are an essential component of the secretion channel (Berger and Christie, 1994; 
Jakubowski et al., 2005; Lai and Kado, 1998).  VirB2 homologs are components of most 
type IVA systems (Cao and Saier, 2001).  Analysis of BcVirB2 revealed a small, 
hydrophobic protein.  In general, VirB2-like proteins display low levels of sequence 
similarity, but a Clustal W alignment with BcVirB2 revealed several conserved Gly 
residues dispersed along the polypeptide.  The ptw phenotype was not expressed by 
AU1054 derivatives with a disruption in bcvirD4 or bcvirB2.  These results correlate 
with the predicted function of the gene products since, successful secretion of an effector 
protein would likely involve: a protein that potentially couples the moiety to the 
secretion system and supplies the necessary energy for export (BcVirD4), and a protein 
that forms the pilus through which the moiety would be exported (BcVirB2).   
 By combining mutational analysis with cytotoxic assays employing both plant 
protoplasts, a type IV secretion system has been identified that appears to export an 
effector molecule that is proteinacious in nature and responsible for the activity.  This 
activity plays an important role in the ability of B. cenocepacia strain AU1054 to cause 
watersoaking of plant tissue.  Currently, the role of the putative virulence effector 
protein in contributing to growth and infection in a pulmonary environment is unknown; 
however, the ptw phenotype appears to be common among isolates belonging to B. 
cenocepacia that infect CF patients. 
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 Most bacterial protein secretion systems recognize their substrates through a signal in 
the N terminus. For example, there is a clear consensus in the cleavable N-terminal 
signal peptide sequences recognized by the Sec-dependent and twin Arg translocation 
systems (Dilks et al., 2003; Cao and Saier, 2003).  However, to date no consensus has 
been found to define the N-terminal signal of effectors secreted by type III or type IV 
secretion systems. Recent studies of A. tumefaciens and B. henselae type IV secretion 
systems have shown that the interaction between the C-termini of effector proteins and 
VirD4 is a critical step in effector translocation.  In these studies, a positively charged C-
terminal signal was present in several type IV secreted proteins including the VirD2 and 
VirE2 proteins of A. tumefaciens and the MobA relaxase of RSF1010 (Vergunst et al., 
2005).  In strain AU1054 an ORF which showed similarity to VirD2 like proteins 
(relaxosomes) was identified.  The ORF, designated bcvirD2 was predicted to function 
as a relaxosome by ProtSite.  Like VirD2 this ORF had a higher incidence of Arg 
residues than expected for B. cenocepacia proteins; however, the C-terminal 20 amino 
acids had a charge of 0 (Fig. 4.4).  In strain AU1054, an ORF designated bcvirP3 was 
identified that had no known homologs by BLAST analysis.  The protein depicted by 
this ORF had a positively charged C-terminal region.  The C-termini of BcVirP3 showed 
a higher incidence of Arg residues than expected for B. cenocepacia proteins, and an 
alignment of the 30 C-terminal amino acids showed similarity in the position of these 
residues (Fig. 4.4).  Site-directed mutagenesis indicated that BcVirP3 was involved in 
the expression of the ptw phenotype. 
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  It has been established in A. tumefaciens that two ‘oncogenic suppressors’ act on a 
common target, the VirD4 receptor, to block passage of the T-DNA and the VirE2 
effector protein through the VirB/D4 type IV secretion system.  One suppressor factor, 
RSF1010, is a promiscuous plasmid that parasitizes the VirB/D4 system as well as many 
other type IV secretion systems of Gram-negative bacteria (Rawlings and Tietze, 2001).  
The second suppressor factor is the Osa protein of pSa, which blocks VirD4 receptor 
activity not as a competing substrate, but rather through a mechanism shared by related 
fertility inhibition factors encoded by IncP, W, and N conjugative plasmids (Cascales et 
al., 2005).  By utilizing an RSF1010 derivative (pML122-Tp), it was shown that the 
BcVirB/D type IV secretion system was able to mobilize DNA substrates since, wild-
type AU1054 was able to mobilize pML122-Tp and pURFO47-Tp, which are not self-
transmissible, whereas a derivative of AU1054 with an insertionally inactivated 
BcVirD4 was not able to mobilize either the RSF1010 derivative or pURFO47-Tp.  It 
was also shown that the Osa protein is able to render AU1054 avirulent in plant tissue as 
shown by the lack of watersoaking in an AU1054 derivative containing Osa.  It is 
noteworthy, that RSF1010 blocks access of the VirE2 effector of A. tumefaciens to the 
VirD4 receptor, and thus inhibits T-DNA transfer.  This was not the case in a B. 
cenocepacia AU1054 derivative harboring an RSF1010 derivative (pML122-Tp) since 
this strain remained capable of expressing the ptw phenotype on onion tissue.  In A. 
tumefaciens, it is hypothesized that RSF1010 inhibits VirE2 translocation by a 
mechanism other than simple competitive inhibition (Cascales et al., 2005). 
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 In conclusion, this study (Chapter IV) has identified a group IVA type IV secretion 
system and a putative effector in B. cenocepacia strain AU1054 that is involved in the 
production of the ptw phenotype. The type IV secretion system was also shown to be 
responsible for mobilization of DNA indicating that it is a group IVA type IV secretion 
system.  Mutational analysis of the BcVirB/D system indicates that BcVirB2 and 
BcVirD4 may play a role in expression of the ptw phenotype and DNA transfer.  Culture 
supernatant studies on plant protoplasts indicate that an effector protein translocated into 
the extracellular milieu by the BcVirB/D system is involved in the observed toxicity to 
plant cells.  Preliminary characterization of the transfer function indicates that Osa can 
disrupt transfer of proteins via the BcVirB/D system and future experiments will 
determine if Osa can disrupt DNA transfer as observed in A. tumefaciens. 
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CHAPTER V 
CONCLUSION 
 
The Burkholderia cepacia complex (Bcc) contains nine genetically distinct but 
phenotypically similar species (Mahenthiralingam et al., 2005). Originally identified as 
phytopathogens (Burkholder, 1950), this group of organisms has become a focus of 
attention as human pathogens following isolation from the respiratory tracts of patients 
that are immunocompromised or have cystic fibrosis (CF) (Rosenstein and Hall, 1980; 
Isles et al., 1984; Thomassen et al., 1985). Although all nine species have been 
recovered from CF patients, B. cenocepacia and B. multivorans account for the great 
majority (~85%) of infection in patients in North America and Europe (Agodi et al., 
2001; LiPuma et al., 2001; Speert et al., 2002). Genotyping studies have also identified 
several epidemic strains that are common to multiple CF patients. Most epidemic strains 
identified to date, including strain ET12 (common among infected patients in Canada 
and UK) (Johnson et al., 1994; Pitt et al., 1996; Mahenthiralingam et al., 2002) and 
strain PHDC (widespread in the United States) (Chen et al., 2001; Reik et al., 2005) are 
members of the B. cenocepacia species. 
 Although the pathogenic mechanisms involved in human infection by B. cenocepacia 
are largely unknown, several putative virulence factors have been described 
(Mahenthiralingam et al., 2005). These include, cable pili and the associated adhesion 
(Sajjan et al., 2002; Urban et al., 2005), flagella (Tomich et al., 2002; Urban et al., 
2004), lipopolysaccharide and surface exopolysaccharides (Shaw et al., 1995; Chung et 
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al., 2003), type III secretion system (Tomich et al., 2003), production of siderophores 
(Visser et al., 2004), catalase and superoxide dismutase (Lefebre and Valvano, 2001), 
proteases and lipases (McKevitt et al., 1989) and quorum sensing system (Sokol et al., 
2003). To date the role of these factors in contributing to lung disease has not been 
clearly elucidated.  In this research type IV secretion systems, which are an important 
mechanism involved in pathogenesis of bacteria, were identified and studied. 
 In a CF clinical isolate of B. cenocepacia, strain K56-2 of the ET12 lineage, two type 
IV secretion systems were identified (Chapter II).  One is a plasmid-encoded type IV 
secretion system, designated Ptw, which is a member of the effector translocator 
subfamily; and the other is a chromosomally encoded type IV secretion system, 
designated BcVirB/D, for which the function is at this time unknown. The Ptw system is 
a chimeric type IV secretion system containing homologs to components of multiple 
type IV secretion systems.  These studies have shown that the Ptw system is responsible 
for the production of the ptw phenotype and at least partially responsible for the 
stimulation of release of IL-8 from human bronchial epithelial cells, by strain K56-2.   
 An effector, designated PtwE1, involved in production of the ptw phenotype in B. 
cenocepacia strain K56-2 was identified (Chapter III).  PtwE1 was also shown to be 
translocated into the extracellular milieu via the Ptw type IV secretion system.  A 
positively charged C-terminal transport signal as well as a functional Ptw system was 
also found to be necessary for the translocation process. Future studies will involve 
elucidation of the of the interaction between PtwE1 and the Ptw type IV secretion 
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system as well as experiments to determine the role of PtwE1 in the stimulation of 
release of IL-8 from human bronchial epithelial cells.  
 In a CF clinical isolate of B. cenocepacia, strain AU1054 of the PHDC lineage, a 
chromosomally encoded type IV secretion system was identified which showed 
homology to the VirB/D4 system of A. tumefaciens.  This system, designated BcVirB/D, 
was shown to be involved in production of the ptw phenotype.  The BcVirB/D system 
was able to mobilize DNA and effector proteins, and therefore is a member of the group 
IVA type IV secretion systems. Studies indicated that an effector protein translocated 
into the extracellular milieu by the BcVirB/D system is involved in the observed toxicity 
to plant cells.  Preliminary characterization of the transfer function indicates that an 
oncogenic suppression activity protein (Osa) can disrupt transfer of effector proteins via 
the BcVirB/D system.  Future studies will determine if Osa can disrupt DNA transfer 
and elucidate the interaction between BcVirP3 and the BcVirB/D system.    
The studies conducted during my dissertation research have established a beginning 
point to determine the role of type IV secretion systems in pathogenesis caused by B. 
cenocepacia. 
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Restriction enzyme and sequence analyses of pDrive-ptwD4 
 
 
Predicted and obtained results for digestion of pDrive-ptwD4 with SmaI 
 
Correct insertion yields fragments of sizes 2.1 and 3.7 kb 
Incorrect insertion yields fragments of sizes 4.0 and 1.8 kb 
 
 
Sequencing results obtained from pDrive-ptwD4 
 
 
tgactcagcgaaggaacgagctaccgagcttttgcggggtagccagaaatgacgggaaaa 
aagccaaacgggctcttccaggatttttccaccggctcggaaatctggactcaccgtgtc 
gcgctggtgctcgtcgcgatccgaaatatcctgctgctctctttgtttctcggtctggcg 
gccgggttcatctacgccgcattcttcgtcgaccgcgacatctggcgtccagcagtcgcg 
aacgttatcgcgcatcttcggtcggtcgtcatgatgacggcggtaccgatggaatacgaa 
gtcaacggccagaccgtgcgacttcccgtcgatcaagttgtcgccctgacggacccagtg 
tgggatgtggcttatttctttttgcggcgattcctgatcattgtcgcaaccgtcacggca 
tgtacatgcgtctcgatcgctgcctactggtatgagttcggtcgcagcacgatggccgac 
aaggatctgcgtggcgcaacgctcgtcaacgggaagcaactggcgaagatgattcggcaa 
gacgatatggagagcccgtattcgatagcgggcgtgccgatgctgcgcaacgcggagacc 
ctgcataccctggtggtcggcgcacagggtacgggtaagtctcagcagttcttcgatcgg 
ctcaggcaagtccgcgcccgtgggaagcgcgcgatcgtatacgatccgtcgggcgaattt 
gcggaggaatttttccgggaaggcaaggacgtcatgatgaatccgttcgacgaccgttcg 
ccaaactggaacatcaagtatgagatcgaggaggagtaccactatgacagcatggcaacc 
gcgctgattcccgatccgcgcgaagccgatccattttggtcattggcggggcgcgaggtg 
tttcgagatgtcgcgcgtacgttgcacagagagggcaatctgacgaaccgcaatctttac 
aattcgatcgcaatgagcaacctcgacgcgatctaccagttgctgcgcaataccgccggc 
gcgtcgtacgtcgatcccaagaccgagcgcacgggtatgtcgttgaagatgaccgtccag 
aaccagctttcctctttcaggtatctccgtgatgatggaaagccgttctcgatccgtcag 
tggatttacaacgagagtgattcgtggatgttcatctcgacccgtgaggaaatgctcgag 
gcgatcaagccaatcatgtcgctctggatcgacatcgcgatcaaagcggtgctcaacctc 
acaccgattcatcgcgagcgactgcacttctcgatcgacgaagtcccgaccctgcagaag 
ctcgatatcatgaagctcgcggtgagcaatacgcggaagtacggcttatgcatgatgctc 
ggtgcgcaggatatgccgcagttcctcgacatctacggggaatacctcgcgcggacgatt 
atcaacgggtgtcaaaccaagctgttgttgcgcgtaaccgacgcagaagccgctgagatg 
ttctcgaaaatcatcgggcagacggaagtcgaggaaaaggacgagtcgctgtcgtttggt 
gtgaactctcagcgggacggattcagcatcgcgaagcgtcggctgctgcgcgacctagcg 
ttgccctcacagatattgcgactgcgggacatgacaggctatttggtctatcccggcgaa 
tacccgatcgctcgcgtgaagtacgggtttgtcaaaccgcggaaaaacgcacctgctttt 
atcaagcgtcaggcattctccgaactattcgcgccggcggccggctcgccggcaaccgct 
gccgcttcggaatccgtagtcgctggcccatcacctgactggatcgcgcacccggagata 
ctcgtcgcggcgagcggcggcgtcgatccggaaactggcgaaatcctgccaccccgcccg 
ggcgcctggcgctggggcgacggcaatcaacgaggagaccatgcatgaaggccctttgtc 
gtgttttgtccaccgccctttttcttgcggtgcccgccgtgagcgcattcgcgcagtctg 
cgcccgggttgcttccaccggat 
 
Note:  Primers and start codon are highlighted. 
Note:  Vector sequence has been removed.
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Restriction enzyme and sequence analyses of pDrive-ptwE1 
 
 
Predicted and obtained results for digestion of pDrive-ptwE1 with ClaI 
 
Correct insertion yields fragments of sizes 2.5 and 1.9 kb 
Incorrect insertion yields fragments of sizes 2.2 and 2.2 kb 
 
 
Sequencing results obtained from pDrive-ptwE1 
 
ctgttaggtgaaaatccggcgcgcgggaaagtcacacgtgtttgcggaatgcatgcattc 
cgcaaatcttcgactccccgcccgacaccgacgtcgagcggcacaccgaccgtctgcaca 
cgcccaaaaatttcccgacgccgcattgaccacagatccaccgcgccccgcgctcacacc 
ggtgttgccacacactgacgtgtggacaacaccgcgcggcgaccggctccgtgatcttta 
tcgatcacggccgttggtccggcaccgtggatatgtggacaatgctcaccggtccaccac 
cgcgtcaccttctgctactgtcctgcccacactaccgccgtccccgaacctgtatattcc 
ctgctgcctccacctcccttcttccttccgacgttgcactgaacagctccgctccgctcc 
gaggtgaagatggcgaaaatccaccgctcacgatccaaaccacgccgtcgctttttcccc 
gattacgccgattcccttgagcgggaaccgccgtaccttaccgggtgaaggct 
 
Note:  Primers and start codon are highlighted. 
Note:  Vector sequence has been removed.
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Restriction enzyme and sequence analyses of pDrive-ptwD4::Cm 
 
 
Predicted and obtained results for digestion of pDrive-ptwD4::Cm with ScaI 
 
Correct insertion yields fragments of sizes 3.3 and 3.5 kb 
Incorrect insertion yields fragments of sizes 4.4 and 2.4 kb 
 
 
Sequencing results obtained from pDrive-ptwD4::Cm 
 
tgactcagcgaaggaacgagctaccgagcttttgcggggtagccagaaatgacgggaaaaaagccaaacgggctcttcc
aggatttttccaccggctcggaaatctggactcaccgtgtcgcgctggtgctcgtcgcgatccgaaatatcctgctgct
ctctttgtttctcggtctggcggccgggttcatctacgccgcattcttcgtcgaccgcgacatctggcgtccagcagtc
gcgaacgttatcgcgcatcttcggtcggtcgtcatgatgacggcggtaccgatggaatacgaagtcaacggccagaccg
tgcgacttcccgtcgatcaagttgtcgccctgacggacccagtgtgggatgtggcttatttctttttgcggcgattcct
gatcattgtcgcaaccgtcacggcatgtacatgcgtctcgatcgctgcctactggtatgagttcggtcgcagcacgatg
gccgacaaggatctgcgtggcgcaacgctcgtcaacgggaagcaactggcgaagatgattcggcaagacgatatggaga
gcccgtattcgatagcgggcgtgccgatgctgcgcaacgcggagaccctgcataccctggtggtcggcgcacagggtac
gggtaagtctcagcagttcttcgatcggctcaggcaagtccgcgcccgtgggaagcgcgcgatcgtatacgatccgtcg
ggcgaatttgcggaggaatttttccgggaaggcaaggacgtcatgatgaatccgttcgacgaccgttcgccaaactgga
acatcaagtatgagatcgaggaggagtaccactatgacagcatggcaaccgcgctgattcccgatccgcgcgaagccga
tccattttggtcattggcggggcgcgaggtgtttcgagatgtcgcgcgtacgttgcacagagagggcaatctgacgaac
cgcaatctttacaattcgatcgcaatgagcaacctcgacgcgatctaccagttgctgcgcaataccgccggcgcgtcgt
acgtcgatcccaagaccgagcgcacgggtatgtcgttgaagatgaccgtccagaaccagctttcctctttcaggtatct
ccgtgatgatggaaagccgttctcgatccgtcagtggatttacaacgagagtgattcgtggatgttcatctcgacccgt
gaggaaatgctcgaggcgatcaagccaatcatgtcgctctggatcgacatcgcgatcaaagcggtgctcaacctcacac
cgattcatcgcgagcgactgcacttctcgatcgacgaagtcccgaccctgcagaagctcgatgtaagaggttccaactt
tcaccataatgaaataagatcactaccgggcgtattttttgagttatcgagattttcaggagctaaggaagctaaaatg
gagaaaaaaatcactggatataccaccgttgatatatcccaatggcatcgtaaagaacattttgaggcatttcagtcag
ttgctcaatgtacctataaccagaccgttcagctggatattacggcctttttaaagaccgtaaagaaaaataagcacaa
gttttatccggcctttattcacattcttgcccgcctgatgaatgctcatccggaattccgtatggcaatgaaagacggt
gagctggtgatatgggatagtgttcacccttgttacaccgttttccatgagcaaactgaaacgttttcatcgctctgga
gtgaataccacgacgatttccggcagtttctacacatatattcgcaagatgtggcgtgttacggtgaaaacctggccta
tttccctaaagggtttattgagaatatgtttttcgtctcagccaatccctgggtgagtttcaccagttttgatttaaac
gtggccaatatggacaacttcttcgcccccgttttcaccatgggcaaatattatacgcaaggcgacaaggtgctgatgc
cgctggcgattcaggttcatcatgccgtttgtgatggcttccatgtcggcagaatgcttaatgaattacaacagtactg
cgatgagtggcagggcggggcgtaatttttttaaggcagttattggtgcccttaaacgcctggtgctacgcctgaataa
gtgataataagcggatgaatggcagaaattcgaaagcaaattcgacccggtcgtcggttcagggcagggtcgttaaata
gccgcttatgtctattgctggtttaccggtttattgactaccggaagcagtgtgaccgtgtgcttctcaaatgcctgag
gccagtttgctcaggctctccccgtggaggtaataattgacgatatatcatgaagctcgcggtgagcaatacgcggaag
tacggcttatgcatgatgctcggtgcgcaggatatgccgcagttcctcgacatctacggggaatacctcgcgcggacga
ttatcaacgggtgtcaaaccaagctgttgttgcgcgtaaccgacgcagaagccgctgagatgttctcgaaaatcatcgg
gcagacggaagtcgaggaaaaggacgagtcgctgtcgtttggtgtgaactctcagcgggacggattcagcatcgcgaag
cgtcggctgctgcgcgacctagcgttgccctcacagatattgcgactgcgggacatgacaggctatttggtctatcccg
gcgaatacccgatcgctcgcgtgaagtacgggtttgtcaaaccgcggaaaaacgcacctgcttttatcaagcgtcaggc
attctccgaactattcgcgccggcggccggctcgccggcaaccgctgccgcttcggaatccgtagtcgctggcccatca
cctgactggatcgcgcacccggagatactcgtcgcggcgagcggcggcgtcgatccggaaactggcgaaatcctgccac
cccgcccgggcgcctggcgctggggcgacggcaatcaacgaggagaccatgcatgaaggccctttgtcgtgttttgtcc
accgccctttttcttgcggtgcccgccgtgagcgcattcgcgcagtctgcgcccgggttgcttccaccggat 
 
Note:  Primers, start codon, and Cm gene are highlighted  
Note:  Vector sequence has been removed.
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Restriction enzyme and sequence analyses of pDrive-ptwE1::Cm 
 
 
Predicted and obtained results for digestion of pDrive-ptwE1::Cm with ScaI 
 
Correct insertion yields fragments of sizes 2.5 and 2.9 kb 
Incorrect insertion yields fragments of sizes 2.0 and 3.3 kb 
 
 
Sequencing results obtained from pDrive-ptwE1::Cm 
 
ctgttaggtgaaaatccggcgcgcgggaaagtcacacgtgtttgcggaatgcatgcattccgcaaatcttc
gactccccgcccgacaccgacgtcgagcggcacaccgaccgtctgcacacgcccaaaaatttcccgacgcc
gcattgaccacagatccaccgcgccccgcgctcacaccggtgttgccacacactgacgtgtggacaacacc
gcgcggcgaccggctccgtgatctttatcgatcacgggtaagaggttccaactttcaccataatgaaataa
gatcactaccgggcgtattttttgagttatcgagattttcaggagctaaggaagctaaaatggagaaaaaa
atcactggatataccaccgttgatatatcccaatggcatcgtaaagaacattttgaggcatttcagtcagt
tgctcaatgtacctataaccagaccgttcagctggatattacggcctttttaaagaccgtaaagaaaaata
agcacaagttttatccggcctttattcacattcttgcccgcctgatgaatgctcatccggaattccgtatg
gcaatgaaagacggtgagctggtgatatgggatagtgttcacccttgttacaccgttttccatgagcaaac
tgaaacgttttcatcgctctggagtgaataccacgacgatttccggcagtttctacacatatattcgcaag
atgtggcgtgttacggtgaaaacctggcctatttccctaaagggtttattgagaatatgtttttcgtctca
gccaatccctgggtgagtttcaccagttttgatttaaacgtggccaatatggacaacttcttcgcccccgt
tttcaccatgggcaaatattatacgcaaggcgacaaggtgctgatgccgctggcgattcaggttcatcatg
ccgtttgtgatggcttccatgtcggcagaatgcttaatgaattacaacagtactgcgatgagtggcagggc
ggggcgtaatttttttaaggcagttattggtgcccttaaacgcctggtgctacgcctgaataagtgataat
aagcggatgaatggcagaaattcgaaagcaaattcgacccggtcgtcggttcagggcagggtcgttaaata
gccgcttatgtctattgctggtttaccggtttattgactaccggaagcagtgtgaccgtgtgcttctcaaa
tgcctgaggccagtttgctcaggctctccccgtggaggtaataattgacgatatccgttggtccggcaccg
tggatatgtggacaatgctcaccggtccaccaccgcgtcaccttctgctactgtcctgcccacactaccgc
cgtccccgaacctgtatattccctgctgcctccacctcccttcttccttccgacgttgcactgaacagctc
cgctccgctccgaggtgaagatggcgaaaatccaccgctcacgatccaaaccacgccgtcgctttttcccc
gattacgccgattcccttgagcgggaaccgccgtaccttaccgggtgaaggct 
 
Note:  Primers, start codon, and Cm gene are highlighted  
Note:  Vector sequence has been removed.
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Restriction enzyme and sequence analyses of pJQ200SK-ptwD4::Cm 
 
 
Predicted and obtained results for digestion of pJQ200SK-ptwD4::Cm with SalI 
 
Correct insertion yields fragments of sizes 0.2 and 5.3 kb 
Incorrect insertion yields fragments of sizes 2.8 and 2.7 kb 
 
 
Sequencing results obtained from pJQ200SK-ptwD4::Cm 
 
tgactcagcgaaggaacgagctaccgagcttttgcggggtagccagaaatgacgggaaaaaagccaaacgggctcttcc
aggatttttccaccggctcggaaatctggactcaccgtgtcgcgctggtgctcgtcgcgatccgaaatatcctgctgct
ctctttgtttctcggtctggcggccgggttcatctacgccgcattcttcgtcgaccgcgacatctggcgtccagcagtc
gcgaacgttatcgcgcatcttcggtcggtcgtcatgatgacggcggtaccgatggaatacgaagtcaacggccagaccg
tgcgacttcccgtcgatcaagttgtcgccctgacggacccagtgtgggatgtggcttatttctttttgcggcgattcct
gatcattgtcgcaaccgtcacggcatgtacatgcgtctcgatcgctgcctactggtatgagttcggtcgcagcacgatg
gccgacaaggatctgcgtggcgcaacgctcgtcaacgggaagcaactggcgaagatgattcggcaagacgatatggaga
gcccgtattcgatagcgggcgtgccgatgctgcgcaacgcggagaccctgcataccctggtggtcggcgcacagggtac
gggtaagtctcagcagttcttcgatcggctcaggcaagtccgcgcccgtgggaagcgcgcgatcgtatacgatccgtcg
ggcgaatttgcggaggaatttttccgggaaggcaaggacgtcatgatgaatccgttcgacgaccgttcgccaaactgga
acatcaagtatgagatcgaggagcagtaccactatgacagcatggcaaccgcgctgattcccgatccgcgcgaagccga
tccattttggtcattggcggggcgcgaggtgtttcgagatgtcgcgcgtacgttgcacagagagggcaatctgacgaac
cgcaatctttacaattcgatcgcaatgagcaacctcgacgcgatctaccagttgctgcgcaataccgccggcgcgtcgt
acgtcgatcccaagaccgagcgcacgggtatgtcgttgaagatgaccgtccagaaccagctttcctctttcaggtatct
ccgtgatgatggaaagccgttctcgatccgtcagtggatttacaacgagagtgattcgtggatgttcatctcgacccgt
gaggaaatgctcgaggcgatcaagccaatcatgtcgctctggatcgacatcgcgatcaaagcggtgctcaacctcacac
cgattcatcgcgagcgactgcacttctcgatcgacgaagtcccgaccctgcagaagctcgatgtaagaggttccaactt
tcaccataatgaaataagatcactaccgggcgtattttttgagttatcgagattttcaggagctaaggaagctaaaatg
gagaaaaaaatcactggatataccaccgttgatatatcccaatggcatcgtaaagaacattttgaggcatttcagtcag
ttgctcaatgtacctataaccagaccgttcagctggatattacggcctttttaaagaccgtaaagaaaaataagcacaa
gttttatccggcctttattcacattcttgcccgcctgatgaatgctcatccggaattccgtatggcaatgaaagacggt
gagctggtgatatgggatagtgttcacccttgttacaccgttttccatgagcaaactgaaacgttttcatcgctctgga
gtgaataccacgacgatttccggcagtttctacacatatattcgcaagatgtggcgtgttacggtgaaaacctggccta
tttccctaaagggtttattgagaatatgtttttcgtctcagccaatccctgggtgagtttcaccagttttgatttaaac
gtggccaatatggacaacttcttcgcccccgttttcaccatgggcaaatattatacgcaaggcgacaaggtgctgatgc
cgctggcgattcaggttcatcatgccgtttgtgatggcttccatgtcggcagaatgcttaatgaattacaacagtactg
cgatgagtggcagggcggggcgtaatttttttaaggcagttattggtgcccttaaacgcctggtgctacgcctgaataa
gtgataataagcggatgaatggcagaaattcgaaagcaaattcgacccggtcgtcggttcagggcagggtcgttaaata
gccgcttatgtctattgctggtttaccggtttattgactaccggaagcagtgtgaccgtgtgcttctcaaatgcctgag
gccagtttgctcaggctctccccgtggaggtaataattgacgatatatcatgaagctcgcggtgagcaatacgcggaag
tacggcttatgcatgatgctcggtgcgcaggatatgccgcagttcctcgacatctacggggaatacctcgcgcggacga
ttatcaacgggtgtcaaaccaagctgttgttgcgcgtaaccgacgcagaagccgctgagatgttctcgaaaatcatcgg
gcagacggaagtcgaggaaaaggacgagtcgctgtcgtttggtgtgaactctcagcgggacggattcagcatcgcgaag
cgtcggctgctgcgcgaccatgcgttgccctcacagatattgcgactgcgggacatgacaggctatttggtctatcccg
gcgaatacccgatcgctcgcgtgaagtacgggtttgtcaaaccgcggaaaaacgcacctgcttttatcaagcgtcaggc
attctccgaactattcgcgccggcggccggctcgccggcaaccgctgccgcttcggaatccgtagtcgctggcccatca
cctgactggatcgcgcacccggagatactcgtcgcggcgagcggcggcgtcgatccggaaactggcgaaatcctgccac
cccgcccgggcgcctggcgctggggcgacggcaatcaacgaggagaccatgcatgaaggccctttgtcgtgttttgtcc
accgccctttttcttgcggtgcccgccgtgagcgcattcgcgcagtctgcgcccgggttgcttccaccggat 
 
Note:  Primers, start codon, and Cm gene are highlighted  
Note:  Vector sequence has been removed.
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Restriction enzyme and sequence analyses of pJQ200SK-ptwE1::Cm 
 
 
Predicted and obtained results for digestion of pJQ200SK-ptwE1::Cm with EcoRI 
 
Correct insertion yields fragments of sizes 0.6 and 3.5 kb 
Incorrect insertion yields fragments of sizes 1.0 and 3.1 kb 
 
 
Sequencing results obtained from pJQ200SK-ptwE1::Cm  
 
ctgttaggtgaaaatccggcgcgcgggaaagtcacacgtgtttgcggaatgcatgcattccgcaaatcttc
gactccccgcccgacaccgacgtcgagcggcacaccgaccgtctgcacacgcccaaaaatttcccgacgcc
gcattgaccacagatccaccgcgccccgcgctcacaccggtgttgccacacactgacgtgtggacaacacc
gcgcggcgaccggctccgtgatctttatcgatcacgggtaagaggttccaactttcaccataatgaaataa
gatcactaccgggcgtattttttgagttatcgagattttcaggagctaaggaagctaaaatggagaaaaaa
atcactggatataccaccgttgatatatcccaatggcatcgtaaagaacattttgaggcatttcagtcagt
tgctcaatgtacctataaccagaccgttcagctggatattacggcctttttaaagaccgtaaagaaaaata
agcacaagttttatccggcctttattcacattcttgcccgcctgatgaatgctcatccggaattccgtatg
gcaatgaaagacggtgagctggtgatatgggatagtgttcacccttgttacaccgttttccatgagcaaac
tgaaacgttttcatcgctctggagtgaataccacgacgatttccggcagtttctacacatatattcgcaag
atgtggcgtgttacggtgaaaacctggcctatttccctaaagggtttattgagaatatgtttttcgtctca
gccaatccctgggtgagtttcaccagttttgatttaaacgtggccaatatggacaacttcttcgcccccgt
tttcaccatgggcaaatattatacgcaaggcgacaaggtgctgatgccgctggcgattcaggttcatcatg
ccgtttgtgatggcttccatgtcggcagaatgcttaatgaattacaacagtactgcgatgagtggcagggc
ggggcgtaatttttttaaggcagttattggtgcccttaaacgcctggtgctacgcctgaataagtgataat
aagcggatgaatggcagaaattcgaaagcaaattcgacccggtcgtcggttcagggcagggtcgttaaata
gccgcttatgtctattgctggtttaccggtttattgactaccggaagcagtgtgaccgtgtgcttctcaaa
tgcctgaggccagtttgctcaggctctccccgtggaggtaataattgacgatatccgttggtccggcaccg
tggatatgtggacaatgctcaccggtccaccaccgcgtcaccttctgctactgtcctgcccacactaccgc
cgtccccgaacctgtatattccctgctgcctccacctcccttcttccttccgacgttgcactgaacagctc
cgctccgctccgaggtgaagatggcgaaaatccaccgctcacgatccaaaccacgccgtcgctttttcccc
gattacgccgattcccttgagcgggaaccgccgtaccttaccgggtgaaggct 
 
Note:  Primers, start codon, and Cm gene are highlighted  
Note:  Vector sequence has been removed.
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Predicted and obtained results of restriction enzyme digests and Southern blot 
analysis of HI3802 and HI3802 (ptwD4::Cm) based on sequence data obtained from 
the Sanger Centre J2315 sequencing project. 
 
Probe=ptwD4 PCR Product 
 HI3802 HI3802 (ptwD4::Cm) 
BamHI 10 kb 11 kb 
BamHI/EcoRI 4 kb 1.7 kb & 3.2 kb 
BamHI/ScaI 7.8 kb 1.3 kb & 9.7 kb 
BamHI/NotI 10 kb 8.8 kb 
 
 
Ladder 10, 8 ,6 ,5 ,4 ,3 ,2 ,1.5 ,1, and 0.5 kb 
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Probe=Cm PCR Product 
 HI3802 HI3802 (ptwD4::Cm) 
BamHI N/A 11 kb 
BamHI/EcoRI N/A 1.7 kb & 3.2 kb 
BamHI/ScaI N/A 1.3 kb & 9.7 kb 
BamHI/NotI N/A 8.8 kb 
 
 
Ladder 10, 8 ,6 ,5 ,4 ,3 ,2 ,1.5 ,1, and 0.5 kb  
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Predicted and obtained results of restriction enzyme digests and Southern blot 
analysis of HI3802 and HI3802 (ptwE1::Cm) based on sequence data obtained from 
the Sanger Centre J2315 sequencing project. 
 
Probe=ptwE1 PCR Product 
 HI3802 HI3802 (ptwE1::Cm) 
BamHI 10 kb 11 kb 
BamHI/EcoRI 4 kb 0.57 kb & 4.3 kb 
BamHI/ScaI 10 kb 3.9 kb & 7.0 kb 
BamHI/NotI 7.75 kb 8.76 kb 
 
 
Ladder 10, 8 ,6 ,5 ,4 ,3 ,2 ,1.5 ,1, and 0.5 kb  
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Probe=Cm PCR Product 
 HI3802 HI3802 (ptwE1::Cm) 
BamHI N/A 11 kb 
BamHI/EcoRI N/A 0.57 kb & 4.3 kb 
BamHI/ScaI N/A 3.9 kb & 7.0 kb 
BamHI/NotI N/A 8.76 kb 
 
 
Ladder 10, 8 ,6 ,5 ,4 ,3 ,2 ,1.5 ,1, and 0.5 kb  
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Fig. E-1. Cloning vector pBCRLAR. See Table 3.1 for description.
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Restriction enzyme and sequence analyses of pFUSE-ptwB4 
 
 
Predicted and obtained results for digestion of pFUSE-ptwB4 with SalI 
 
Correct insertion yields fragments of sizes 7.2 and 5.2 kb 
Incorrect insertion yields fragments of sizes 5.8 and 6.6 kb 
 
Sequencing results obtained from pFUSE-ptwB4 
 
tatgaacatcgagatccagacctactggaacgtcgaaacgctctactacgtgctcaacgccgtcgcatcgg
tgatgacgagcggcgggtggcccggcttgatcaagttcgtcttcctcgttgcgttgctcatcgcgatgttc
gcgtacatggggcgccacggcgacatggcgatgtggttcattcaggcgttcgcgtttgtcacgattctcaa
tatgccgatcgcgcgagtgatgctttccgatcgcacggacctccagccccctcggcaggtcgatcatgtgc
cggtggcgcttgccgcaatcgcgcaggcaagctcgctttcgttcgggttcctgacgcgcgcgtacgaaacc
gcgttcaatgttccggatgatctcggtctcgcgaagggtgacgtaggctttggtcaccgaattctgcggca
ggtgaattccgcagtggtacgcgatcctgcgctccgcgccgacctgatgcagttcttcaaggagtgtacga
agtacgacatcctggacggggcgatcgcgcccagccagatcgtcggtgcgacggacacgtggaacacgatc
ttcagcaataccagccctgcccgcttcgttacatacaacgtgctgacggctcaacccgtcacggatacgtg
ccagaacgtggcgctgcttctcaagccacgagtggacgctgccgtcgcggacgcacaagcattttatggcc
gcaaggcgtttccgcaggtgagctcggacgggatcgctcagcagatgttcctctcgaccgtctcgacgtcc
tactcgtggctcctcgacgcatcgcagtcagcctcggatgccatgaagcaggcgatgttcaacaacatctg
gcgggacgcgggtcccggcatcgcgcgcgcgcacgacgacccggcggcgatcgccgacacaaacgctctta
tcgcggaggcagaagcggcgcgccaggcgaacgggtcgaatagcgccctaagcctgctcggccaagaaacg
atcccgcacatgcgcaactggatcgaagcgatcacctacgccctgttccctgtcatggtcttgctgatgat
cgtggtaccgcaggagaaggcgaagtacgtcctcggcggctatttcatgatcctcgtgtggatcgggttgt
ggccgctgctgttcgcaatcatcaaccacctgtcactaatgtggctgcactacaagctgacggcgctgcac
ctgtcggccggcgtgccgttccagctctcctcggcgttcgattcgactctggtcgacgagcaggcgatgat
cggatacatggtggtgctcgtgccgttcatcgcgggcgcaatcgtcaagatgggcgacggcgcgatcttcg
gcctggccgatcgagctttgagtggcttcgccaccgccggttcgcgggccggcgccgcaattgcgtccggc
aactacagcatgggacaggccggccttgacaccgcatcggtcaacactacgacgatgcagaagttcgacgg
caacatgctgatgaattccggcatgaagacggtccagctttcggacggttccacgatgtcggtatccagca
acggccgcgctgcgtatcagaagttcgcgaaccaccttctgacgtcgatgcagctcgaagatgcccagaac
tctggtcacagtttcgaccggtttagcggtacaacatcgacgtcgggctggagcagttcgacgcgttcggg
aagttcggtcggcagcagcgagagtttcgggcacgcgtccgagcgcggtgcgactcagagcatcgggtcgg
aaactgcgacgacgatgtccggcggtaccagcggccgcgcaatgcacgacgagagcgtcggacaaaccaat
cagatcgggacacggtttggtacgggcatcggtgccaccgacagtattcaacttcacgccggcgggagtgg
tcaccttggaatcgatgcttcccagggcggcgccactccgcgcgcaccgggcgccggcgctagtgaccgcg
acgcgcgtcgggttgccaacgctatgaagcaagggggcgcgtcggcagagcaaatcgattccgcgatgcag
aacatgcgcggcaaccaagcggcggcggaaggcgcaccttctgtccggcgcggcggtggcgcttcgctgag
ccttggggcgcaagtaaccggtattcgaaactacacggccggccacgatcgcgactggtcgtcgcaatcgg
accatcgcactggtgattcggtatcgtcgggcagcgaagttagccaaacgggttcgtccagcacacgtaac
gcaactggtacccaatcgtcgcaatcggatcgccatgattcgtcggcaactcggtctagcttttcggaaag
cgcgttccagcgcgagcatggcgtgcacagcgaggctggctcgcgttccacttcgtcagacggcaattcga
tgcgcttcgcgatcgagcgaaatctggcggaagatcccgacttcatgatgaaggtcggccagcgcaaccac
gtttcggcgacgcgcatgtggcagatgtccgaggacaaggtaatcggcatggccgccgagtatctggactg
gaaagcgatggcgcagaacatgcgcggcccacaaggagccggagccaatgacgatgccgtcgcccccaagt
tggcccacgactttggatcgtcgtcgcgtggtcgagctggtgccggccacacctccgctggcgccggcgat
ttcggaggccgggtcaaggcaacgggcttctcctcgaccgatccggtcaagccgaacatgacgtcgccgac
cgaaatctcggcagcacagcacgcgcttgatcaaggtcgcggcatcggccaacgcgcgaaggattttgacg
cggacgtgcacaagcacgcgagcccggaccgggcgcttggcgaggggcgcgtgacccagaccgaggtgaat
gcggcgaacgaggatcgggatcttgccgataccgtccgccggtcatggaatgccccgcgccgggcgctcgg
gatgaaggaatacgacgactacgacacgaaggatgtcccgccggagatcaagaaatga 
 
Note: Primers and start codon are highlighted  
Note:  Vector sequence has been removed.
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Restriction enzyme and sequence analyses of pDrive-GST 
 
 
Predicted and obtained results for digestion of pDrive-GST with BamHI 
 
Correct insertion yields fragments of sizes 0.7 and 3.9 kb 
Incorrect insertion yields fragments of sizes 0.05 and 4.5 kb 
 
 
Sequencing results obtained from pDrive-GST 
 
atgtcccctatactaggttattggaaaattaagggccttgtgcaacccactcgacttcttttggaatatct
tgaagaaaaatatgaagagcatttgtatgagcgcgatgaaggtgataaatggcgaaacaaaaagtttgaat
tgggtttggagtttcccaatcttccttattatattgatggtgatgttaaattaacacagtctatggccatc
atacgttatatagctgacaagcacaacatgttgggtggttgtccaaaagagcgtgcagagatttcaatgct
tgaaggagcggttttggatattagatacggtgtttcgagaattgcatatagtaaagactttgaaactctca
aagttgattttcttagcaagctacctgaaatgctgaaaatgttcgaagatcgtttatgtcataaaacatat
ttaaatggtgatcatgtaacccatcctgacttcatgttgtatgacgctcttgatgttgttttatacatgga
cccaatgtgcctggatgcgttcccaaaattagtttgttttaaaaaacgtattgaagctatcccacaaattg
ataagtacttgaaatccagcaagtatatagcatggcctttgcagggctggcaagccacgtttggtggtggc
gaccatcctccaaaatcggatctggttccgcgtggatccccggaattcccgggtcgactcgagcggccgca
tcgtgactga 
 
Note:  Primers and start codon are highlighted.  
Note:  Vector sequence has been removed. 
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Restriction enzyme and sequence analyses of pDrive-ptwE1-GST 
 
 
Predicted and obtained results for digestion of pDrive-ptwE1-GST with BsaAI/XbaI 
 
Correct insertion yields fragments of sizes 1.1 and 3.9 kb 
Incorrect insertion yields fragments of sizes 0.8 and 4.2 kb 
 
 
Sequencing results obtained from pDrive-ptwE1-GST 
 
ctgttaggtgaaaatccggcgcgcgggaaagtcacacgtgtttgcggaatgcatgcattccgcaaatcttc
gactccccgcccgacaccgacgtcgagcggcacaccgaccgtctgcacacgcccaaaaatttcccgacgcc
gcattgaccacagatccaccgcgccccgcgctcacaccggtgttgccacacactgacgtgtggacaacacc
gcgcggcgaccggctccgtgatctttatcgatcacggccgttggtccggcaccgtggatatgtggacaatg
ctcaccggtccaccaccgcgtcaccttctgctactgtcctgcccacactaccgccgtccccgaacctgtat
attccctgctgcctccacctcccttcttccttccgacgttgcactgaacagctccgctccgctccgaggat
gtcccctatactaggttattggaaaattaagggccttgtgcaacccactcgacttcttttggaatatcttg
aagaaaaatatgaagagcatttgtatgagcgcgatgaaggtgataaatggcgaaacaaaaagtttgaattg
ggtttggagtttcccaatcttccttattatattgatggtgatgttaaattaacacagtctatggccatcat
acgttatatagctgacaagcacaacatgttgggtggttgtccaaaagagcgtgcagagatttcaatgcttg
aaggagcggttttggatattagatacggtgtttcgagaattgcatatagtaaagactttgaaactctcaaa
gttgattttcttagcaagctacctgaaatgctgaaaatgttcgaagatcgtttatgtcataaaacatattt
aaatggtgatcatgtaacccatcctgacttcatgttgtatgacgctcttgatgttgttttatacatggacc
caatgtgcctggatgcgttcccaaaattagtttgttttaaaaaacgtattgaagctatcccacaaattgat
aagtacttgaaatccagcaagtatatagcatggcctttgcagggctggcaagccacgtttggtggtggcga
ccatcctccaaaatcggatctggttccgcgtggatccccggaattcccgggtcgactcgagcggccgcatc
gtgactga 
 
Note:  Start codon is highlighted. 
Note:  Vector sequence has been removed. 
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Restriction enzyme and sequence analyses of pDrive-GST-ptwE1 
 
 
Predicted and obtained results for digestion of pDrive-GST-ptwE1 with BsaAI/XbaI 
 
Correct insertion yields fragments of sizes 0.4 and 4.6 kb 
Incorrect insertion yields fragments of sizes 0.04 and 5.0 kb 
 
 
Sequencing results obtained from pDrive-GST-ptwE1 
 
atgtcccctatactaggttattggaaaattaagggccttgtgcaacccactcgacttcttttggaatatct
tgaagaaaaatatgaagagcatttgtatgagcgcgatgaaggtgataaatggcgaaacaaaaagtttgaat
tgggtttggagtttcccaatcttccttattatattgatggtgatgttaaattaacacagtctatggccatc
atacgttatatagctgacaagcacaacatgttgggtggttgtccaaaagagcgtgcagagatttcaatgct
tgaaggagcggttttggatattagatacggtgtttcgagaattgcatatagtaaagactttgaaactctca
aagttgattttcttagcaagctacctgaaatgctgaaaatgttcgaagatcgtttatgtcataaaacatat
ttaaatggtgatcatgtaacccatcctgacttcatgttgtatgacgctcttgatgttgttttatacatgga
cccaatgtgcctggatgcgttcccaaaattagtttgttttaaaaaacgtattgaagctatcccacaaattg
ataagtacttgaaatccagcaagtatatagcatggcctttgcagggctggcaagccacgtttggtggtggc
gaccatcctccaaaatcggatctggttccgcgtggatccccggaattcccgggtcgactcgagcggccgca
tcgtgacatgcattccgcaaatcttcgactccccgcccgacaccgacgtcgagcggcacaccgaccgtctg
cacacgcccaaaaatttcccgacgccgcattgaccacagatccaccgcgccccgcgctcacaccggtgttg
ccacacactgacgtgtggacaacaccgcgcggcgaccggctccgtgatctttatcgatcacggccgttggt
ccggcaccgtggatatgtggacaatgctcaccggtccaccaccgcgtcaccttctgctactgtcctgccca
cactaccgccgtccccgaacctgtatattccctgctgcctccacctcccttcttccttccgacgttgcact
gaacagctccgctccgctccgaggtgaagatggcgaaaatccaccgctcacgatccaaaccacgccgtcgc
tttttccccgattacgccgattcccttgagcgggaaccgccgtaccttaccgggtgaaggct 
 
Note:  Start codon is highlighted. 
Note:  Vector sequence has been removed. 
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Restriction enzyme and sequence analyses of pDrive-ptwE1::Cm-GST 
 
 
Predicted and obtained results for digestion of pDrive-ptwE1::Cm-GST with BsaAI/XbaI 
 
Correct insertion yields fragments of sizes 2.1 and 3.9 kb 
Incorrect insertion yields fragments of sizes 0.8 and 5.2 kb 
 
 
Sequencing results obtained from pDrive-ptwE1::Cm-GST 
 
ctgttaggtgaaaatccggcgcgcgggaaagtcacacgtgtttgcggaatgcatgcattccgcaaatcttc
gactccccgcccgacaccgacgtcgagcggcacaccgaccgtctgcacacgcccaaaaatttcccgacgcc
gcattgaccacagatccaccgcgccccgcgctcacaccggtgttgccacacactgacgtgtggacaacacc
gcgcggcgaccggctccgtgatctttatcgatcacgggtaagaggttccaactttcaccataatgaaataa
gatcactaccgggcgtattttttgagttatcgagattttcaggagctaaggaagctaaaatggagaaaaaa
atcactggatataccaccgttgatatatcccaatggcatcgtaaagaacattttgaggcatttcagtcagt
tgctcaatgtacctataaccagaccgttcagctggatattacggcctttttaaagaccgtaaagaaaaata
agcacaagttttatccggcctttattcacattcttgcccgcctgatgaatgctcatccggaattccgtatg
gcaatgaaagacggtgagctggtgatatgggatagtgttcacccttgttacaccgttttccatgagcaaac
tgaaacgttttcatcgctctggagtgaataccacgacgatttccggcagtttctacacatatattcgcaag
atgtggcgtgttacggtgaaaacctggcctatttccctaaagggtttattgagaatatgtttttcgtctca
gccaatccctgggtgagtttcaccagttttgatttaaacgtggccaatatggacaacttcttcgcccccgt
tttcaccatgggcaaatattatacgcaaggcgacaaggtgctgatgccgctggcgattcaggttcatcatg
ccgtttgtgatggcttccatgtcggcagaatgcttaatgaattacaacagtactgcgatgagtggcagggc
ggggcgtaatttttttaaggcagttattggtgcccttaaacgcctggtgctacgcctgaataagtgataat
aagcggatgaatggcagaaattcgaaagcaaattcgacccggtcgtcggttcagggcagggtcgttaaata
gccgcttatgtctattgctggtttaccggtttattgactaccggaagcagtgtgaccgtgtgcttctcaaa
tgcctgaggccagtttgctcaggctctccccgtggaggtaataattgacgatatccgttggtccggcaccg
tggatatgtggacaatgctcaccggtccaccaccgcgtcaccttctgctactgtcctgcccacactaccgc
cgtccccgaacctgtatattccctgctgcctccacctcccttcttccttccgacgttgcactgaacagctc
cgctccgctccgaggatgtcccctatactaggttattggaaaattaagggccttgtgcaacccactcgact
tcttttggaatatcttgaagaaaaatatgaagagcatttgtatgagcgcgatgaaggtgataaatggcgaa
acaaaaagtttgaattgggtttggagtttcccaatcttccttattatattgatggtgatgttaaattaaca
cagtctatggccatcatacgttatatagctgacaagcacaacatgttgggtggttgtccaaaagagcgtgc
agagatttcaatgcttgaaggagcggttttggatattagatacggtgtttcgagaattgcatatagtaaag
actttgaaactctcaaagttgattttcttagcaagctacctgaaatgctgaaaatgttcgaagatcgttta
tgtcataaaacatatttaaatggtgatcatgtaacccatcctgacttcatgttgtatgacgctcttgatgt
tgttttatacatggacccaatgtgcctggatgcgttcccaaaattagtttgttttaaaaaacgtattgaag
ctatcccacaaattgataagtacttgaaatccagcaagtatatagcatggcctttgcagggctggcaagcc
acgtttggtggtggcgaccatcctccaaaatcggatctggttccgcgtggatccccggaattcccgggtcg
actcgagcggccgcatcgtgactga 
 
Note: Start codon and Cm gene are highlighted. 
Note:  Vector sequence has been removed. 
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Restriction enzyme and sequence analyses of pDrive-GST-ptwE1::Cm 
 
 
Predicted and obtained results for digestion of pDrive-GST-ptwE1::Cm with BsaAI/XbaI 
 
Correct insertion yields fragments of sizes 1.4 and 4.6 kb 
Incorrect insertion yields fragments of sizes 0.04 and 6.0 kb 
 
 
Sequencing results obtained from pDrive-GST-ptwE1::Cm 
 
atgtcccctatactaggttattggaaaattaagggccttgtgcaacccactcgacttcttttggaatatct
tgaagaaaaatatgaagagcatttgtatgagcgcgatgaaggtgataaatggcgaaacaaaaagtttgaat
tgggtttggagtttcccaatcttccttattatattgatggtgatgttaaattaacacagtctatggccatc
atacgttatatagctgacaagcacaacatgttgggtggttgtccaaaagagcgtgcagagatttcaatgct
tgaaggagcggttttggatattagatacggtgtttcgagaattgcatatagtaaagactttgaaactctca
aagttgattttcttagcaagctacctgaaatgctgaaaatgttcgaagatcgtttatgtcataaaacatat
ttaaatggtgatcatgtaacccatcctgacttcatgttgtatgacgctcttgatgttgttttatacatgga
cccaatgtgcctggatgcgttcccaaaattagtttgttttaaaaaacgtattgaagctatcccacaaattg
ataagtacttgaaatccagcaagtatatagcatggcctttgcagggctggcaagccacgtttggtggtggc
gaccatcctccaaaatcggatctggttccgcgtggatccccggaattcccgggtcgactcgagcggccgca
tcgtgacatgcattccgcaaatcttcgactccccgcccgacaccgacgtcgagcggcacaccgaccgtctg
cacacgcccaaaaatttcccgacgccgcattgaccacagatccaccgcgccccgcgctcacaccggtgttg
ccacacactgacgtgtggacaacaccgcgcggcgaccggctccgtgatctttatcgatcacgggtaagagg
ttccaactttcaccataatgaaataagatcactaccgggcgtattttttgagttatcgagattttcaggag
ctaaggaagctaaaatggagaaaaaaatcactggatataccaccgttgatatatcccaatggcatcgtaaa
gaacattttgaggcatttcagtcagttgctcaatgtacctataaccagaccgttcagctggatattacggc
ctttttaaagaccgtaaagaaaaataagcacaagttttatccggcctttattcacattcttgcccgcctga
tgaatgctcatccggaattccgtatggcaatgaaagacggtgagctggtgatatgggatagtgttcaccct
tgttacaccgttttccatgagcaaactgaaacgttttcatcgctctggagtgaataccacgacgatttccg
gcagtttctacacatatattcgcaagatgtggcgtgttacggtgaaaacctggcctatttccctaaagggt
ttattgagaatatgtttttcgtctcagccaatccctgggtgagtttcaccagttttgatttaaacgtggcc
aatatggacaacttcttcgcccccgttttcaccatgggcaaatattatacgcaaggcgacaaggtgctgat
gccgctggcgattcaggttcatcatgccgtttgtgatggcttccatgtcggcagaatgcttaatgaattac
aacagtactgcgatgagtggcagggcggggcgtaatttttttaaggcagttattggtgcccttaaacgcct
ggtgctacgcctgaataagtgataataagcggatgaatggcagaaattcgaaagcaaattcgacccggtcg
tcggttcagggcagggtcgttaaatagccgcttatgtctattgctggtttaccggtttattgactaccgga
agcagtgtgaccgtgtgcttctcaaatgcctgaggccagtttgctcaggctctccccgtggaggtaataat
tgacgatatccgttggtccggcaccgtggatatgtggacaatgctcaccggtccaccaccgcgtcaccttc
tgctactgtcctgcccacactaccgccgtccccgaacctgtatattccctgctgcctccacctcccttctt
ccttccgacgttgcactgaacagctccgctccgctccgaggtgaagatggcgaaaatccaccgctcacgat
ccaaaccacgccgtcgctttttccccgattacgccgattcccttgagcgggaaccgccgtaccttaccggg
tgaaggct 
 
Note:  Start codon and Cm gene are highlighted. 
Note:  Vector sequence has been removed. 
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Restriction enzyme and sequence analyses of pJQ200SK-ptwE1-GST 
 
 
Predicted and obtained results for digestion of pJQ200SK-ptwE1-GST with ClaI/XbaI 
 
Correct insertion yields fragments of sizes 0.2 and 3.9 kb 
Incorrect insertion yields fragments of sizes 0.9 and 3.2 kb 
 
 
Sequencing results obtained from pJQ200SK -ptwE1-GST 
 
ctgttaggtgaaaatccggcgcgcgggaaagtcacacgtgtttgcggaatgcatgcattccgcaaatcttc
gactccccgcccgacaccgacgtcgagcggcacaccgaccgtctgcacacgcccaaaaatttcccgacgcc
gcattgaccacagatccaccgcgccccgcgctcacaccggtgttgccacacactgacgtgtggacaacacc
gcgcggcgaccggctccgtgatctttatcgatcacggccgttggtccggcaccgtggatatgtggacaatg
ctcaccggtccaccaccgcgtcaccttctgctactgtcctgcccacactaccgccgtccccgaacctgtat
attccctgctgcctccacctcccttcttccttccgacgttgcactgaacagctccgctccgctccgaggat
gtcccctatactaggttattggaaaattaagggccttgtgcaacccactcgacttcttttggaatatcttg
aagaaaaatatgaagagcatttgtatgagcgcgatgaaggtgataaatggcgaaacaaaaagtttgaattg
ggtttggagtttcccaatcttccttattatattgatggtgatgttaaattaacacagtctatggccatcat
acgttatatagctgacaagcacaacatgttgggtggttgtccaaaagagcgtgcagagatttcaatgcttg
aaggagcggttttggatattagatacggtgtttcgagaattgcatatagtaaagactttgaaactctcaaa
gttgattttcttagcaagctacctgaaatgctgaaaatgttcgaagatcgtttatgtcataaaacatattt
aaatggtgatcatgtaacccatcctgacttcatgttgtatgacgctcttgatgttgttttatacatggacc
caatgtgcctggatgcgttcccaaaattagtttgttttaaaaaacgtattgaagctatcccacaaattgat
aagtacttgaaatccagcaagtatatagcatggcctttgcagggctggcaagccacgtttggtggtggcga
ccatcctccaaaatcggatctggttccgcgtggatccccggaattcccgggtcgactcgagcggccgcatc
gtgactga 
 
Note:  Start codon is highlighted. 
Note:  Vector sequence has been removed. 
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Restriction enzyme and sequence analyses of pJQ200SK-GST-ptwE1 
 
 
Predicted and obtained results for digestion of pJQ200SK-GST-ptwE1 with ClaAI/XbaI 
 
Correct insertion yields fragments of sizes 0.9 and 3.3 kb 
Incorrect insertion yields fragments of sizes 0.3 and 3.9 kb 
 
 
Sequencing results obtained from pJQ200SK-GST-ptwE1 
 
atgtcccctatactaggttattggaaaattaagggccttgtgcaacccactcgacttcttttggaatatct
tgaagaaaaatatgaagagcatttgtatgagcgcgatgaaggtgataaatggcgaaacaaaaagtttgaat
tgggtttggagtttcccaatcttccttattatattgatggtgatgttaaattaacacagtctatggccatc
atacgttatatagctgacaagcacaacatgttgggtggttgtccaaaagagcgtgcagagatttcaatgct
tgaaggagcggttttggatattagatacggtgtttcgagaattgcatatagtaaagactttgaaactctca
aagttgattttcttagcaagctacctgaaatgctgaaaatgttcgaagatcgtttatgtcataaaacatat
ttaaatggtgatcatgtaacccatcctgacttcatgttgtatgacgctcttgatgttgttttatacatgga
cccaatgtgcctggatgcgttcccaaaattagtttgttttaaaaaacgtattgaagctatcccacaaattg
ataagtacttgaaatccagcaagtatatagcatggcctttgcagggctggcaagccacgtttggtggtggc
gaccatcctccaaaatcggatctggttccgcgtggatccccggaattcccgggtcgactcgagcggccgca
tcgtgacatgcattccgcaaatcttcgactccccgcccgacaccgacgtcgagcggcacaccgaccgtctg
cacacgcccaaaaatttcccgacgccgcattgaccacagatccaccgcgccccgcgctcacaccggtgttg
ccacacactgacgtgtggacaacaccgcgcggcgaccggctccgtgatctttatcgatcacggccgttggt
ccggcaccgtggatatgtggacaatgctcaccggtccaccaccgcgtcaccttctgctactgtcctgccca
cactaccgccgtccccgaacctgtatattccctgctgcctccacctcccttcttccttccgacgttgcact
gaacagctccgctccgctccgaggtgaagatggcgaaaatccaccgctcacgatccaaaccacgccgtcgc
tttttccccgattacgccgattcccttgagcgggaaccgccgtaccttaccgggtgaaggct 
 
Note:  Start codon is highlighted. 
Note:  Vector sequence has been removed. 
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Restriction enzyme and sequence analyses of pJQ200SK-ptwE1::Cm-GST 
 
 
Predicted and obtained results for digestion of pJQ200SK-ptwE1::Cm-GST with 
ClaAI/XbaI 
 
Correct insertion yields fragments of sizes 0.2 and 4.9 kb 
Incorrect insertion yields fragments of sizes 1.9 and 3.2 kb 
 
 
Sequencing results obtained from pJQ200SK-ptwE1::Cm-GST 
 
ctgttaggtgaaaatccggcgcgcgggaaagtcacacgtgtttgcggaatgcatgcattccgcaaatcttc
gactccccgcccgacaccgacgtcgagcggcacaccgaccgtctgcacacgcccaaaaatttcccgacgcc
gcattgaccacagatccaccgcgccccgcgctcacaccggtgttgccacacactgacgtgtggacaacacc
gcgcggcgaccggctccgtgatctttatcgatcacgggtaagaggttccaactttcaccataatgaaataa
gatcactaccgggcgtattttttgagttatcgagattttcaggagctaaggaagctaaaatggagaaaaaa
atcactggatataccaccgttgatatatcccaatggcatcgtaaagaacattttgaggcatttcagtcagt
tgctcaatgtacctataaccagaccgttcagctggatattacggcctttttaaagaccgtaaagaaaaata
agcacaagttttatccggcctttattcacattcttgcccgcctgatgaatgctcatccggaattccgtatg
gcaatgaaagacggtgagctggtgatatgggatagtgttcacccttgttacaccgttttccatgagcaaac
tgaaacgttttcatcgctctggagtgaataccacgacgatttccggcagtttctacacatatattcgcaag
atgtggcgtgttacggtgaaaacctggcctatttccctaaagggtttattgagaatatgtttttcgtctca
gccaatccctgggtgagtttcaccagttttgatttaaacgtggccaatatggacaacttcttcgcccccgt
tttcaccatgggcaaatattatacgcaaggcgacaaggtgctgatgccgctggcgattcaggttcatcatg
ccgtttgtgatggcttccatgtcggcagaatgcttaatgaattacaacagtactgcgatgagtggcagggc
ggggcgtaatttttttaaggcagttattggtgcccttaaacgcctggtgctacgcctgaataagtgataat
aagcggatgaatggcagaaattcgaaagcaaattcgacccggtcgtcggttcagggcagggtcgttaaata
gccgcttatgtctattgctggtttaccggtttattgactaccggaagcagtgtgaccgtgtgcttctcaaa
tgcctgaggccagtttgctcaggctctccccgtggaggtaataattgacgatatccgttggtccggcaccg
tggatatgtggacaatgctcaccggtccaccaccgcgtcaccttctgctactgtcctgcccacactaccgc
cgtccccgaacctgtatattccctgctgcctccacctcccttcttccttccgacgttgcactgaacagctc
cgctccgctccgaggatgtcccctatactaggttattggaaaattaagggccttgtgcaacccactcgact
tcttttggaatatcttgaagaaaaatatgaagagcatttgtatgagcgcgatgaaggtgataaatggcgaa
acaaaaagtttgaattgggtttggagtttcccaatcttccttattatattgatggtgatgttaaattaaca
cagtctatggccatcatacgttatatagctgacaagcacaacatgttgggtggttgtccaaaagagcgtgc
agagatttcaatgcttgaaggagcggttttggatattagatacggtgtttcgagaattgcatatagtaaag
actttgaaactctcaaagttgattttcttagcaagctacctgaaatgctgaaaatgttcgaagatcgttta
tgtcataaaacatatttaaatggtgatcatgtaacccatcctgacttcatgttgtatgacgctcttgatgt
tgttttatacatggacccaatgtgcctggatgcgttcccaaaattagtttgttttaaaaaacgtattgaag
ctatcccacaaattgataagtacttgaaatccagcaagtatatagcatggcctttgcagggctggcaagcc
acgtttggtggtggcgaccatcctccaaaatcggatctggttccgcgtggatccccggaattcccgggtcg
actcgagcggccgcatcgtgactga 
 
Note: Start codon and Cm gene are highlighted. 
Note:  Vector sequence has been removed. 
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Restriction enzyme and sequence analyses of pJQ200SK-GST-ptwE1::Cm 
 
 
Predicted and obtained results for digestion of pJQ200SK-GST-ptwE1::Cm with 
ClaAI/XbaI 
 
Correct insertion yields fragments of sizes 0.9 and 4.3 kb 
Incorrect insertion yields fragments of sizes 1.3 and 3.9 kb 
 
 
Sequencing results obtained from pJQ200SK-GST-ptwE1::Cm 
 
atgtcccctatactaggttattggaaaattaagggccttgtgcaacccactcgacttcttttggaatatct
tgaagaaaaatatgaagagcatttgtatgagcgcgatgaaggtgataaatggcgaaacaaaaagtttgaat
tgggtttggagtttcccaatcttccttattatattgatggtgatgttaaattaacacagtctatggccatc
atacgttatatagctgacaagcacaacatgttgggtggttgtccaaaagagcgtgcagagatttcaatgct
tgaaggagcggttttggatattagatacggtgtttcgagaattgcatatagtaaagactttgaaactctca
aagttgattttcttagcaagctacctgaaatgctgaaaatgttcgaagatcgtttatgtcataaaacatat
ttaaatggtgatcatgtaacccatcctgacttcatgttgtatgacgctcttgatgttgttttatacatgga
cccaatgtgcctggatgcgttcccaaaattagtttgttttaaaaaacgtattgaagctatcccacaaattg
ataagtacttgaaatccagcaagtatatagcatggcctttgcagggctggcaagccacgtttggtggtggc
gaccatcctccaaaatcggatctggttccgcgtggatccccggaattcccgggtcgactcgagcggccgca
tcgtgacatgcattccgcaaatcttcgactccccgcccgacaccgacgtcgagcggcacaccgaccgtctg
cacacgcccaaaaatttcccgacgccgcattgaccacagatccaccgcgccccgcgctcacaccggtgttg
ccacacactgacgtgtggacaacaccgcgcggcgaccggctccgtgatctttatcgatcacgggtaagagg
ttccaactttcaccataatgaaataagatcactaccgggcgtattttttgagttatcgagattttcaggag
ctaaggaagctaaaatggagaaaaaaatcactggatataccaccgttgatatatcccaatggcatcgtaaa
gaacattttgaggcatttcagtcagttgctcaatgtacctataaccagaccgttcagctggatattacggc
ctttttaaagaccgtaaagaaaaataagcacaagttttatccggcctttattcacattcttgcccgcctga
tgaatgctcatccggaattccgtatggcaatgaaagacggtgagctggtgatatgggatagtgttcaccct
tgttacaccgttttccatgagcaaactgaaacgttttcatcgctctggagtgaataccacgacgatttccg
gcagtttctacacatatattcgcaagatgtggcgtgttacggtgaaaacctggcctatttccctaaagggt
ttattgagaatatgtttttcgtctcagccaatccctgggtgagtttcaccagttttgatttaaacgtggcc
aatatggacaacttcttcgcccccgttttcaccatgggcaaatattatacgcaaggcgacaaggtgctgat
gccgctggcgattcaggttcatcatgccgtttgtgatggcttccatgtcggcagaatgcttaatgaattac
aacagtactgcgatgagtggcagggcggggcgtaatttttttaaggcagttattggtgcccttaaacgcct
ggtgctacgcctgaataagtgataataagcggatgaatggcagaaattcgaaagcaaattcgacccggtcg
tcggttcagggcagggtcgttaaatagccgcttatgtctattgctggtttaccggtttattgactaccgga
agcagtgtgaccgtgtgcttctcaaatgcctgaggccagtttgctcaggctctccccgtggaggtaataat
tgacgatatccgttggtccggcaccgtggatatgtggacaatgctcaccggtccaccaccgcgtcaccttc
tgctactgtcctgcccacactaccgccgtccccgaacctgtatattccctgctgcctccacctcccttctt
ccttccgacgttgcactgaacagctccgctccgctccgaggtgaagatggcgaaaatccaccgctcacgat
ccaaaccacgccgtcgctttttccccgattacgccgattcccttgagcgggaaccgccgtaccttaccggg
tgaaggct 
 
Note:  Start codon and Cm gene are highlighted. 
Note:  Vector sequence has been removed. 
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Restriction enzyme and sequence analyses of pDrive-bcvirB2 
 
 
Predicted and obtained results for digestion of pDrive-bcvirB2 with BamHI/EcoRV 
 
Correct insertion yields fragments of sizes 0.3 and 3.9 kb 
Incorrect insertion yields fragments of sizes 0.1 and 4.1 kb 
 
 
Sequencing results obtained from pDrive-bcvirB2 
 
gatggagtgcattatgaaatctgtattcctaattagcataagcgacgtgagactgagaaaaacgtgtgttg
cgtggatctcgtcgaattggcgccgcattgcagtgctcggcgtgctcgtcatggcaacccctccggcatct
gcacaactcagtcaggtcaataccttgctgatcactattcagaacacgttgctcggtgtgggcggggtggt
gtgttcgatttccatcatctgggccggcttcaaaatgatgtttcagcacgcccggtttggcgatatcgcgc
atgttttcgtcggtggccttttcgttggctgcgcaacggtcattgctggcatgttgattccgacggcctaa 
 
Note:  Primers and start codon are highlighted. 
Note:  Vector sequence has been removed.
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Restriction enzyme and sequence analyses of pDrive-bcvirD4 
 
 
Predicted and obtained results for digestion of pDrive-bcvirD4 with BamHI 
 
Correct insertion yields fragments of sizes 1.7 and 4.1 kb 
Incorrect insertion yields fragments of sizes 0.2 and 5.6 kb 
 
 
Sequencing results obtained from pDrive-bcvirD4 
 
catggtacgacggccgttttccgaatatggggagacgtgtggccggtgcgggcctcatggggttgcttgtc
gccttcggcggccctgcgcttgccgtgtatacgtggctggaacaagcaggccgcagacccttgtatggcga
cgcgcgctttgcgaacgatgcggagattcgtcgggcggggctgttatgagacagattgcacccgcgaagtc
tcaaccgacgcttgtggtgggccgttggcgtggccgctatctgcgctttgccggtcagcaattcgtgctac
ttgccgcgcccgctcgttcaggaaagggcgtggggattgtgatcccgaatctgctgagctattccgactcc
gtggtcgtgcttgatatcaaacaggaaaattttcgtctcacggcaggctttcggcgcgcgcacggacaagc
cgtgtacctgttcaatccgtttgcagaagatggctgcacgcaccgctacaacccgttgtcggtcattgcag
acgacatgtttcgcgtcggcgacattctggcgatcggttatgtgttgtatccggccggcgggcatgacgaa
ttctggaaagaccaggcacgcaaccttctgttgggactggtcctgctgctgtgcgatttgcgtgaggcgcg
tcgtgctggcgcgagcggggtgcccgactacccgatcacaatgggcgaggtattgcggcaatcgtcgggaa
atggtcagccggtcaaaacctacttgaaccggatgcttatacagcatcgacagtacttgagccgcgcctgt
attgatgcactgaatcgattcctcgcgaatgacgacaaggtcctggcgagcattctggccacttttaatgc
gccactgacgatctgggccaacccgattgttgacgcggcgacgagcgcgaacgactttgatctgcgagacg
tcagacgccgcaagatgtccgtatatcttggcgtgacgcccgatcacttaagtgaggcggcgatactgatg
aatctgatgttctcgcagctcgtgaatctgaacacgaaggagttggcagaggacaatccggcattgaagta
tcaatgcctgctgctgctcgacgagatgacggcaatcggaaaaatccagattatcgcgcgtgcggtggcct
atatggcgggctacaacctgcgcctactctcgatcgtgcagtccgactcgcagctcgagtctgtgtatggc
cgagctgacgcgaggaccattgtcacgaatcatgcgatgcagattcttttcgccccgcgcgaacagaagga
cgccaatgcctactccgagatgctcggcacgcgcacggagcgatcgcgcaccacgagccgatcgaatggca
tgttcggtgcgcgcggcggtgcgagcgagagcttttccgatcaacgtcgtgcgctgatgttgccgcaggag
atcaaggagctcgcgcgcgacaaggaaatcattcttctcgaaaataccaagccgattttggcagaccggat
ctgctattggcgcgatcgtgcatttacttcacgggtaatggacgcgccagcggtgcctgcactcgatctcg
tgagatttggtgcacaaatcgagcagcggctgcgcgaactgagcgatgacgacgtcgatgaacagacgggc
gagctgacgcatgtgcgagcggactatctggaacttgtacacgcctgggatccgcgcgagctgccgcaggc
gctggacaatgtcagttgcgaggaggcagccgcgtatgtggatcggcatttcacgctgctgggcgtgccgg
ccgaggacgtagcgcgcgccggacgtcggttggcgcgcggcgaagatggcatgactgatactgagacgggc
gcgcgcaagcgcgacccgagccccgtcgcccgggcaagtggtggtgttcaatga 
 
Note:  Primers and start codon are highlighted. 
Note:  Vector sequence has been removed 
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Restriction enzyme and sequence analyses of pDrive-bcvirP3 
 
 
Predicted and obtained results for digestion of pDrive-bcvirP3 with SacI 
 
Correct insertion yields fragments of sizes 0.1 and 4.3 kb 
Incorrect insertion yields fragments of sizes 0.4 and 4.0 kb 
 
 
Sequencing results obtained from pDrive-bcvirP3 
 
catgggatcgcgaaaccgagcgcgcattgcggtcgaactgggtgcgctaaagcctttgtggcaggcacgat
gtgcgcagaacggggtgagcgccggtgagggcatcaggcggctcgtggccgaagcactggacattgcccat
gacccgccggacacggccgcaatactttcgacgccgagcgagccgtttgtacggatcggcgtgggtctgat
gccggccgagttggaatgtatcaaagggctggcacatgtgcaggggttcaccgccaatcgatggattgctg
cgttaattcgcgcccatctgaccggagaaccgcaactgggaaatcgggagatgatgctgcttgcggaatcg
aatcggcagcttgctgcgattcgtacgcggctgggtgagctcgcgcgcaacacgggcgagggccaccacgt
gcccgagtgggagcacgcgcgcgccatgatccttacacatctgcgttttgtcgcacagttgctgcaaacca
acctggaccgatggagccgttga 
 
Note:  Primers and start codon are highlighted. 
Note:  Vector sequence has been removed. 
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Restriction enzyme and sequence analyses of pDrive-bcvirB2::Cm 
 
 
Predicted and obtained results for digestion of pDrive-bcvirB2::Cm with BamHI/EcoRV 
 
Correct insertion yields fragments of sizes 1.3 and 3.9 kb 
Incorrect insertion yields fragments of sizes 0.1 and 5.1 kb 
 
 
Sequencing results obtained from pDrive-bcvirB2::Cm 
 
gatggagtgcattatgaaatctgtattcctaattagcataagcgacgtgagactgagaaaaacgtgtgttg
cgtggatctcgtcgaattggcgccgcattgcagtgctcggcgtgctcgtcatggcaacccctccggcatct
gcacaactcagtcaggtcaataccttgctgatcactattcagaacacgttgctcggtgtgggcggggtggt
gtgttcgatttccatcatctgggccggcttcaaaatgatgtttcagcacgcccggtttggcgatgtaagag
gttccaactttcaccataatgaaataagatcactaccgggcgtattttttgagttatcgagattttcagga
gctaaggaagctaaaatggagaaaaaaatcactggatataccaccgttgatatatcccaatggcatcgtaa
agaacattttgaggcatttcagtcagttgctcaatgtacctataaccagaccgttcagctggatattacgg
cctttttaaagaccgtaaagaaaaataagcacaagttttatccggcctttattcacattcttgcccgcctg
atgaatgctcatccggaattccgtatggcaatgaaagacggtgagctggtgatatgggatagtgttcaccc
ttgttacaccgttttccatgagcaaactgaaacgttttcatcgctctggagtgaataccacgacgatttcc
ggcagtttctacacatatattcgcaagatgtggcgtgttacggtgaaaacctggcctatttccctaaaggg
tttattgagaatatgtttttcgtctcagccaatccctgggtgagtttcaccagttttgatttaaacgtggc
caatatggacaacttcttcgcccccgttttcaccatgggcaaatattatacgcaaggcgacaaggtgctga
tgccgctggcgattcaggttcatcatgccgtttgtgatggcttccatgtcggcagaatgcttaatgaatta
caacagtactgcgatgagtggcagggcggggcgtaatttttttaaggcagttattggtgcccttaaacgcc
tggtgctacgcctgaataagtgataataagcggatgaatggcagaaattcgaaagcaaattcgacccggtc
gtcggttcagggcagggtcgttaaatagccgcttatgtctattgctggtttaccggtttattgactaccgg
aagcagtgtgaccgtgtgcttctcaaatgcctgaggccagtttgctcaggctctccccgtggaggtaataa
ttgacgatatatcgcgcatgttttcgtcggtggccttttcgttggctgcgcaacggtcattgctggcatgt
tgattccgacggcctaa 
 
Note:  Primers, start codon, and Cm gene are highlighted. 
Note:  Vector sequence has been removed.
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Restriction enzyme and sequence analyses of pDrive-bcvirD4::Cm 
 
 
Predicted and obtained results for digestion of pDrive-bcvirD4::Cm with BamHI 
 
Correct insertion yields fragments of sizes 2.7 and 4.1 kb 
Incorrect insertion yields fragments of sizes 0.2 and 6.6 kb 
 
 
Sequencing results obtained from pDrive-bcvirD4::Cm 
 
catggtacgacggccgttttccgaatatggggagacgtgtggccggtgcgggcctcatggggttgcttgtcgccttcgg
cggccctgcgcttgccgtgtatacgtggctggaacaagcaggccgcagacccttgtatggcgacgcgcgctttgcgaac
gatgcggagattcgtcgggcggggctgttatgagacagattgcacccgcgaagtctcaaccgacgcttgtggtgggccg
ttggcgtggccgctatctgcgctttgccggtcagcaattcgtgctacttgccgcgcccgctcgttcaggaaagggcgtg
gggattgtgatcccgaatctgctgagctattccgactccgtggtcgtgcttgatatcaaacaggaaaattttcgtctca
cggcaggctttcggcgcgcgcacggacaagccgtgtacctgttcaatccgtttgcagaagatggctgcacgcaccgcta
caacccgttgtcggtcattgcagacgacatgtttcgcgtcggcgacattctggcgatcggttatgtgttgtatccggcc
ggcgggcatgacgaattctggaaagaccaggcacgcaaccttctgttgggactggtcctgctgctgtgcgatttgcgtg
aggcgcgtcgtgctggcgcgagcggggtgcccgactacccgatcacaatgggcgaggtattgcggcaatcgtcgggaaa
tggtcagccggtcaaaacctacttgaaccggatgcttatacagcatcgacagtgtaagaggttccaactttcaccataa
tgaaataagatcactaccgggcgtattttttgagttatcgagattttcaggagctaaggaagctaaaatggagaaaaaa
atcactggatataccaccgttgatatatcccaatggcatcgtaaagaacattttgaggcatttcagtcagttgctcaat
gtacctataaccagaccgttcagctggatattacggcctttttaaagaccgtaaagaaaaataagcacaagttttatcc
ggcctttattcacattcttgcccgcctgatgaatgctcatccggaattccgtatggcaatgaaagacggtgagctggtg
atatgggatagtgttcacccttgttacaccgttttccatgagcaaactgaaacgttttcatcgctctggagtgaatacc
acgacgatttccggcagtttctacacatatattcgcaagatgtggcgtgttacggtgaaaacctggcctatttccctaa
agggtttattgagaatatgtttttcgtctcagccaatccctgggtgagtttcaccagttttgatttaaacgtggccaat
atggacaacttcttcgcccccgttttcaccatgggcaaatattatacgcaaggcgacaaggtgctgatgccgctggcga
ttcaggttcatcatgccgtttgtgatggcttccatgtcggcagaatgcttaatgaattacaacagtactgcgatgagtg
gcagggcggggcgtaatttttttaaggcagttattggtgcccttaaacgcctggtgctacgcctgaataagtgataata
agcggatgaatggcagaaattcgaaagcaaattcgacccggtcgtcggttcagggcagggtcgttaaatagccgcttat
gtctattgctggtttaccggtttattgactaccggaagcagtgtgaccgtgtgcttctcaaatgcctgaggccagtttg
ctcaggctctccccgtggaggtaataattgacgatatacttgagccgcgcctgtattgatgcactgaatcgattcctcg
cgaatgacgacaaggtcctggcgagcattctggccacttttaatgcgccactgacgatctgggccaacccgattgttga
cgcggcgacgagcgcgaacgactttgatctgcgagacgtcagacgccgcaagatgtccgtatatcttggcgtgacgccc
gatcacttaagtgaggcggcgatactgatgaatctgatgttctcgcagctcgtgaatctgaacacgaaggagttggcag
aggacaatccggcattgaagtatcaatgcctgctgctgctcgacgagatgacggcaatcggaaaaatccagattatcgc
gcgtgcggtggcctatatggcgggctacaacctgcgcctactctcgatcgtgcagtccgactcgcagctcgagtctgtg
tatggccgagctgacgcgaggaccattgtcacgaatcatgcgatgcagattcttttcgccccgcgcgaacagaaggacg
ccaatgcctactccgagatgctcggcacgcgcacggagcgatcgcgcaccacgagccgatcgaatggcatgttcggtgc
gcgcggcggtgcgagcgagagcttttccgatcaacgtcgtgcgctgatgttgccgcaggagatcaaggagctcgcgcgc
gacaaggaaatcattcttctcgaaaataccaagccgattttggcagaccggatctgctattggcgcgatcgtgcattta
cttcacgggtaatggacgcgccagcggtgcctgcactcgatctcgtgagatttggtgcacaaatcgagcagcggctgcg
cgaactgagcgatgacgacgtcgatgaacagacgggcgagctgacgcatgtgcgagcggactatctggaacttgtacac
gcctgggatccgcgcgagctgccgcaggcgctggacaatgtcagttgcgaggaggcagccgcgtatgtggatcggcatt
tcacgctgctgggcgtgccggccgaggacgtagcgcgcgccggacgtcggttggcgcgcggcgaagatggcatgactga
tactgagacgggcgcgcgcaagcgcgacccgagccccgtcgcccgggcaagtggtggtgttcaatga 
 
Note:  Primers, start codon, and Cm gene are highlighted. 
Note:  Vector sequence has been removed.
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Restriction enzyme and sequence analyses of pDrive-bcvirP3::Cm 
 
 
Predicted and obtained results for digestion of pDrive-bcvirP3::Cm with SacI 
 
Correct insertion yields fragments of sizes 0.1 and 5.3 kb 
Incorrect insertion yields fragments of sizes 1.4 and 4.0 kb 
 
 
Sequencing results obtained from pDrive-bcvirP3::Cm 
 
catgggatcgcgaaaccgagcgcgcattgcggtcgaactgggtgcgctaaagcctttgtggcaggcacgat
gtgcgcagaacggggtgagcgccggtgagggcatcaggcggctcgtggccgaagcactggacattgcccat
gacccgccggacacggccgcaatactttcgacgccgagcgagccgtttgtacggatcggcgtgggtctgat
gccggccgagttggaatgtatcaaagggctggcacatgtgcaggggttcaccgccaatcgatggattgctg
cgttaattcgcgcccatctgaccggagaaccgcaactgggaaatcgggagatgatgctgcttgcggaatcg
aatcggcagcttgctgcgattcgtacgcggctgggtgagctcgcgcgcaacacgggcgagggccaccacgt
aagaggttccaactttcaccataatgaaataagatcactaccgggcgtattttttgagttatcgagatttt
caggagctaaggaagctaaaatggagaaaaaaatcactggatataccaccgttgatatatcccaatggcat
cgtaaagaacattttgaggcatttcagtcagttgctcaatgtacctataaccagaccgttcagctggatat
tacggcctttttaaagaccgtaaagaaaaataagcacaagttttatccggcctttattcacattcttgccc
gcctgatgaatgctcatccggaattccgtatggcaatgaaagacggtgagctggtgatatgggatagtgtt
cacccttgttacaccgttttccatgagcaaactgaaacgttttcatcgctctggagtgaataccacgacga
tttccggcagtttctacacatatattcgcaagatgtggcgtgttacggtgaaaacctggcctatttcccta
aagggtttattgagaatatgtttttcgtctcagccaatccctgggtgagtttcaccagttttgatttaaac
gtggccaatatggacaacttcttcgcccccgttttcaccatgggcaaatattatacgcaaggcgacaaggt
gctgatgccgctggcgattcaggttcatcatgccgtttgtgatggcttccatgtcggcagaatgcttaatg
aattacaacagtactgcgatgagtggcagggcggggcgtaatttttttaaggcagttattggtgcccttaa
acgcctggtgctacgcctgaataagtgataataagcggatgaatggcagaaattcgaaagcaaattcgacc
cggtcgtcggttcagggcagggtcgttaaatagccgcttatgtctattgctggtttaccggtttattgact
accggaagcagtgtgaccgtgtgcttctcaaatgcctgaggccagtttgctcaggctctccccgtggaggt
aataattgacgatatgtgcccgagtgggagcacgcgcgcgccatgatccttacacatctgcgttttgtcgc
acagttgctgcaaaccaacctggaccgatggagccgttga 
 
Note:  Primers, start codon, and Cm gene are highlighted. 
Note:  Vector sequence has been removed.
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Restriction enzyme and sequence analyses of pJQ200SK-bcvirB2::Cm 
 
 
Predicted and obtained results for digestion of with pJQ200SK-bcvirB2::Cm with SmaI 
 
Correct insertion yields fragments of sizes 0 and 5.9 kb 
Incorrect insertion yields fragments of sizes 2.9 and 3.0 kb 
 
 
Sequencing results obtained from pJQ200SK-bcvirB2::Cm  
 
gatggagtgcattatgaaatctgtattcctaattagcataagcgacgtgagactgagaaaaacgtgtgttg
cgtggatctcgtcgaattggcgccgcattgcagtgctcggcgtgctcgtcatggcaacccctccggcatct
gcacaactcagtcaggtcaataccttgctgatcactattcagaacacgttgctcggtgtgggcggggtggt
gtgttcgatttccatcatctgggccggcttcaaaatgatgtttcagcacgcccggtttggcgatgtaagag
gttccaactttcaccataatgaaataagatcactaccgggcgtattttttgagttatcgagattttcagga
gctaaggaagctaaaatggagaaaaaaatcactggatataccaccgttgatatatcccaatggcatcgtaa
agaacattttgaggcatttcagtcagttgctcaatgtacctataaccagaccgttcagctggatattacgg
cctttttaaagaccgtaaagaaaaataagcacaagttttatccggcctttattcacattcttgcccgcctg
atgaatgctcatccggaattccgtatggcaatgaaagacggtgagctggtgatatgggatagtgttcaccc
ttgttacaccgttttccatgagcaaactgaaacgttttcatcgctctggagtgaataccacgacgatttcc
ggcagtttctacacatatattcgcaagatgtggcgtgttacggtgaaaacctggcctatttccctaaaggg
tttattgagaatatgtttttcgtctcagccaatccctgggtgagtttcaccagttttgatttaaacgtggc
caatatggacaacttcttcgcccccgttttcaccatgggcaaatattatacgcaaggcgacaaggtgctga
tgccgctggcgattcaggttcatcatgccgtttgtgatggcttccatgtcggcagaatgcttaatgaatta
caacagtactgcgatgagtggcagggcggggcgtaatttttttaaggcagttattggtgcccttaaacgcc
tggtgctacgcctgaataagtgataataagcggatgaatggcagaaattcgaaagcaaattcgacccggtc
gtcggttcagggcagggtcgttaaatagccgcttatgtctattgctggtttaccggtttattgactaccgg
aagcagtgtgaccgtgtgcttctcaaatgcctgaggccagtttgctcaggctctccccgtggaggtaataa
ttgacgatatatcgcgcatgttttcgtcggtggccttttcgttggctgcgcaacggtcattgctggcatgt
tgattccgacggcctaa 
 
Note:  Primers, start codon, and Cm gene are highlighted. 
Note:  Vector sequence has been removed.
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Restriction enzyme and sequence analyses of pJQ200SK-bcvirD4::Cm 
 
 
Predicted and obtained results for digestion of with pJQ200SK-bcvirD4::Cm with 
BamHI 
 
Correct insertion yields fragments of sizes 2.7 and 3.2 kb 
Incorrect insertion yields fragments of sizes 0.2 and 5.7 kb 
 
 
Sequencing results obtained from pJQ200SK-bcvirD4::Cm  
 
catggtacgacggccgttttccgaatatggggagacgtgtggccggtgcgggcctcatggggttgcttgtcgccttcgg
cggccctgcgcttgccgtgtatacgtggctggaacaagcaggccgcagacccttgtatggcgacgcgcgctttgcgaac
gatgcggagattcgtcgggcggggctgttatgagacagattgcacccgcgaagtctcaaccgacgcttgtggtgggccg
ttggcgtggccgctatctgcgctttgccggtcagcaattcgtgctacttgccgcgcccgctcgttcaggaaagggcgtg
gggattgtgatcccgaatctgctgagctattccgactccgtggtcgtgcttgatatcaaacaggaaaattttcgtctca
cggcaggctttcggcgcgcgcacggacaagccgtgtacctgttcaatccgtttgcagttgatggctgcacgcaccgcta
caacccgttgtcggtcattgcagacgacatgtttcgcgtcggcgacattctggcgatcggttatgtgttgtatccggcc
ggcgggcatgacgaattctggaaagaccaggcacgcaaccttctgttgggactggtcctcgtgctgtgcgatttgcgtg
aggcgcgtcgtgctggcgcgagcggggtgcccgactacccgatcacaatgggcgaggtattgcggcaatcgtcgggaaa
tggtcagccggtcaaaacctacttgaaccggatgcttatacagcatcgacagtgtaagaggttccaactttcaccataa
tgaaataagatcactaccgggcgtattttttgagttatcgagattttcaggagctaaggaagctaaaatggagaaaaaa
atcactggatataccaccgttgatatatcccaatggcatcgtaaagaacattttgaggcatttcagtcagttgctcaat
gtacctataaccagaccgttcagctggatattacggcctttttaaagaccgtaaagaaaaataagcacaagttttatcc
ggcctttattcacattcttgcccgcctgatgaatgctcatccggaattccgtatggcaatgaaagacggtgagctggtg
atatgggatagtgttcacccttgttacaccgttttccatgagcaaactgaaacgttttcatcgctctggagtgaatacc
acgacgatttccggcagtttctacacatatattcgcaagatgtggcgtgttacggtgaaaacctggcctatttccctaa
agggtttattgagaatatgtttttcgtctcagccaatccctgggtgagtttcaccagttttgatttaaacgtggccaat
atggacaacttcttcgcccccgttttcaccatgggcaaatattatacgcaaggcgacaaggtgctgatgccgctggcga
ttcaggttcatcatgccgtttgtgatggcttccatgtcggcagaatgcttaatgaattacaacagtactgcgatgagtg
gcagggcggggcgtaatttttttaaggcagttattggtgcccttaaacgcctggtgctacgcctgaataagtgataata
agcggatgaatggcagaaattcgaaagcaaattcgacccggtcgtcggttcagggcagggtcgttaaatagccgcttat
gtctattgctggtttaccggtttattgactaccggaagcagtgtgaccgtgtgcttctcaaatgcctgaggccagtttg
ctcaggctctccccgtggaggtaataattgacgatatacttgagccgcgcctgtattgatgcactgaatcgattcctcg
cgaatgacgacaaggtcctggcgagcattctggccacttttaatgcgccactgacgatctgggccaacccgattgttga
cgcggcgacgagcgcgaacgactttgatctgcgagacgtcagacgccgcaagatgtccgtatatcttggcgtgacgccc
gatcacttaagtgaggcggcgatactgatgaatctgatgttctcgcagctcgtgaatctgaacacgaaggagttggcag
aggacaatccggcattgaagtatcaatgcctgctgctgctcgacgagatgacggcaatcggaaaaatccagattatcgc
gcgtgcggtggcctatatggcgggctacaacctgcgcctactctcgatcgtgcagtccgactcgcagctcgagtctgtg
tatggccgagctgacgcgaggaccattgtcacgaatcatgcgatgcagattcttttcgccccgcccgaacagaaggacg
ccaatgcctactccgagatgctcggcacgcgcacggagcgatcgcgcaccacgagccgatcgaatggcatgttcggtgc
gcgcggcggtgcgagcgagagcttttccgatcaacgtcgtgcgctgatgttgccgcaggagatcaaggagctcgcgcgc
gacaaggaaatcattcttctcgaaaataccaagccgattttggcagaccggatctgctattggcgcgatcgtgcattta
cttcacgggtaatggacgcgccagcggtgcctgcactcgatctcgtgagatttggtgcacaaatcgagcagcggctgcg
cgaactgagcgatgacgacgtcgatgaacagacgggcgagctgacgcatgtgcgagcggactatctggaacttgtacac
gcctgggatccgcgcgagctgccgcaggcgctggacaatgtcagttgcgaggaggcagccgcgtatgtggatcggcatt
tcacgctgctgggcgtgccggccgaggacgtagcgcgcgccggacgtcggttggcgcgcggcgaagatggcatgactga
tactgagacgggcgcgcgcaagcgcgacccgagccccgtcgcccgggcaagtggtggtgttcaatga 
 
Note:  Primers, start codon, and Cm gene are highlighted. 
Note:  Vector sequence has been removed.
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Restriction enzyme and sequence analyses of pJQ200SK-bcvirP3::Cm 
 
 
Predicted and obtained results for digestion of pJQ200SK-bcvirD4::Cm with SacI
Correct insertion yields fragments of sizes 0.1 and 4.4 kb 
Incorrect insertion yields fragments of sizes 1.4 and 3.1 kb 
 
 
Sequencing results obtained from pJQ200SK-bcvirD4::Cm 
 
catgggatcgcgaaaccgagcgcgcattgcggtcgaactgggtgcgctaaagcctttgtggcaggcacgat
gtgcgcagaacggggtgagcgccggtgagggcatcaggcggctcgtggccgaagcactggacattgcccat
gacccgccggacacggccgcaatactttcgacgccgagcgagccgtttgtacggatcggcgtgggtctgat
gccggccgagttggaatgtatcaaagggctggcacatgtgcaggggttcaccgccaatcgatggattgctg
cgttaattcgcgcccatctgaccggagaaccgcaactgggaaatcgggagatgatgctgcttgcggaatcg
aatcggcagcttgctgcgattcgtacgcggctgggtgagctcgcgcgcaacacgggcgagggccaccacgt
aagaggttccaactttcaccataatgaaataagatcactaccgggcgtattttttgagttatcgagatttt
caggagctaaggaagctaaaatggagaaaaaaatcactggatataccaccgttgatatatcccaatggcat
cgtaaagaacattttgaggcatttcagtcagttgctcaatgtacctataaccagaccgttcagctggatat
tacggcctttttaaagaccgtaaagaaaaataagcacaagttttatccggcctttattcacattcttgccc
gcctgatgaatgctcatccggaattccgtatggcaatgaaagacggtgagctggtgatatgggatagtgtt
cacccttgttacaccgttttccatgagcaaactgaaacgttttcatcgctctggagtgaataccacgacga
tttccggcagtttctacacatatattcgcaagatgtggcgtgttacggtgaaaacctggcctatttcccta
aagggtttattgagaatatgtttttcgtctcagccaatccctgggtgagtttcaccagttttgatttaaac
gtggccaatatggacaacttcttcgcccccgttttcaccatgggcaaatattatacgcaaggcgacaaggt
gctgatgccgctggcgattcaggttcatcatgccgtttgtgatggcttccatgtcggcagaatgcttaatg
aattacaacagtactgcgatgagtggcagggcggggcgtaatttttttaaggcagttattggtgcccttaa
acgcctggtgctacgcctgaataagtgataataagcggatgaatggcagaaattcgaaagcaaattcgacc
cggtcgtcggttcagggcagggtcgttaaatagccgcttatgtctattgctggtttaccggtttattgact
accggaagcagtgtgaccgtgtgcttctcaaatgcctgaggccagtttgctcaggctctccccgtggaggt
aataattgacgatatgtgcccgagtgggagcacgcgcgcgccatgatccttacacatctgcgttttgtcgc
acagttgctgcaaaccaacctggaccgatggagccgttga 
 
Note:  Primers, start codon, and Cm gene are highlighted. 
Note:  Vector sequence has been removed.
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Predicted and obtained results of restriction enzyme digests follow by Southern blot 
analysis of AU1054, AU1054 (bcvirB2::Cm), AU1054 (bcvirD4::Cm), and AU1054 
(bcvirP3::Cm) based on sequence data obtained from the JGI AU1054 sequencing 
project. 
 
Probe=bcvirB2 PCR Product 
 AU1054 AU1054 
(bcvirB2::Cm) 
AU1054 
(bcvirD4::Cm) 
AU1054 
(bcvirP3::Cm) 
ApaI 16.4 kb 17.5 kb 17.5 kb 16.4 kb 
ApaI/ScaI 13.7 kb 10 & 4.6 kb 14.4 kb 13.7 kb 
 
 
Ladder 10, 8 ,6 ,5 ,4 ,3 ,2 ,1.5 ,1, and 0.5 kb  
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Probe=bcvirD4 PCR Product 
 AU1054 AU1054 
(bcvirB2::Cm) 
AU1054 
(bcvirD4::Cm) 
AU1054 
(bcvirP3::Cm) 
ApaI 16.4 kb 17.5 kb  17.5 kb 16.4 kb 
ApaI/ScaI 13.7 & 2.8 kb 10 kb 14.4 & 3.1 kb 13.7 & 2.8 kb 
 
 
Ladder 10, 8 ,6 ,5 ,4 ,3 ,2 ,1.5 ,1, and 0.5 kb  
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Probe=bcvirP3 PCR Product 
 AU1054 AU1054 
(bcvirB2::Cm) 
AU1054 
(bcvirD4::Cm) 
AU1054 
(bcvirP3::Cm) 
ApaI 8.2 kb 8.2 kb 8.2 kb 9.2 kb 
ApaI/ScaI 8.2 kb 8.2 kb 8.2 kb 7.7 & 1.5 kb 
 
 
Ladder 10, 8 ,6 ,5 ,4 ,3 ,2 ,1.5 ,1, and 0.5 kb  
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Probe=Cm PCR Product 
 AU1054 AU1054 
(bcvirB2::Cm) 
AU1054 
(bcvirD4::Cm) 
AU1054 
(bcvirP3::Cm) 
ApaI N/A 17.5 kb 17.5 kb 9.2 kb 
ApaI/ScaI N/A 10 & 4.6 kb 14.4 & 3.1 kb 7.7 & 1.5 kb 
 
 
Ladder 10, 8 ,6 ,5 ,4 ,3 ,2 ,1.5 ,1, and 0.5 kb  
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